data_2k0c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k0c _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.53 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 35.0 p-90 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.38 0.61 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -120.07 140.68 50.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.167 -0.958 . . . . 0.0 109.816 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 12' ' ' VAL . 19.2 t -87.43 115.92 25.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.519 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -94.51 -5.22 46.55 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.256 -0.903 . . . . 0.0 110.929 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -68.77 -31.21 70.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.95 -1.094 . . . . 0.0 109.634 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.409 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.9 p -135.74 21.03 3.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.811 . . . . 0.0 111.234 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mp 58.83 46.55 13.84 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.292 -0.88 . . . . 0.0 111.838 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.409 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 48.0 t -127.89 134.66 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.153 -0.967 . . . . 0.0 110.117 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -96.65 145.69 25.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.005 -1.059 . . . . 0.0 110.507 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.53 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 m-20 -125.73 142.1 51.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.202 -0.936 . . . . 0.0 109.876 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -90.95 170.69 9.39 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.766 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.38 -34.32 80.4 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.898 1.473 . . . . 0.0 110.418 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.21 -36.67 82.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.111 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' A' ' 19' ' ' VAL . . . -51.52 -179.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.462 -0.774 . . . . 0.0 110.667 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 74.2 t -155.31 -47.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -137.32 119.54 15.63 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.51 ' O ' ' N ' ' A' ' 25' ' ' GLU . 14.6 t -45.04 140.49 2.69 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.097 0.951 . . . . 0.0 111.595 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.09 -44.45 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.629 -1.294 . . . . 0.0 111.62 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.24 93.2 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.294 -0.879 . . . . 0.0 112.516 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.5 p -140.57 11.9 2.3 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.894 -1.129 . . . . 0.0 112.088 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.3 mt-10 40.8 78.01 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.63 -0.669 . . . . 0.0 111.247 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 21' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.922 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 121.385 0.612 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 47.5 p-10 -132.84 148.43 52.3 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.402 -0.811 . . . . 0.0 110.117 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 t -83.0 106.13 14.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.045 -1.035 . . . . 0.0 109.911 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -71.59 -18.13 62.24 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.423 -0.798 . . . . 0.0 110.185 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.0 m -60.87 -44.35 97.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.867 . . . . 0.0 111.082 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.405 ' O ' HG22 ' A' ' 12' ' ' VAL . 14.0 p -128.96 33.77 4.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.04 -1.037 . . . . 0.0 110.897 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.0 tp 42.49 65.66 0.88 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.56 -0.712 . . . . 0.0 112.409 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.423 ' CG1' ' SG ' ' A' ' 21' ' ' CYS . 39.4 t -133.81 135.53 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.945 -1.097 . . . . 0.0 109.906 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -100.78 141.01 34.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.245 -0.909 . . . . 0.0 110.702 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.467 ' ND2' ' HA ' ' A' ' 21' ' ' CYS . 3.6 m-20 -145.91 121.12 10.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 109.557 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -70.2 178.01 1.2 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.412 -0.805 . . . . 0.0 110.298 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.11 -29.83 84.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.0 1.526 . . . . 0.0 109.764 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.64 -37.8 88.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.459 -0.776 . . . . 0.0 109.764 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.42 ' O ' ' CG1' ' A' ' 19' ' ' VAL . . . -54.92 -172.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.405 -0.809 . . . . 0.0 110.426 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -168.91 -37.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.467 -0.771 . . . . 0.0 109.113 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -131.9 111.04 11.23 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.675 0.75 . . . . 0.0 109.402 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 25' ' ' GLU . 8.9 t -45.99 141.27 3.26 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.902 0.858 . . . . 0.0 110.924 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.68 -43.86 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.611 -1.306 . . . . 0.0 111.639 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.07 89.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.319 -0.863 . . . . 0.0 112.437 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.9 p -142.77 13.07 1.89 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.003 -1.061 . . . . 0.0 112.1 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 21' ' ' CYS . 96.7 mt-10 43.78 73.08 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.418 -0.801 . . . . 0.0 110.105 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.944 -0.472 . . . . 0.0 110.558 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.477 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 19.7 p-90 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.359 0.599 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -130.41 134.29 47.01 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.083 -1.01 . . . . 0.0 109.908 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.7 t -83.66 114.79 21.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.361 -0.837 . . . . 0.0 108.769 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -92.06 -7.3 49.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.002 -1.061 . . . . 0.0 110.631 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.4 p -68.5 -33.88 74.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 109.406 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.6 p -128.3 20.46 6.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.363 -0.836 . . . . 0.0 111.108 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt 53.15 48.99 20.97 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.291 -0.881 . . . . 0.0 112.393 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.2 t -128.07 131.79 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.852 -1.155 . . . . 0.0 110.527 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -89.18 142.49 27.6 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.593 -0.692 . . . . 0.0 109.992 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.443 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 8.4 m-20 -129.92 126.21 37.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.961 -1.087 . . . . 0.0 110.114 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 15.5 mmtp -73.14 171.43 10.46 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.55 -0.719 . . . . 0.0 110.592 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 34.7 Cg_exo -55.44 -32.02 80.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.915 1.481 . . . . 0.0 110.028 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -66.47 -31.05 71.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.401 -0.812 . . . . 0.0 109.703 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.443 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -61.52 151.01 34.11 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.347 0.594 . . . . 0.0 110.536 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.2 t -137.5 -42.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.516 -0.74 . . . . 0.0 109.195 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -130.46 107.72 9.43 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.466 -0.894 . . . . 0.0 108.701 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.5 t -45.54 130.25 8.75 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.471 0.653 . . . . 0.0 110.837 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.7 t -62.71 -46.73 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.206 -0.934 . . . . 0.0 112.079 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.22 -38.59 91.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.781 -1.199 . . . . 0.0 109.673 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -155.43 83.22 1.05 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.057 0.932 . . . . 0.0 109.043 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.5 mt-10 -33.68 92.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.056 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 24' ' ' CYS . 13.4 p . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.129 -0.982 . . . . 0.0 110.147 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.541 ' CZ2' ' CB ' ' A' ' 14' ' ' ASN . 29.0 p-90 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.553 0.692 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -130.91 127.64 38.9 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.438 -0.788 . . . . 0.0 109.926 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.405 ' SG ' ' CG2' ' A' ' 26' ' ' THR . 30.6 t -76.97 120.46 22.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.628 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -92.8 -8.58 43.22 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.465 -0.772 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 m -64.17 -44.55 91.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 110.521 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.428 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.3 p -124.14 18.81 9.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 110.915 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 97.3 mt 56.53 52.59 9.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.36 -0.837 . . . . 0.0 111.572 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.428 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 37.9 t -127.15 132.76 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.304 -0.873 . . . . 0.0 109.6 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -93.62 136.48 33.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 110.637 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' CZ2' ' A' ' 5' ' ' TRP . 1.6 m120 -126.18 130.38 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.111 -0.993 . . . . 0.0 109.576 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -69.15 166.89 24.4 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 0.0 109.864 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -52.71 -36.59 73.24 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 124.041 1.548 . . . . 0.0 109.754 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.34 -35.87 76.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.917 . . . . 0.0 109.849 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.88 146.02 48.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 110.193 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -157.38 23.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.393 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -158.0 75.27 0.75 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.486 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.6 t -45.27 129.47 8.04 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.031 0.92 . . . . 0.0 111.078 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.19 -43.73 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.106 . . . . 0.0 111.576 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.19 -40.69 96.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.368 -0.833 . . . . 0.0 112.211 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 p -149.95 24.39 0.85 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.833 -1.167 . . . . 0.0 111.344 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 21' ' ' CYS . 75.2 tt0 36.9 96.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.392 0.615 . . . . 0.0 112.447 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.405 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 22.3 p . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.422 -0.799 . . . . 0.0 109.831 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 26.8 p-90 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.261 0.553 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -130.69 134.58 47.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.049 -1.032 . . . . 0.0 110.456 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 t -87.59 118.27 26.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.83 . . . . 0.0 109.699 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -89.89 -11.96 40.35 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.16 -0.962 . . . . 0.0 111.09 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.2 p -66.97 -31.42 71.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.912 -1.117 . . . . 0.0 110.29 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.414 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.8 p -133.92 24.8 3.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.988 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 37.6 tp 46.83 57.33 5.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.277 -0.89 . . . . 0.0 111.531 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.414 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 41.8 t -131.28 133.78 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.987 -1.071 . . . . 0.0 109.866 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -101.19 130.77 47.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.292 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.482 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 85.6 m-20 -132.17 125.73 31.91 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.056 -1.027 . . . . 0.0 109.936 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 2.6 mttt -78.34 176.53 3.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.813 . . . . 0.0 110.477 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 32.2 Cg_exo -56.36 -29.73 78.22 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.016 1.534 . . . . 0.0 110.01 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -64.89 -36.0 82.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.362 -0.836 . . . . 0.0 109.831 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.428 ' O ' ' CG2' ' A' ' 19' ' ' VAL . . . -52.35 -179.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.334 -0.854 . . . . 0.0 110.095 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 76.6 t -154.73 -43.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.959 . . . . 0.0 109.099 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.77 110.79 8.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.567 0.698 . . . . 0.0 109.305 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.47 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 12.2 t -46.2 132.21 9.96 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.503 0.668 . . . . 0.0 111.075 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.55 -46.72 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.524 -0.735 . . . . 0.0 111.731 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.7 96.02 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.964 -1.085 . . . . 0.0 109.694 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.439 ' O ' ' C ' ' A' ' 25' ' ' GLU . 32.1 p -153.63 81.91 1.17 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.794 0.807 . . . . 0.0 109.201 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.47 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.1 mt-10 -30.37 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.545 0.688 . . . . 0.0 112.12 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 24' ' ' CYS . 78.0 p . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.482 -0.762 . . . . 0.0 110.035 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.442 0.639 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.46 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 47.0 p-10 -134.82 151.89 51.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.31 -0.869 . . . . 0.0 110.256 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' VAL . 13.4 t -84.31 107.06 16.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.343 -0.848 . . . . 0.0 110.365 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -72.05 -18.71 61.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.27 -0.894 . . . . 0.0 110.279 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.8 m -60.97 -45.1 96.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.912 . . . . 0.0 110.661 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.9 p -121.85 29.74 6.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.126 -0.984 . . . . 0.0 110.783 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 35.1 tp 44.45 55.46 5.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.522 -0.736 . . . . 0.0 111.594 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 7' ' ' CYS . 34.7 t -129.26 133.88 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.999 -1.063 . . . . 0.0 109.808 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.46 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . 88.6 mt-30 -100.33 132.35 45.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.98 . . . . 0.0 110.606 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.453 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 4.0 m-20 -118.01 124.24 47.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.46 -0.775 . . . . 0.0 109.433 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -68.0 170.67 6.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.981 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -54.92 -32.58 78.73 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.987 1.52 . . . . 0.0 110.013 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.49 -34.34 78.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 109.818 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -51.96 -179.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.408 -0.807 . . . . 0.0 110.507 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 69.8 t -155.17 -45.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 99.6 mttt -139.62 118.76 12.68 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 25' ' ' GLU . 12.5 t -45.57 130.18 8.82 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.581 0.705 . . . . 0.0 111.384 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.77 -46.46 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.411 -0.806 . . . . 0.0 111.641 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.4 97.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.911 -1.118 . . . . 0.0 109.33 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.436 ' O ' ' C ' ' A' ' 25' ' ' GLU . 31.0 p -155.45 84.99 1.05 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.834 0.826 . . . . 0.0 109.25 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 24' ' ' CYS . 95.7 mt-10 -30.99 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.591 0.71 . . . . 0.0 112.683 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.519 0 O-C-N 121.58 -0.7 . . . . 0.0 109.926 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.496 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 45.7 p-90 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.395 0.617 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 45.0 p-10 -136.82 148.79 47.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.352 -0.843 . . . . 0.0 110.124 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.6 t -83.89 135.54 34.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.867 . . . . 0.0 109.833 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -101.61 -16.9 16.58 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.097 -1.002 . . . . 0.0 110.854 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.5 p -65.29 -31.23 72.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.003 -1.06 . . . . 0.0 110.277 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.2 p -131.02 21.74 4.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 110.854 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 41.2 tp 49.4 59.59 4.37 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.217 -0.927 . . . . 0.0 111.424 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 28.0 t -132.72 135.03 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.126 -0.984 . . . . 0.0 110.262 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -99.44 137.23 38.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.164 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.496 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 61.7 m-20 -131.13 134.47 46.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.162 -0.961 . . . . 0.0 109.703 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -76.94 169.71 19.9 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 110.421 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -54.27 -33.29 75.05 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.168 1.615 . . . . 0.0 110.586 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.4 mp0 -65.64 -36.33 83.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.146 -0.971 . . . . 0.0 110.203 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.447 ' O ' ' CG2' ' A' ' 19' ' ' VAL . . . -52.38 175.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.442 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 76.0 t -156.94 -41.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.332 -0.855 . . . . 0.0 109.167 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HG3' HG11 ' A' ' 19' ' ' VAL . 96.9 mttt -127.33 107.41 9.96 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.141 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.461 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.4 t -46.64 132.42 10.95 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.52 0.676 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.05 -45.73 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.835 . . . . 0.0 111.659 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.26 99.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.851 -1.156 . . . . 0.0 109.556 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -155.02 83.66 1.08 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.793 0.806 . . . . 0.0 108.87 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.461 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.5 mt-10 -31.45 91.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.519 0.676 . . . . 0.0 112.333 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 24' ' ' CYS . 6.6 m . . . . . 0 N--CA 1.487 1.42 0 O-C-N 121.422 -0.799 . . . . 0.0 109.372 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.502 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 48.4 p-90 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.251 0.548 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -129.74 130.04 44.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.265 -0.897 . . . . 0.0 110.416 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.9 t -75.55 100.27 4.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.422 -0.799 . . . . 0.0 109.83 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -69.51 -16.53 63.46 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.475 -0.765 . . . . 0.0 110.563 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.1 m -60.95 -44.43 97.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.034 -1.041 . . . . 0.0 110.392 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.9 p -124.24 21.16 8.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.014 -1.053 . . . . 0.0 111.282 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.5 mt 53.84 52.31 13.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.172 -0.955 . . . . 0.0 111.959 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 48.8 t -129.0 132.14 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.089 -1.007 . . . . 0.0 109.685 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -96.45 137.02 36.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.0 110.565 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 79.6 m-20 -132.46 124.43 28.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.368 -0.832 . . . . 0.0 109.874 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.401 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 37.8 mtpt -73.39 168.39 25.72 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.929 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 52.2 Cg_exo -51.94 -33.15 50.71 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.797 1.419 . . . . 0.0 110.581 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -60.89 -35.13 75.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.925 . . . . 0.0 108.879 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.444 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -52.96 177.45 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.623 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 78.3 t -155.8 -43.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -0.82 . . . . 0.0 108.804 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 97.4 mttt -136.49 112.36 9.55 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.802 0.811 . . . . 0.0 109.228 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.446 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.1 t -45.37 131.73 8.08 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.755 0.788 . . . . 0.0 111.473 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.1 t -64.01 -46.66 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.052 -1.03 . . . . 0.0 111.106 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.84 88.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.576 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 26' ' ' THR . 32.1 p -148.48 81.12 1.46 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.823 0.821 . . . . 0.0 109.081 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 21' ' ' CYS . 95.8 mt-10 -30.54 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.615 0.721 . . . . 0.0 112.209 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 24' ' ' CYS . 6.7 p . . . . . 0 N--CA 1.487 1.407 0 O-C-N 121.737 -0.602 . . . . 0.0 109.921 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.46 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 51.0 p-90 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.361 0.6 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -135.22 150.33 50.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.046 -1.034 . . . . 0.0 110.311 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.7 t -90.15 123.72 34.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.0 110.098 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -96.76 -4.19 41.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.169 -0.957 . . . . 0.0 111.143 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.6 p -74.19 -23.17 59.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.91 -1.119 . . . . 0.0 109.847 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.5 p -141.31 21.35 2.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.371 -0.83 . . . . 0.0 111.014 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt 54.23 48.96 19.68 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.325 -0.859 . . . . 0.0 111.686 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 41.0 t -125.35 132.21 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -0.967 . . . . 0.0 109.811 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -97.44 139.37 33.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.186 -0.946 . . . . 0.0 110.356 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 95.2 m-20 -134.65 106.02 6.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.294 -0.879 . . . . 0.0 110.014 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 3.1 mttm -56.55 172.93 0.32 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.857 . . . . 0.0 110.372 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 31.7 Cg_exo -56.89 -29.29 81.24 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.959 1.505 . . . . 0.0 110.231 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -65.14 -34.66 78.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 109.972 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -52.54 -177.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.78 . . . . 0.0 110.364 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.417 ' CG1' ' HG3' ' A' ' 20' ' ' LYS . 20.6 t -155.13 -44.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 108.882 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HG3' ' CG1' ' A' ' 19' ' ' VAL . 99.2 mttt -142.56 115.62 8.84 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.804 0.811 . . . . 0.0 109.571 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.426 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 12.2 t -45.73 132.41 8.7 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.877 0.846 . . . . 0.0 111.793 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.92 -47.06 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.451 -0.781 . . . . 0.0 111.301 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.94 83.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.066 -1.021 . . . . 0.0 109.573 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 26' ' ' THR . 32.0 p -146.91 80.72 1.54 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.807 0.813 . . . . 0.0 109.426 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.426 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 96.6 mt-10 -29.24 89.7 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.487 0.661 . . . . 0.0 112.666 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 24' ' ' CYS . 2.1 p . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.756 -0.59 . . . . 0.0 109.912 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.478 0.656 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -125.73 142.64 51.41 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.012 -1.055 . . . . 0.0 110.291 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.2 t -87.78 117.21 26.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.945 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 42.3 p-10 -92.77 -8.21 44.35 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.055 -1.028 . . . . 0.0 110.619 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.2 m -63.16 -43.55 97.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 109.037 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.422 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -123.11 21.06 9.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.579 -0.7 . . . . 0.0 110.319 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 tp 53.08 59.36 4.5 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.482 -0.761 . . . . 0.0 111.548 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 38.6 t -131.95 134.56 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -0.91 . . . . 0.0 109.722 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.99 136.01 38.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.164 -0.96 . . . . 0.0 110.589 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.457 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 99.4 m-20 -137.09 123.79 21.12 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.84 172.77 6.38 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.988 . . . . 0.0 110.612 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -53.96 -32.96 70.45 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.16 1.61 . . . . 0.0 110.379 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.77 -32.17 73.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.014 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.457 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -50.85 178.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.405 -0.81 . . . . 0.0 110.383 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.6 -41.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.475 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.86 108.14 6.46 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 25' ' ' GLU . 14.3 t -46.02 137.18 6.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.894 0.854 . . . . 0.0 110.931 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.04 -44.81 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 111.958 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.65 85.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.166 -0.959 . . . . 0.0 112.35 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 25' ' ' GLU . 26.8 p -146.75 24.6 1.2 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.844 -1.16 . . . . 0.0 111.741 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.0 mt-10 28.87 86.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.309 -0.869 . . . . 0.0 110.352 179.383 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.462 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 48.3 p-90 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.33 0.586 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -120.9 140.74 51.39 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.307 -0.871 . . . . 0.0 109.99 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.6 t -84.52 113.41 21.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.19 -0.944 . . . . 0.0 109.206 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -88.69 -10.02 49.95 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.27 -0.894 . . . . 0.0 111.059 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.1 p -66.93 -31.5 72.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.008 -1.057 . . . . 0.0 109.989 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.413 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.1 p -133.55 22.53 3.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 111.341 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.1 mt 55.58 48.68 18.15 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.237 -0.914 . . . . 0.0 111.746 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.413 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 40.9 t -126.53 132.07 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.195 -0.94 . . . . 0.0 109.708 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.03 134.2 42.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.085 -1.009 . . . . 0.0 110.492 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 m-20 -120.17 131.5 55.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.195 -0.941 . . . . 0.0 109.934 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -80.28 173.38 7.81 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.9 . . . . 0.0 110.03 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -54.74 -34.48 84.53 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.982 1.517 . . . . 0.0 110.249 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.74 -35.6 80.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.562 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.447 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -51.09 174.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.486 -0.759 . . . . 0.0 110.419 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 75.4 t -156.44 -44.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -133.1 112.53 11.85 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 25' ' ' GLU . 12.4 t -45.74 138.4 4.74 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.086 0.946 . . . . 0.0 111.316 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.63 -44.84 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.636 -1.29 . . . . 0.0 111.871 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.01 90.91 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.212 -0.93 . . . . 0.0 112.61 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.3 p -140.5 16.28 2.37 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.833 -1.167 . . . . 0.0 111.961 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.2 mt-10 38.43 78.36 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.692 -0.63 . . . . 0.0 111.784 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.463 ' CE2' ' HB2' ' A' ' 14' ' ' ASN . 33.2 p-90 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.368 0.604 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -135.06 151.07 50.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.159 -0.963 . . . . 0.0 110.091 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.8 t -90.96 111.25 22.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.163 -0.961 . . . . 0.0 110.657 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -80.56 -17.17 52.29 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.511 -0.743 . . . . 0.0 110.515 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.4 m -62.22 -44.35 96.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -0.998 . . . . 0.0 110.895 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.0 p -120.4 24.22 10.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 111.347 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt 53.81 50.9 15.92 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.289 -0.882 . . . . 0.0 111.637 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 40.2 t -130.15 133.4 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.146 -0.971 . . . . 0.0 110.506 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -96.8 137.29 36.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.055 -1.028 . . . . 0.0 110.064 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.463 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 2.4 m-20 -119.24 120.45 37.07 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.149 -0.97 . . . . 0.0 110.403 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.38 172.19 2.75 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.954 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.48 -33.6 92.81 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.996 1.524 . . . . 0.0 110.174 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.87 -36.1 79.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -0.801 . . . . 0.0 109.765 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.02 157.91 29.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 0.0 110.55 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.9 t -147.05 -41.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.418 -0.802 . . . . 0.0 108.93 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.439 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . 97.4 mttt -115.57 101.55 8.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.421 -0.8 . . . . 0.0 108.984 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.2 t -45.27 133.02 7.29 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.183 0.992 . . . . 0.0 111.256 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.72 -43.4 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 111.546 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.47 91.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.189 -0.944 . . . . 0.0 112.429 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 p -151.01 21.43 0.77 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.771 -1.205 . . . . 0.0 111.406 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 21' ' ' CYS . 86.4 tt0 41.14 91.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.731 -0.606 . . . . 0.0 111.489 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 C--N 1.301 -1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.378 179.156 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.453 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 53.7 p-90 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.487 0.661 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -131.07 146.75 52.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.389 -0.819 . . . . 0.0 109.658 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.432 ' HB3' ' CG2' ' A' ' 12' ' ' VAL . 6.5 t -79.19 114.59 18.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 110.273 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -71.47 -24.1 61.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.0 110.191 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.8 m -62.15 -45.61 92.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.885 . . . . 0.0 110.5 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.425 ' SG ' ' CG1' ' A' ' 12' ' ' VAL . 14.0 p -125.28 13.73 8.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.166 -0.959 . . . . 0.0 110.934 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.7 tp 48.25 85.31 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.261 -0.9 . . . . 0.0 112.219 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' A' ' 7' ' ' CYS . 18.6 m -138.64 163.6 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 109.299 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -108.3 107.87 18.64 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.046 -1.034 . . . . 0.0 110.836 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.453 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 44.3 m-20 -125.79 125.68 43.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.183 -0.948 . . . . 0.0 109.186 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -80.35 176.38 3.85 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.895 . . . . 0.0 110.482 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.17 -32.14 78.87 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.124 1.592 . . . . 0.0 110.437 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.58 -31.89 72.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 110.162 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.9 176.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -0.858 . . . . 0.0 110.602 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.92 -38.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.402 -0.812 . . . . 0.0 109.538 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . 99.2 mttt -127.73 101.95 6.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.458 -0.776 . . . . 0.0 109.603 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.9 t -47.29 131.82 13.09 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.937 0.875 . . . . 0.0 110.759 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -67.78 -43.48 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 111.419 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.39 -40.25 96.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.236 -0.915 . . . . 0.0 112.341 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.7 p -149.97 22.26 0.87 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.92 -1.112 . . . . 0.0 111.17 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' CYS . 82.5 tt0 35.77 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.423 0.63 . . . . 0.0 112.538 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 C--N 1.301 -1.522 0 O-C-N 121.407 -0.808 . . . . 0.0 108.966 178.417 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.53 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 24.2 p-90 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.348 0.595 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 7' ' ' CYS . 67.8 t0 -131.97 139.35 48.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.165 -0.96 . . . . 0.0 110.418 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.426 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 13.5 t -89.6 112.99 24.36 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.394 -0.816 . . . . 0.0 109.617 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -91.91 -7.22 49.81 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.163 -0.96 . . . . 0.0 110.511 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -66.99 -34.13 77.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.023 -1.048 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 12.8 p -128.27 18.95 6.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 110.432 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 75.5 mt 58.87 45.35 15.41 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.677 -0.639 . . . . 0.0 111.869 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -128.57 132.96 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.07 -1.018 . . . . 0.0 110.184 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -100.86 144.45 29.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.74 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.53 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.2 m-20 -121.03 122.54 40.32 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.028 -1.045 . . . . 0.0 109.894 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttm -67.84 168.87 11.06 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.25 -0.906 . . . . 0.0 109.614 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.71 -35.49 78.47 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.91 1.479 . . . . 0.0 110.601 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -66.66 -35.03 79.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.553 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -51.3 179.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.499 -0.751 . . . . 0.0 110.075 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -162.45 -39.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.007 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . 96.7 mttt -135.44 111.8 9.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 25' ' ' GLU . 11.5 t -45.68 130.6 9.13 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.997 0.903 . . . . 0.0 111.344 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -68.28 -43.09 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.02 -1.05 . . . . 0.0 111.377 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.37 92.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.262 -0.899 . . . . 0.0 112.44 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.6 p -147.38 20.11 1.2 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.733 -1.23 . . . . 0.0 111.553 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 80.9 tt0 42.38 90.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.661 -0.649 . . . . 0.0 111.767 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.407 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 2.1 p . . . . . 0 C--N 1.301 -1.515 0 O-C-N 121.365 -0.835 . . . . 0.0 109.237 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 59.1 p-90 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.207 0.527 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.415 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 46.8 p-10 -130.5 148.74 52.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.143 -0.973 . . . . 0.0 110.59 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.4 t -85.31 113.8 21.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.145 -0.972 . . . . 0.0 109.689 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -83.06 -14.05 54.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.359 -0.838 . . . . 0.0 110.503 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.6 m -61.96 -43.47 98.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 109.711 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.403 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.2 p -120.83 21.91 11.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.832 . . . . 0.0 110.925 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.7 mt 54.15 47.6 22.84 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.242 -0.911 . . . . 0.0 111.995 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 43.9 t -125.94 130.7 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.837 -1.164 . . . . 0.0 110.238 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.415 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . 54.7 tt0 -97.53 132.46 43.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.071 -1.018 . . . . 0.0 110.218 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.422 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 3.0 m-20 -117.02 127.27 54.01 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.138 -0.976 . . . . 0.0 109.658 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -69.82 170.91 8.34 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.985 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -54.9 -32.54 78.41 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.011 1.532 . . . . 0.0 110.512 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.49 -32.07 73.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -64.39 -179.95 0.52 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.395 -0.815 . . . . 0.0 110.412 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.94 -42.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 62.3 pttt -128.96 114.74 16.81 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.111 0.958 . . . . 0.0 109.141 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.0 t -46.43 132.0 10.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.52 -0.737 . . . . 0.0 111.344 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -64.11 -46.25 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.508 -0.745 . . . . 0.0 111.88 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.36 -41.24 94.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.953 -1.092 . . . . 0.0 109.849 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 32.1 p -152.45 80.66 1.24 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.032 0.92 . . . . 0.0 109.146 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 21' ' ' CYS . 95.5 mt-10 -31.35 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.374 0.607 . . . . 0.0 112.549 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.095 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.282 0.563 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.408 ' HB3' ' HG3' ' A' ' 13' ' ' GLN . 49.3 p-10 -119.99 151.28 39.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.936 -1.102 . . . . 0.0 111.148 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.7 t -94.6 121.21 35.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.093 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -96.85 -14.79 21.61 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.051 -1.031 . . . . 0.0 110.526 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -60.09 -39.02 84.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.052 -1.03 . . . . 0.0 109.892 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 13.7 p -124.83 22.24 8.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.86 . . . . 0.0 111.073 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 84.6 mt 56.09 44.9 24.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.511 -0.743 . . . . 0.0 112.007 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.48 130.16 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.069 -1.02 . . . . 0.0 109.829 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.408 ' HG3' ' HB3' ' A' ' 6' ' ' ASP . 56.7 tt0 -101.24 145.55 28.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.043 -1.036 . . . . 0.0 110.17 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -134.12 149.7 51.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.065 -1.022 . . . . 0.0 110.091 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.415 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 8.6 mttt -82.2 169.73 17.35 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 109.949 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 34.3 Cg_exo -56.51 -33.19 91.98 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.091 1.574 . . . . 0.0 110.731 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -65.41 -27.89 68.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 110.011 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.53 178.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.37 -0.831 . . . . 0.0 110.394 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.1 t -152.15 -46.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -139.99 117.86 11.74 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 109.103 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 25' ' ' GLU . 18.1 t -45.42 140.06 3.33 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.2 1.0 . . . . 0.0 111.585 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.37 -44.49 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.847 -1.158 . . . . 0.0 111.894 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.4 -38.7 85.06 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.173 -0.954 . . . . 0.0 112.358 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 25' ' ' GLU . 20.5 p -147.0 22.36 1.22 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.81 -1.181 . . . . 0.0 111.451 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 21' ' ' CYS . 94.6 mt-10 31.54 85.11 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.925 . . . . 0.0 109.58 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.528 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 52.2 p-90 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.158 0.504 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -124.62 149.01 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.956 . . . . 0.0 110.773 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.6 t -92.8 120.9 33.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.36 -0.838 . . . . 0.0 110.429 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.6 p30 -96.86 -6.08 36.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.821 -1.175 . . . . 0.0 110.279 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.4 m -63.13 -42.39 99.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.167 -0.958 . . . . 0.0 109.409 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.415 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.6 p -125.04 18.14 8.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.535 -0.728 . . . . 0.0 111.35 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mp 62.95 43.45 6.72 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.217 -0.927 . . . . 0.0 111.767 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.415 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 48.8 t -125.81 134.96 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.263 -0.898 . . . . 0.0 109.917 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -98.41 145.09 27.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.078 -1.014 . . . . 0.0 110.016 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.528 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 m-20 -122.47 131.44 53.86 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.093 -1.005 . . . . 0.0 110.466 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -78.08 168.99 22.99 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 110.048 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.97 -33.77 73.98 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.896 1.472 . . . . 0.0 109.911 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.88 -40.27 91.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.142 -0.974 . . . . 0.0 109.904 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 19' ' ' VAL . . . -54.0 -179.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 109.895 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 40.2 t -157.7 -43.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.408 ' HG3' HG12 ' A' ' 19' ' ' VAL . 98.8 mttt -134.49 116.03 14.63 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.7 t -45.73 131.64 9.03 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.93 0.872 . . . . 0.0 111.946 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.81 -46.27 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.522 -0.736 . . . . 0.0 111.373 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.03 88.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.157 -0.965 . . . . 0.0 109.345 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -153.97 84.52 1.15 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.13 0.967 . . . . 0.0 109.242 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 21' ' ' CYS . 92.0 mt-10 -33.07 88.38 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 24' ' ' CYS . 21.4 p . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.0 . . . . 0.0 109.818 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 33.3 p-90 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.442 0.639 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 43.8 p-10 -118.13 142.79 47.05 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.466 -0.771 . . . . 0.0 110.017 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 t -88.97 113.22 24.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.17 -0.956 . . . . 0.0 109.689 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 43.3 p-10 -84.98 -8.87 58.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.943 . . . . 0.0 109.94 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -64.46 -44.37 91.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.157 -0.964 . . . . 0.0 110.123 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.404 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -126.03 28.75 6.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 111.306 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt 53.21 42.74 32.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.27 -0.894 . . . . 0.0 111.978 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 44.0 t -125.0 134.75 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.785 -1.197 . . . . 0.0 110.696 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -103.87 142.49 34.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.183 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.437 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 82.3 m-20 -130.43 134.88 47.46 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.023 -1.048 . . . . 0.0 110.302 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.19 169.62 18.42 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.438 -0.789 . . . . 0.0 110.165 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.25 -34.49 88.42 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.958 1.504 . . . . 0.0 110.623 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.82 -32.97 74.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.004 . . . . 0.0 109.766 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.437 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -51.52 179.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.496 -0.752 . . . . 0.0 109.696 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 39.2 t -156.36 -42.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.139 -0.976 . . . . 0.0 108.773 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 99.3 mttt -137.02 115.88 12.25 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.669 0.747 . . . . 0.0 109.309 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.463 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 12.8 t -46.35 132.52 10.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.79 0.805 . . . . 0.0 111.198 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.66 -45.61 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.184 -0.947 . . . . 0.0 111.195 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.94 85.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.959 -1.088 . . . . 0.0 109.757 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.446 ' O ' ' C ' ' A' ' 25' ' ' GLU . 31.8 p -148.97 78.47 1.4 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.762 0.791 . . . . 0.0 109.166 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.463 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 95.5 mt-10 -29.22 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.594 0.712 . . . . 0.0 111.867 -178.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 24' ' ' CYS . 42.8 p . . . . . 0 N--CA 1.49 1.542 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.999 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.465 0.65 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.432 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 79.9 m-20 -139.36 154.32 47.84 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 110.138 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 t -89.09 114.23 25.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 110.285 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -80.66 -18.74 47.09 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.22 -0.925 . . . . 0.0 110.494 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.1 m -61.67 -44.6 96.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.934 . . . . 0.0 110.71 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.0 p -118.89 26.3 9.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.106 -0.996 . . . . 0.0 111.033 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 37.2 tp 48.27 56.39 7.48 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.324 -0.86 . . . . 0.0 111.224 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 28.9 t -130.16 133.51 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.005 -1.06 . . . . 0.0 110.088 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . 84.4 mt-30 -101.05 133.69 45.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 110.103 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 78.6 m-20 -128.98 119.69 24.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.04 -1.038 . . . . 0.0 109.713 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.55 174.74 2.34 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 110.303 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -56.2 -30.55 80.3 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.166 1.614 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -62.38 -37.52 86.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.875 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -54.22 -174.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 110.031 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 80.7 t -155.67 -46.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 99.7 mttt -140.9 120.94 13.69 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.674 0.75 . . . . 0.0 109.047 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 25' ' ' GLU . 9.7 t -46.36 130.09 10.66 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.697 0.76 . . . . 0.0 111.017 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.49 -46.02 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.25 -0.906 . . . . 0.0 111.64 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.5 -41.47 96.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.97 -1.081 . . . . 0.0 109.75 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.43 ' O ' ' C ' ' A' ' 25' ' ' GLU . 32.1 p -153.57 80.77 1.17 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 122.068 0.937 . . . . 0.0 109.036 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 21' ' ' CYS . 96.5 mt-10 -30.3 93.3 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.544 0.688 . . . . 0.0 112.432 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.8 p . . . . . 0 N--CA 1.49 1.543 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.492 179.097 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 46.9 p-90 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.601 0.715 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -135.88 149.57 49.04 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.242 -0.911 . . . . 0.0 109.778 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' VAL . 8.2 t -87.44 120.29 28.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.979 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -95.09 -6.02 42.95 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.254 -0.904 . . . . 0.0 110.759 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.3 p -74.7 -21.29 59.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.913 -1.117 . . . . 0.0 109.941 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.418 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -141.15 20.87 2.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.693 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt 54.82 58.37 4.87 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.413 -0.804 . . . . 0.0 111.592 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.418 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 27.3 t -131.63 135.94 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.899 . . . . 0.0 110.247 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -103.14 134.05 47.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.451 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 94.9 m-20 -134.66 116.41 14.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.062 -1.024 . . . . 0.0 110.494 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.403 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -69.52 176.66 1.55 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.0 110.496 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 35.4 Cg_exo -54.23 -32.02 69.0 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.936 1.492 . . . . 0.0 110.321 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.51 -35.73 81.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 110.607 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -60.35 176.69 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.002 . . . . 0.0 110.5 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 44.9 t -156.66 -43.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.325 -0.859 . . . . 0.0 109.23 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.28 106.86 9.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.487 -0.758 . . . . 0.0 109.716 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 25' ' ' GLU . 15.9 t -45.91 135.16 7.42 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.063 0.935 . . . . 0.0 111.253 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.93 -43.33 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.192 -0.942 . . . . 0.0 111.038 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.27 89.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.355 -0.841 . . . . 0.0 112.187 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 25' ' ' GLU . 23.1 p -155.83 25.25 0.38 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.939 -1.1 . . . . 0.0 111.104 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.9 mt-10 33.96 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.424 0.63 . . . . 0.0 111.952 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.5 m . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 110.219 179.609 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.238 0.542 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.76 -43.44 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.351 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.86 -0.15 59.12 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.1 p -128.24 150.35 50.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.988 -1.301 . . . . 0.0 109.751 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.53 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 35.0 p-90 -148.56 157.85 43.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.024 -1.048 . . . . 0.0 110.473 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -120.07 140.68 50.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.167 -0.958 . . . . 0.0 109.816 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 12' ' ' VAL . 19.2 t -87.43 115.92 25.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.519 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -94.51 -5.22 46.55 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.256 -0.903 . . . . 0.0 110.929 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -68.77 -31.21 70.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.95 -1.094 . . . . 0.0 109.634 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.409 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.9 p -135.74 21.03 3.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.811 . . . . 0.0 111.234 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mp 58.83 46.55 13.84 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.292 -0.88 . . . . 0.0 111.838 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.409 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 48.0 t -127.89 134.66 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.153 -0.967 . . . . 0.0 110.117 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -96.65 145.69 25.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.005 -1.059 . . . . 0.0 110.507 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.53 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 m-20 -125.73 142.1 51.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.202 -0.936 . . . . 0.0 109.876 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -90.95 170.69 9.39 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.766 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.38 -34.32 80.4 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.898 1.473 . . . . 0.0 110.418 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.21 -36.67 82.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.111 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' A' ' 19' ' ' VAL . . . -51.52 -179.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.462 -0.774 . . . . 0.0 110.667 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 74.2 t -155.31 -47.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -137.32 119.54 15.63 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.51 ' O ' ' N ' ' A' ' 25' ' ' GLU . 14.6 t -45.04 140.49 2.69 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.097 0.951 . . . . 0.0 111.595 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.09 -44.45 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.629 -1.294 . . . . 0.0 111.62 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.24 93.2 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.294 -0.879 . . . . 0.0 112.516 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.5 p -140.57 11.9 2.3 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.894 -1.129 . . . . 0.0 112.088 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.3 mt-10 40.8 78.01 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.63 -0.669 . . . . 0.0 111.247 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 21' ' ' CYS . 0.6 OUTLIER -71.2 149.59 94.35 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.922 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 38.6 Cg_exo -58.29 -23.53 63.1 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.905 1.476 . . . . 0.0 110.303 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' HG3' ' CZ2' ' A' ' 5' ' ' TRP . 1.5 ttpt 63.03 65.86 1.29 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.881 . . . . 0.0 109.847 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 21.1 Cg_exo -61.22 145.21 98.86 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.921 1.485 . . . . 0.0 110.434 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.25 103.42 3.02 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.3 m -123.05 129.09 51.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -1.176 . . . . 0.0 110.167 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.99 -40.26 98.06 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.5 t -123.41 130.87 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.141 -1.211 . . . . 0.0 110.387 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.05 -42.03 97.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 110.384 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.201 179.791 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.319 0.58 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.6 mt -119.89 129.22 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.039 -1.038 . . . . 0.0 110.671 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -173.52 175.27 46.26 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.7 p -79.1 166.09 22.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -1.199 . . . . 0.0 110.045 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -141.24 153.4 45.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.25 -0.906 . . . . 0.0 110.289 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 47.5 p-10 -132.84 148.43 52.3 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.402 -0.811 . . . . 0.0 110.117 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 t -83.0 106.13 14.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.045 -1.035 . . . . 0.0 109.911 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -71.59 -18.13 62.24 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.423 -0.798 . . . . 0.0 110.185 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.0 m -60.87 -44.35 97.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.867 . . . . 0.0 111.082 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.405 ' O ' HG22 ' A' ' 12' ' ' VAL . 14.0 p -128.96 33.77 4.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.04 -1.037 . . . . 0.0 110.897 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.0 tp 42.49 65.66 0.88 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.56 -0.712 . . . . 0.0 112.409 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.423 ' CG1' ' SG ' ' A' ' 21' ' ' CYS . 39.4 t -133.81 135.53 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.945 -1.097 . . . . 0.0 109.906 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -100.78 141.01 34.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.245 -0.909 . . . . 0.0 110.702 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.467 ' ND2' ' HA ' ' A' ' 21' ' ' CYS . 3.6 m-20 -145.91 121.12 10.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 109.557 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -70.2 178.01 1.2 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.412 -0.805 . . . . 0.0 110.298 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.11 -29.83 84.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.0 1.526 . . . . 0.0 109.764 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.64 -37.8 88.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.459 -0.776 . . . . 0.0 109.764 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.42 ' O ' ' CG1' ' A' ' 19' ' ' VAL . . . -54.92 -172.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.405 -0.809 . . . . 0.0 110.426 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.42 ' CG1' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -168.91 -37.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.467 -0.771 . . . . 0.0 109.113 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -131.9 111.04 11.23 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.675 0.75 . . . . 0.0 109.402 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' A' ' 25' ' ' GLU . 8.9 t -45.99 141.27 3.26 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.902 0.858 . . . . 0.0 110.924 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.68 -43.86 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.611 -1.306 . . . . 0.0 111.639 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.07 89.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.319 -0.863 . . . . 0.0 112.437 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.9 p -142.77 13.07 1.89 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.003 -1.061 . . . . 0.0 112.1 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 21' ' ' CYS . 96.7 mt-10 43.78 73.08 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.418 -0.801 . . . . 0.0 110.105 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -44.54 157.21 0.32 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.944 -0.472 . . . . 0.0 110.558 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -66.91 -14.96 45.72 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 124.192 1.627 . . . . 0.0 109.631 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.68 75.17 0.57 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.247 -0.908 . . . . 0.0 109.97 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -60.31 145.14 99.22 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.092 1.575 . . . . 0.0 110.031 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.5 55.78 0.55 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.4 p -63.37 -33.77 76.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -1.212 . . . . 0.0 109.731 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.02 151.25 51.82 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.71 140.27 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -1.13 . . . . 0.0 110.045 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.79 -43.19 99.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.447 -0.783 . . . . 0.0 110.61 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 117.888 -1.053 . . . . 0.0 110.264 -179.819 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.385 0.612 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.03 -42.89 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.429 -0.795 . . . . 0.0 109.903 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 168.69 -168.38 41.02 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.1 m -121.07 131.14 54.09 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.078 -1.248 . . . . 0.0 109.839 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.477 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 19.7 p-90 -142.7 161.42 38.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 110.371 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -130.41 134.29 47.01 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.083 -1.01 . . . . 0.0 109.908 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.7 t -83.66 114.79 21.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.361 -0.837 . . . . 0.0 108.769 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -92.06 -7.3 49.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.002 -1.061 . . . . 0.0 110.631 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.4 p -68.5 -33.88 74.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 109.406 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.6 p -128.3 20.46 6.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.363 -0.836 . . . . 0.0 111.108 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt 53.15 48.99 20.97 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.291 -0.881 . . . . 0.0 112.393 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.2 t -128.07 131.79 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.852 -1.155 . . . . 0.0 110.527 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -89.18 142.49 27.6 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.593 -0.692 . . . . 0.0 109.992 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.443 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 8.4 m-20 -129.92 126.21 37.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.961 -1.087 . . . . 0.0 110.114 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 15.5 mmtp -73.14 171.43 10.46 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.55 -0.719 . . . . 0.0 110.592 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 34.7 Cg_exo -55.44 -32.02 80.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.915 1.481 . . . . 0.0 110.028 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -66.47 -31.05 71.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.401 -0.812 . . . . 0.0 109.703 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.443 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -61.52 151.01 34.11 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.347 0.594 . . . . 0.0 110.536 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.2 t -137.5 -42.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.516 -0.74 . . . . 0.0 109.195 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -130.46 107.72 9.43 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.466 -0.894 . . . . 0.0 108.701 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.5 t -45.54 130.25 8.75 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.471 0.653 . . . . 0.0 110.837 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.7 t -62.71 -46.73 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.206 -0.934 . . . . 0.0 112.079 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.22 -38.59 91.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.781 -1.199 . . . . 0.0 109.673 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -155.43 83.22 1.05 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.057 0.932 . . . . 0.0 109.043 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.5 mt-10 -33.68 92.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.056 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 24' ' ' CYS . 13.4 p -54.01 158.07 3.82 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.129 -0.982 . . . . 0.0 110.147 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -77.7 18.92 0.79 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.866 1.456 . . . . 0.0 111.996 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 5.4 mmtt -45.26 -46.62 32.83 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 120.948 -1.095 . . . . 0.0 111.728 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 28' ' ' LYS . 20.7 Cg_exo -62.7 144.9 94.77 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.302 1.159 . . . . 0.0 109.731 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.98 23.71 71.18 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 91.3 m -122.16 127.37 49.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.227 -1.161 . . . . 0.0 109.994 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.28 16.85 61.78 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.8 t -123.47 130.22 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.33 -1.1 . . . . 0.0 109.545 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.63 -39.01 89.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.318 -0.863 . . . . 0.0 110.198 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 . . . . . 0 C--N 1.299 -1.592 0 CA-C-O 118.346 -0.835 . . . . 0.0 109.987 -179.291 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.318 0.58 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.66 -43.39 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.387 -0.82 . . . . 0.0 110.197 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 94.54 10.49 57.98 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 m -73.09 134.79 44.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.962 -1.317 . . . . 0.0 109.562 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.541 ' CZ2' ' CB ' ' A' ' 14' ' ' ASN . 29.0 p-90 -140.17 155.36 46.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.904 -1.122 . . . . 0.0 110.626 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -130.91 127.64 38.9 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.438 -0.788 . . . . 0.0 109.926 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.405 ' SG ' ' CG2' ' A' ' 26' ' ' THR . 30.6 t -76.97 120.46 22.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.628 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -92.8 -8.58 43.22 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.465 -0.772 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 m -64.17 -44.55 91.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 110.521 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.428 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.3 p -124.14 18.81 9.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 110.915 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 97.3 mt 56.53 52.59 9.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.36 -0.837 . . . . 0.0 111.572 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.428 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 37.9 t -127.15 132.76 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.304 -0.873 . . . . 0.0 109.6 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -93.62 136.48 33.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 110.637 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' CZ2' ' A' ' 5' ' ' TRP . 1.6 m120 -126.18 130.38 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.111 -0.993 . . . . 0.0 109.576 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -69.15 166.89 24.4 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 0.0 109.864 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -52.71 -36.59 73.24 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 124.041 1.548 . . . . 0.0 109.754 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.34 -35.87 76.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.917 . . . . 0.0 109.849 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.88 146.02 48.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 110.193 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -157.38 23.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.393 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -158.0 75.27 0.75 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.486 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.6 t -45.27 129.47 8.04 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.031 0.92 . . . . 0.0 111.078 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.19 -43.73 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.106 . . . . 0.0 111.576 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.19 -40.69 96.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.368 -0.833 . . . . 0.0 112.211 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 p -149.95 24.39 0.85 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.833 -1.167 . . . . 0.0 111.344 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 21' ' ' CYS . 75.2 tt0 36.9 96.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.392 0.615 . . . . 0.0 112.447 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.405 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 22.3 p -87.45 152.43 52.24 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.422 -0.799 . . . . 0.0 109.831 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -84.62 40.78 0.89 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.768 1.404 . . . . 0.0 110.6 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 37.0 tttm 56.58 67.86 2.49 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.099 -1.0 . . . . 0.0 110.374 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' HD2' ' CE3' ' A' ' 5' ' ' TRP . 24.9 Cg_exo -60.94 144.11 99.5 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.012 1.532 . . . . 0.0 110.462 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.14 159.76 30.33 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.6 p -132.03 159.27 39.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -1.201 . . . . 0.0 110.428 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.61 165.56 54.44 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.1 p -136.6 142.11 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.205 -1.173 . . . . 0.0 109.793 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.67 -45.28 93.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.131 -0.981 . . . . 0.0 109.683 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.934 179.531 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.327 0.584 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.82 -43.21 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.825 . . . . 0.0 110.54 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.91 -42.05 96.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 p -83.74 166.31 18.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.003 -1.293 . . . . 0.0 110.399 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 26.8 p-90 -142.23 159.37 42.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 109.979 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -130.69 134.58 47.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.049 -1.032 . . . . 0.0 110.456 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 t -87.59 118.27 26.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.83 . . . . 0.0 109.699 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -89.89 -11.96 40.35 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.16 -0.962 . . . . 0.0 111.09 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.2 p -66.97 -31.42 71.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.912 -1.117 . . . . 0.0 110.29 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.414 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.8 p -133.92 24.8 3.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.988 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 37.6 tp 46.83 57.33 5.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.277 -0.89 . . . . 0.0 111.531 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.414 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 41.8 t -131.28 133.78 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.987 -1.071 . . . . 0.0 109.866 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -101.19 130.77 47.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.292 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.482 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 85.6 m-20 -132.17 125.73 31.91 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.056 -1.027 . . . . 0.0 109.936 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 2.6 mttt -78.34 176.53 3.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.813 . . . . 0.0 110.477 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 32.2 Cg_exo -56.36 -29.73 78.22 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.016 1.534 . . . . 0.0 110.01 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -64.89 -36.0 82.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.362 -0.836 . . . . 0.0 109.831 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.428 ' O ' ' CG2' ' A' ' 19' ' ' VAL . . . -52.35 -179.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.334 -0.854 . . . . 0.0 110.095 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 76.6 t -154.73 -43.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.959 . . . . 0.0 109.099 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.77 110.79 8.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.567 0.698 . . . . 0.0 109.305 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 12.2 t -46.2 132.21 9.96 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.503 0.668 . . . . 0.0 111.075 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.55 -46.72 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.524 -0.735 . . . . 0.0 111.731 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.7 96.02 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.964 -1.085 . . . . 0.0 109.694 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.439 ' O ' ' C ' ' A' ' 25' ' ' GLU . 32.1 p -153.63 81.91 1.17 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.794 0.807 . . . . 0.0 109.201 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.47 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.1 mt-10 -30.37 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.545 0.688 . . . . 0.0 112.12 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 24' ' ' CYS . 78.0 p -67.6 151.9 96.75 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.482 -0.762 . . . . 0.0 110.035 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.89 41.47 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.977 1.514 . . . . 0.0 110.362 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -101.58 109.22 58.61 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.154 -0.966 . . . . 0.0 110.214 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -61.44 145.28 98.2 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.592 1.312 . . . . 0.0 110.277 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.73 -37.87 95.36 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.9 p -132.77 155.72 48.39 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.312 -1.111 . . . . 0.0 110.176 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.0 176.67 28.42 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.75 157.5 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -1.136 . . . . 0.0 110.226 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.94 -41.85 97.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 110.244 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.228 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.421 0.629 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.2 mm -62.37 -44.58 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.574 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.47 176.87 47.95 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.3 p -92.26 164.6 13.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -1.165 . . . . 0.0 110.343 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -145.43 156.1 43.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.369 -0.832 . . . . 0.0 110.673 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.46 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 47.0 p-10 -134.82 151.89 51.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.31 -0.869 . . . . 0.0 110.256 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' VAL . 13.4 t -84.31 107.06 16.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.343 -0.848 . . . . 0.0 110.365 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -72.05 -18.71 61.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.27 -0.894 . . . . 0.0 110.279 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.8 m -60.97 -45.1 96.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.912 . . . . 0.0 110.661 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.9 p -121.85 29.74 6.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.126 -0.984 . . . . 0.0 110.783 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 35.1 tp 44.45 55.46 5.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.522 -0.736 . . . . 0.0 111.594 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 7' ' ' CYS . 34.7 t -129.26 133.88 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.999 -1.063 . . . . 0.0 109.808 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.46 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . 88.6 mt-30 -100.33 132.35 45.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.98 . . . . 0.0 110.606 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 4.0 m-20 -118.01 124.24 47.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.46 -0.775 . . . . 0.0 109.433 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -68.0 170.67 6.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.981 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -54.92 -32.58 78.73 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.987 1.52 . . . . 0.0 110.013 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.49 -34.34 78.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 109.818 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -51.96 -179.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.408 -0.807 . . . . 0.0 110.507 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 69.8 t -155.17 -45.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 99.6 mttt -139.62 118.76 12.68 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 25' ' ' GLU . 12.5 t -45.57 130.18 8.82 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.581 0.705 . . . . 0.0 111.384 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.77 -46.46 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.411 -0.806 . . . . 0.0 111.641 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.4 97.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.911 -1.118 . . . . 0.0 109.33 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.436 ' O ' ' C ' ' A' ' 25' ' ' GLU . 31.0 p -155.45 84.99 1.05 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.834 0.826 . . . . 0.0 109.25 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 24' ' ' CYS . 95.7 mt-10 -30.99 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.591 0.71 . . . . 0.0 112.683 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -51.28 158.36 1.36 Allowed Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.58 -0.7 . . . . 0.0 109.926 178.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -68.44 -10.74 29.91 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.984 1.518 . . . . 0.0 110.407 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER 54.53 67.38 3.38 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.092 -1.005 . . . . 0.0 110.062 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 20.4 Cg_exo -62.16 146.68 95.95 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.146 1.603 . . . . 0.0 110.364 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.26 -177.02 50.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 88.4 m -117.45 130.96 56.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.413 -1.051 . . . . 0.0 110.293 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.06 22.09 61.74 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.68 130.47 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.074 -1.251 . . . . 0.0 110.284 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -79.0 132.27 36.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.129 -0.982 . . . . 0.0 109.683 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.07 -0.966 . . . . 0.0 110.296 -179.715 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.276 0.56 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 91.0 mt -111.02 130.15 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.969 . . . . 0.0 110.204 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.89 179.53 45.65 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 t -151.76 155.52 38.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -1.097 . . . . 0.0 110.132 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.496 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 45.7 p-90 -143.55 154.14 43.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.044 -1.035 . . . . 0.0 110.647 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 45.0 p-10 -136.82 148.79 47.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.352 -0.843 . . . . 0.0 110.124 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.6 t -83.89 135.54 34.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.867 . . . . 0.0 109.833 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -101.61 -16.9 16.58 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.097 -1.002 . . . . 0.0 110.854 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.5 p -65.29 -31.23 72.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.003 -1.06 . . . . 0.0 110.277 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.2 p -131.02 21.74 4.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 110.854 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 41.2 tp 49.4 59.59 4.37 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.217 -0.927 . . . . 0.0 111.424 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 28.0 t -132.72 135.03 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.126 -0.984 . . . . 0.0 110.262 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -99.44 137.23 38.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.164 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.496 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 61.7 m-20 -131.13 134.47 46.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.162 -0.961 . . . . 0.0 109.703 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -76.94 169.71 19.9 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 110.421 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -54.27 -33.29 75.05 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.168 1.615 . . . . 0.0 110.586 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.4 mp0 -65.64 -36.33 83.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.146 -0.971 . . . . 0.0 110.203 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.447 ' O ' ' CG2' ' A' ' 19' ' ' VAL . . . -52.38 175.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.442 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 76.0 t -156.94 -41.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.332 -0.855 . . . . 0.0 109.167 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HG3' HG11 ' A' ' 19' ' ' VAL . 96.9 mttt -127.33 107.41 9.96 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.141 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.461 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.4 t -46.64 132.42 10.95 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.52 0.676 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.05 -45.73 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.835 . . . . 0.0 111.659 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.26 99.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.851 -1.156 . . . . 0.0 109.556 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -155.02 83.66 1.08 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.793 0.806 . . . . 0.0 108.87 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.461 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.5 mt-10 -31.45 91.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.519 0.676 . . . . 0.0 112.333 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 24' ' ' CYS . 6.6 m -64.39 142.69 98.42 Favored Pre-proline 0 N--CA 1.487 1.42 0 O-C-N 121.422 -0.799 . . . . 0.0 109.372 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -81.46 44.67 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.607 1.32 . . . . 0.0 110.418 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -106.5 116.63 58.75 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.1 -1.0 . . . . 0.0 110.007 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.97 144.68 99.63 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.569 1.3 . . . . 0.0 110.513 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.92 -34.39 89.76 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.5 m -113.27 125.37 54.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.5 -1.0 . . . . 0.0 109.593 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.43 171.06 39.6 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.8 t -125.56 132.94 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.13 . . . . 0.0 110.426 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.75 -43.04 99.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 0.0 110.105 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.144 -179.903 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.309 0.576 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.3 pt -128.06 156.23 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 110.499 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 16' ' ' PRO . . . -128.23 143.48 14.44 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.2 t -152.05 168.11 26.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.237 . . . . 0.0 110.136 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.502 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 48.4 p-90 -135.98 158.59 44.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.081 -1.012 . . . . 0.0 109.906 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -129.74 130.04 44.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.265 -0.897 . . . . 0.0 110.416 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.9 t -75.55 100.27 4.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.422 -0.799 . . . . 0.0 109.83 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -69.51 -16.53 63.46 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.475 -0.765 . . . . 0.0 110.563 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.1 m -60.95 -44.43 97.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.034 -1.041 . . . . 0.0 110.392 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.9 p -124.24 21.16 8.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.014 -1.053 . . . . 0.0 111.282 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.5 mt 53.84 52.31 13.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.172 -0.955 . . . . 0.0 111.959 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 48.8 t -129.0 132.14 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.089 -1.007 . . . . 0.0 109.685 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -96.45 137.02 36.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.0 110.565 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.502 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 79.6 m-20 -132.46 124.43 28.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.368 -0.832 . . . . 0.0 109.874 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.401 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 37.8 mtpt -73.39 168.39 25.72 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.929 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.433 ' HG3' ' O ' ' A' ' 3' ' ' GLY . 52.2 Cg_exo -51.94 -33.15 50.71 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.797 1.419 . . . . 0.0 110.581 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -60.89 -35.13 75.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.925 . . . . 0.0 108.879 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.444 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -52.96 177.45 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.623 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 78.3 t -155.8 -43.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -0.82 . . . . 0.0 108.804 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 97.4 mttt -136.49 112.36 9.55 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.802 0.811 . . . . 0.0 109.228 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.446 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.1 t -45.37 131.73 8.08 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.755 0.788 . . . . 0.0 111.473 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.1 t -64.01 -46.66 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.052 -1.03 . . . . 0.0 111.106 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.84 88.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.576 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 26' ' ' THR . 32.1 p -148.48 81.12 1.46 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.823 0.821 . . . . 0.0 109.081 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 21' ' ' CYS . 95.8 mt-10 -30.54 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.615 0.721 . . . . 0.0 112.209 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 24' ' ' CYS . 6.7 p -62.0 158.5 43.96 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.737 -0.602 . . . . 0.0 109.921 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.3 -8.83 23.19 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 O-C-N 123.996 1.524 . . . . 0.0 110.8 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.55 93.41 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.999 -1.063 . . . . 0.0 110.147 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.15 146.41 97.59 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.022 1.538 . . . . 0.0 110.357 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.71 8.02 59.73 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.8 p -131.56 161.37 32.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.022 -1.281 . . . . 0.0 110.272 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.85 175.99 50.8 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.5 t -63.92 -43.96 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -1.095 . . . . 0.0 110.364 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.39 -41.2 98.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.346 -0.846 . . . . 0.0 110.818 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.4 ttt-85 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.345 -179.872 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.239 0.543 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 pt -129.32 160.58 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 110.413 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.41 165.41 39.7 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.8 m -66.22 131.97 47.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -1.098 . . . . 0.0 110.295 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.476 ' CE2' ' HD2' ' A' ' 28' ' ' LYS . 51.0 p-90 -144.21 159.69 42.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.449 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -135.22 150.33 50.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.046 -1.034 . . . . 0.0 110.311 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.7 t -90.15 123.72 34.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.0 110.098 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -96.76 -4.19 41.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.169 -0.957 . . . . 0.0 111.143 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.6 p -74.19 -23.17 59.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.91 -1.119 . . . . 0.0 109.847 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.5 p -141.31 21.35 2.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.371 -0.83 . . . . 0.0 111.014 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt 54.23 48.96 19.68 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.325 -0.859 . . . . 0.0 111.686 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 41.0 t -125.35 132.21 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -0.967 . . . . 0.0 109.811 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -97.44 139.37 33.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.186 -0.946 . . . . 0.0 110.356 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.46 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 95.2 m-20 -134.65 106.02 6.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.294 -0.879 . . . . 0.0 110.014 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 3.1 mttm -56.55 172.93 0.32 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.857 . . . . 0.0 110.372 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 31.7 Cg_exo -56.89 -29.29 81.24 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.959 1.505 . . . . 0.0 110.231 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -65.14 -34.66 78.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 109.972 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -52.54 -177.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.78 . . . . 0.0 110.364 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.417 ' CG1' ' HG3' ' A' ' 20' ' ' LYS . 20.6 t -155.13 -44.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 108.882 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' HG3' ' CG1' ' A' ' 19' ' ' VAL . 99.2 mttt -142.56 115.62 8.84 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.804 0.811 . . . . 0.0 109.571 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.426 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 12.2 t -45.73 132.41 8.7 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.877 0.846 . . . . 0.0 111.793 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.92 -47.06 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.451 -0.781 . . . . 0.0 111.301 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.94 83.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.066 -1.021 . . . . 0.0 109.573 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 26' ' ' THR . 32.0 p -146.91 80.72 1.54 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.807 0.813 . . . . 0.0 109.426 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.426 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 96.6 mt-10 -29.24 89.7 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.487 0.661 . . . . 0.0 112.666 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 24' ' ' CYS . 2.1 p -48.01 158.53 0.55 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.756 -0.59 . . . . 0.0 109.912 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -65.66 -15.08 47.85 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.084 1.57 . . . . 0.0 110.803 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' HD2' ' CE2' ' A' ' 5' ' ' TRP . 12.1 tttt -48.64 106.05 0.57 Allowed Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.184 -0.948 . . . . 0.0 110.383 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -54.83 -38.35 92.23 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.75 1.395 . . . . 0.0 110.47 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.62 174.54 15.16 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.6 p -65.05 -32.33 73.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -1.18 . . . . 0.0 110.114 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.92 -166.25 53.93 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.4 t -121.19 131.21 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -1.166 . . . . 0.0 109.972 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -118.1 146.58 44.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 110.279 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.336 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.147 0.498 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 3' ' ' GLY . 46.7 pt -73.13 -27.65 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.131 -0.981 . . . . 0.0 110.233 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.408 ' N ' HG13 ' A' ' 2' ' ' ILE . . . 66.42 -174.81 22.08 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 p -84.76 167.56 15.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -1.079 . . . . 0.0 110.127 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -143.58 152.49 41.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 110.244 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -125.73 142.64 51.41 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.012 -1.055 . . . . 0.0 110.291 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.2 t -87.78 117.21 26.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.945 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 42.3 p-10 -92.77 -8.21 44.35 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.055 -1.028 . . . . 0.0 110.619 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.2 m -63.16 -43.55 97.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 109.037 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.422 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -123.11 21.06 9.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.579 -0.7 . . . . 0.0 110.319 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.8 tp 53.08 59.36 4.5 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.482 -0.761 . . . . 0.0 111.548 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 38.6 t -131.95 134.56 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -0.91 . . . . 0.0 109.722 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.99 136.01 38.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.164 -0.96 . . . . 0.0 110.589 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.457 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 99.4 m-20 -137.09 123.79 21.12 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.84 172.77 6.38 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.988 . . . . 0.0 110.612 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -53.96 -32.96 70.45 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.16 1.61 . . . . 0.0 110.379 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.77 -32.17 73.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.014 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.457 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -50.85 178.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.405 -0.81 . . . . 0.0 110.383 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.6 -41.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.475 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.86 108.14 6.46 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 25' ' ' GLU . 14.3 t -46.02 137.18 6.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.894 0.854 . . . . 0.0 110.931 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.04 -44.81 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 111.958 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.65 85.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.166 -0.959 . . . . 0.0 112.35 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 25' ' ' GLU . 26.8 p -146.75 24.6 1.2 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.844 -1.16 . . . . 0.0 111.741 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.0 mt-10 28.87 86.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 p -59.68 156.6 32.63 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.309 -0.869 . . . . 0.0 110.352 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -85.45 31.03 0.49 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.041 1.548 . . . . 0.0 111.047 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -48.47 -49.54 63.2 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 120.928 -1.107 . . . . 0.0 110.52 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 28' ' ' LYS . 24.7 Cg_exo -59.82 142.48 98.7 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.436 1.23 . . . . 0.0 110.043 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.77 -10.26 70.79 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.8 p -132.25 154.97 49.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.003 -1.292 . . . . 0.0 110.074 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -172.91 176.62 45.69 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.44 ' CG1' ' HG3' ' A' ' 35' ' ' ARG . 57.4 t -121.09 130.55 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -1.159 . . . . 0.0 110.11 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.77 -41.49 99.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.296 -0.878 . . . . 0.0 109.812 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 96.2 mtt-85 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.052 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.25 0.547 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.6 pt -68.47 -24.87 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 110.089 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.8 -37.59 94.9 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.4 m -118.96 129.69 55.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.385 -1.068 . . . . 0.0 110.096 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.462 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 48.3 p-90 -141.7 154.62 45.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 0.0 110.316 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -120.9 140.74 51.39 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.307 -0.871 . . . . 0.0 109.99 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.6 t -84.52 113.41 21.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.19 -0.944 . . . . 0.0 109.206 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -88.69 -10.02 49.95 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.27 -0.894 . . . . 0.0 111.059 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.1 p -66.93 -31.5 72.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.008 -1.057 . . . . 0.0 109.989 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.413 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.1 p -133.55 22.53 3.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 111.341 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.1 mt 55.58 48.68 18.15 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.237 -0.914 . . . . 0.0 111.746 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.413 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 40.9 t -126.53 132.07 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.195 -0.94 . . . . 0.0 109.708 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.03 134.2 42.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.085 -1.009 . . . . 0.0 110.492 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 m-20 -120.17 131.5 55.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.195 -0.941 . . . . 0.0 109.934 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -80.28 173.38 7.81 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.9 . . . . 0.0 110.03 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -54.74 -34.48 84.53 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.982 1.517 . . . . 0.0 110.249 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.74 -35.6 80.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.562 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.447 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -51.09 174.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.486 -0.759 . . . . 0.0 110.419 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 75.4 t -156.44 -44.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -133.1 112.53 11.85 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 25' ' ' GLU . 12.4 t -45.74 138.4 4.74 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.086 0.946 . . . . 0.0 111.316 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.63 -44.84 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.636 -1.29 . . . . 0.0 111.871 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.01 90.91 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.212 -0.93 . . . . 0.0 112.61 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.3 p -140.5 16.28 2.37 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.833 -1.167 . . . . 0.0 111.961 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.2 mt-10 38.43 78.36 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.692 -0.63 . . . . 0.0 111.784 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -50.76 157.09 1.41 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.15 -16.15 48.15 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 123.942 1.496 . . . . 0.0 110.864 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' CD ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER 52.07 81.27 0.26 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 0.0 110.138 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.424 ' O ' ' CE ' ' A' ' 28' ' ' LYS . 22.5 Cg_exo -61.15 147.08 96.65 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.011 1.532 . . . . 0.0 110.284 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.72 -6.57 58.9 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.424 ' OG1' ' CD ' ' A' ' 28' ' ' LYS . 63.6 m -120.68 129.38 53.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.008 -1.289 . . . . 0.0 109.872 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -120.81 130.48 8.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 p -64.47 -34.3 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -1.079 . . . . 0.0 110.111 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -74.59 143.23 44.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.233 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.242 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.518 0.675 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.17 -43.21 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.453 -0.779 . . . . 0.0 110.218 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.44 -37.05 94.2 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.3 p -80.71 164.28 22.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.021 -1.282 . . . . 0.0 110.879 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.463 ' CE2' ' HB2' ' A' ' 14' ' ' ASN . 33.2 p-90 -143.76 152.41 41.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.558 -0.714 . . . . 0.0 109.777 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -135.06 151.07 50.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.159 -0.963 . . . . 0.0 110.091 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.8 t -90.96 111.25 22.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.163 -0.961 . . . . 0.0 110.657 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -80.56 -17.17 52.29 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.511 -0.743 . . . . 0.0 110.515 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.4 m -62.22 -44.35 96.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -0.998 . . . . 0.0 110.895 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.0 p -120.4 24.22 10.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 111.347 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt 53.81 50.9 15.92 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.289 -0.882 . . . . 0.0 111.637 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 40.2 t -130.15 133.4 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.146 -0.971 . . . . 0.0 110.506 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -96.8 137.29 36.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.055 -1.028 . . . . 0.0 110.064 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.463 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 2.4 m-20 -119.24 120.45 37.07 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.149 -0.97 . . . . 0.0 110.403 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.38 172.19 2.75 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.954 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.48 -33.6 92.81 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.996 1.524 . . . . 0.0 110.174 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.87 -36.1 79.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -0.801 . . . . 0.0 109.765 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.02 157.91 29.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 0.0 110.55 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.9 t -147.05 -41.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.418 -0.802 . . . . 0.0 108.93 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.439 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . 97.4 mttt -115.57 101.55 8.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.421 -0.8 . . . . 0.0 108.984 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.2 t -45.27 133.02 7.29 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.183 0.992 . . . . 0.0 111.256 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.72 -43.4 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 111.546 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.47 91.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.189 -0.944 . . . . 0.0 112.429 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 p -151.01 21.43 0.77 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.771 -1.205 . . . . 0.0 111.406 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 21' ' ' CYS . 86.4 tt0 41.14 91.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.731 -0.606 . . . . 0.0 111.489 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.0 m -73.22 131.91 82.72 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.378 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.91 45.94 1.93 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.526 1.277 . . . . 0.0 110.811 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.63 93.07 29.34 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.089 -1.007 . . . . 0.0 109.836 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.5 145.07 86.96 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.751 1.395 . . . . 0.0 109.719 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.71 165.98 50.2 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.1 p -134.3 163.24 30.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -1.113 . . . . 0.0 109.607 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.28 164.89 54.9 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.19 -46.06 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.136 -1.214 . . . . 0.0 109.663 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -75.03 134.41 41.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.507 -0.746 . . . . 0.0 110.561 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.458 179.811 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.263 0.554 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.7 pt -69.81 -21.29 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 110.251 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.01 -39.33 97.44 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.5 t -144.86 156.53 44.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -1.21 . . . . 0.0 110.094 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.453 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 53.7 p-90 -142.01 153.85 44.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 110.343 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -131.07 146.75 52.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.389 -0.819 . . . . 0.0 109.658 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.432 ' HB3' ' CG2' ' A' ' 12' ' ' VAL . 6.5 t -79.19 114.59 18.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 110.273 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -71.47 -24.1 61.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.0 110.191 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.8 m -62.15 -45.61 92.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.885 . . . . 0.0 110.5 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.425 ' SG ' ' CG1' ' A' ' 12' ' ' VAL . 14.0 p -125.28 13.73 8.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.166 -0.959 . . . . 0.0 110.934 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.7 tp 48.25 85.31 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.261 -0.9 . . . . 0.0 112.219 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' A' ' 7' ' ' CYS . 18.6 m -138.64 163.6 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 109.299 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -108.3 107.87 18.64 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.046 -1.034 . . . . 0.0 110.836 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 44.3 m-20 -125.79 125.68 43.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.183 -0.948 . . . . 0.0 109.186 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -80.35 176.38 3.85 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.895 . . . . 0.0 110.482 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.17 -32.14 78.87 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.124 1.592 . . . . 0.0 110.437 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.58 -31.89 72.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 110.162 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.9 176.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -0.858 . . . . 0.0 110.602 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.92 -38.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.402 -0.812 . . . . 0.0 109.538 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . 99.2 mttt -127.73 101.95 6.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.458 -0.776 . . . . 0.0 109.603 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.483 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.9 t -47.29 131.82 13.09 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.937 0.875 . . . . 0.0 110.759 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -67.78 -43.48 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 111.419 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.39 -40.25 96.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.236 -0.915 . . . . 0.0 112.341 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.7 p -149.97 22.26 0.87 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.92 -1.112 . . . . 0.0 111.17 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' CYS . 82.5 tt0 35.77 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.423 0.63 . . . . 0.0 112.538 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.436 ' CG2' ' HD2' ' A' ' 27' ' ' PRO . 98.6 m -88.24 145.64 36.38 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.407 -0.808 . . . . 0.0 108.966 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.436 ' HD2' ' CG2' ' A' ' 26' ' ' THR . 50.5 Cg_endo -77.48 47.34 2.25 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.607 1.32 . . . . 0.0 110.58 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -122.92 80.82 50.17 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 110.429 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -53.92 -38.85 86.33 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.825 1.434 . . . . 0.0 110.079 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.55 167.15 38.92 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.5 p -66.5 -33.16 75.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -1.212 . . . . 0.0 110.128 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.77 7.07 86.37 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.45 -45.36 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.899 -1.353 . . . . 0.0 109.865 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.85 -41.16 97.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.826 . . . . 0.0 110.245 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.254 -179.88 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.204 0.526 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 93.7 mt -63.47 -43.47 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.285 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.26 150.15 51.54 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.443 ' CG2' ' HG3' ' A' ' 16' ' ' PRO . 69.6 p -83.24 163.47 20.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.131 -1.217 . . . . 0.0 110.138 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.53 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 24.2 p-90 -144.96 158.64 43.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.948 . . . . 0.0 110.174 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 7' ' ' CYS . 67.8 t0 -131.97 139.35 48.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.165 -0.96 . . . . 0.0 110.418 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 13.5 t -89.6 112.99 24.36 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.394 -0.816 . . . . 0.0 109.617 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -91.91 -7.22 49.81 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.163 -0.96 . . . . 0.0 110.511 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -66.99 -34.13 77.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.023 -1.048 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 12.8 p -128.27 18.95 6.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 110.432 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 75.5 mt 58.87 45.35 15.41 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.677 -0.639 . . . . 0.0 111.869 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -128.57 132.96 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.07 -1.018 . . . . 0.0 110.184 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -100.86 144.45 29.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.74 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.53 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.2 m-20 -121.03 122.54 40.32 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.028 -1.045 . . . . 0.0 109.894 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttm -67.84 168.87 11.06 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.25 -0.906 . . . . 0.0 109.614 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.443 ' HG3' ' CG2' ' A' ' 4' ' ' THR . 47.2 Cg_exo -53.71 -35.49 78.47 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.91 1.479 . . . . 0.0 110.601 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -66.66 -35.03 79.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.553 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -51.3 179.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.499 -0.751 . . . . 0.0 110.075 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -162.45 -39.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.007 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . 96.7 mttt -135.44 111.8 9.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 25' ' ' GLU . 11.5 t -45.68 130.6 9.13 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.997 0.903 . . . . 0.0 111.344 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -68.28 -43.09 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.02 -1.05 . . . . 0.0 111.377 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.37 92.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.262 -0.899 . . . . 0.0 112.44 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.6 p -147.38 20.11 1.2 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.733 -1.23 . . . . 0.0 111.553 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' CYS . 80.9 tt0 42.38 90.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.661 -0.649 . . . . 0.0 111.767 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.407 ' CG2' ' SG ' ' A' ' 7' ' ' CYS . 2.1 p -69.54 157.6 89.09 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.365 -0.835 . . . . 0.0 109.237 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.71 -6.58 19.44 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 123.88 1.463 . . . . 0.0 110.752 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.8 66.7 1.22 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.012 -1.055 . . . . 0.0 109.627 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -53.86 -37.95 85.47 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.087 1.572 . . . . 0.0 110.54 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.49 -128.4 9.33 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.4 p -132.77 156.8 46.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.275 -1.132 . . . . 0.0 110.119 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.58 -165.05 36.87 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -131.88 160.77 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -1.112 . . . . 0.0 109.862 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.31 138.82 43.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.32 -0.862 . . . . 0.0 110.08 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.273 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.346 0.593 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.3 pt -127.5 152.06 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.379 -0.826 . . . . 0.0 109.957 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.44 177.13 45.21 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 62.8 m -117.9 131.81 56.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -1.107 . . . . 0.0 110.262 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 59.1 p-90 -143.36 158.84 43.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.453 -0.779 . . . . 0.0 110.246 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.415 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 46.8 p-10 -130.5 148.74 52.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.143 -0.973 . . . . 0.0 110.59 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.4 t -85.31 113.8 21.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.145 -0.972 . . . . 0.0 109.689 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -83.06 -14.05 54.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.359 -0.838 . . . . 0.0 110.503 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.6 m -61.96 -43.47 98.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 109.711 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.403 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.2 p -120.83 21.91 11.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.832 . . . . 0.0 110.925 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.7 mt 54.15 47.6 22.84 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.242 -0.911 . . . . 0.0 111.995 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 43.9 t -125.94 130.7 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.837 -1.164 . . . . 0.0 110.238 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.415 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . 54.7 tt0 -97.53 132.46 43.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.071 -1.018 . . . . 0.0 110.218 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.422 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 3.0 m-20 -117.02 127.27 54.01 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.138 -0.976 . . . . 0.0 109.658 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -69.82 170.91 8.34 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.985 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -54.9 -32.54 78.41 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.011 1.532 . . . . 0.0 110.512 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.49 -32.07 73.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -64.39 -179.95 0.52 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.395 -0.815 . . . . 0.0 110.412 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.94 -42.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 62.3 pttt -128.96 114.74 16.81 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.111 0.958 . . . . 0.0 109.141 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.0 t -46.43 132.0 10.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.52 -0.737 . . . . 0.0 111.344 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -64.11 -46.25 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.508 -0.745 . . . . 0.0 111.88 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.36 -41.24 94.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.953 -1.092 . . . . 0.0 109.849 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 32.1 p -152.45 80.66 1.24 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.032 0.92 . . . . 0.0 109.146 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 21' ' ' CYS . 95.5 mt-10 -31.35 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.374 0.607 . . . . 0.0 112.549 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.97 154.85 80.42 Favored Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.095 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -66.32 -16.47 51.64 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 123.963 1.507 . . . . 0.0 111.228 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.461 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 12.8 tttp 50.87 64.31 8.42 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.072 -1.017 . . . . 0.0 109.37 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 19.3 Cg_exo -61.83 145.1 97.33 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.887 1.467 . . . . 0.0 110.546 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.15 162.56 35.35 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.2 m -63.53 -45.78 89.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.192 -1.181 . . . . 0.0 110.773 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.64 171.94 42.48 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.06 132.84 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.348 -1.089 . . . . 0.0 110.352 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -117.11 140.81 49.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.229 -0.919 . . . . 0.0 110.464 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.208 -179.997 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.352 0.596 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.0 pt -125.11 160.94 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.754 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.8 -37.96 95.46 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.441 ' N ' ' HG3' ' A' ' 16' ' ' PRO . 31.2 m -72.28 136.34 46.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -1.087 . . . . 0.0 110.984 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -143.54 153.51 42.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -0.971 . . . . 0.0 109.683 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.408 ' HB3' ' HG3' ' A' ' 13' ' ' GLN . 49.3 p-10 -119.99 151.28 39.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.936 -1.102 . . . . 0.0 111.148 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.7 t -94.6 121.21 35.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.093 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -96.85 -14.79 21.61 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.051 -1.031 . . . . 0.0 110.526 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -60.09 -39.02 84.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.052 -1.03 . . . . 0.0 109.892 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 13.7 p -124.83 22.24 8.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.86 . . . . 0.0 111.073 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 84.6 mt 56.09 44.9 24.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.511 -0.743 . . . . 0.0 112.007 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.48 130.16 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.069 -1.02 . . . . 0.0 109.829 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.408 ' HG3' ' HB3' ' A' ' 6' ' ' ASP . 56.7 tt0 -101.24 145.55 28.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.043 -1.036 . . . . 0.0 110.17 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -134.12 149.7 51.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.065 -1.022 . . . . 0.0 110.091 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.415 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 8.6 mttt -82.2 169.73 17.35 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 109.949 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HG3' ' N ' ' A' ' 4' ' ' THR . 34.3 Cg_exo -56.51 -33.19 91.98 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.091 1.574 . . . . 0.0 110.731 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -65.41 -27.89 68.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 110.011 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.53 178.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.37 -0.831 . . . . 0.0 110.394 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.419 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 75.1 t -152.15 -46.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -139.99 117.86 11.74 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 109.103 178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 25' ' ' GLU . 18.1 t -45.42 140.06 3.33 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.2 1.0 . . . . 0.0 111.585 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.37 -44.49 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.847 -1.158 . . . . 0.0 111.894 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.4 -38.7 85.06 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.173 -0.954 . . . . 0.0 112.358 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 25' ' ' GLU . 20.5 p -147.0 22.36 1.22 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.81 -1.181 . . . . 0.0 111.451 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 21' ' ' CYS . 94.6 mt-10 31.54 85.11 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.0 156.99 11.9 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.925 . . . . 0.0 109.58 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.89 -12.17 34.45 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.885 1.466 . . . . 0.0 111.103 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER 61.23 73.51 0.59 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.09 -1.006 . . . . 0.0 109.765 -179.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.12 -40.46 85.69 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.97 1.51 . . . . 0.0 110.207 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.12 -175.88 54.92 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 83.7 m -112.71 121.22 44.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -1.158 . . . . 0.0 109.809 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.18 -15.23 57.98 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.0 t -119.73 132.59 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.052 -1.264 . . . . 0.0 110.303 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -111.78 144.93 40.26 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.216 -0.928 . . . . 0.0 110.429 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.483 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.497 0.665 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 3' ' ' GLY . 18.0 tt -67.55 -36.83 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.823 . . . . 0.0 110.236 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.421 ' N ' ' CG2' ' A' ' 2' ' ' ILE . . . 70.27 -156.49 53.37 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.3 m -121.52 131.2 54.0 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.035 -1.274 . . . . 0.0 110.631 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.528 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 52.2 p-90 -135.9 156.48 48.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.082 -1.011 . . . . 0.0 109.829 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -124.62 149.01 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.956 . . . . 0.0 110.773 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.6 t -92.8 120.9 33.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.36 -0.838 . . . . 0.0 110.429 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.6 p30 -96.86 -6.08 36.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.821 -1.175 . . . . 0.0 110.279 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.4 m -63.13 -42.39 99.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.167 -0.958 . . . . 0.0 109.409 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.415 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.6 p -125.04 18.14 8.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.535 -0.728 . . . . 0.0 111.35 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mp 62.95 43.45 6.72 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.217 -0.927 . . . . 0.0 111.767 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.415 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 48.8 t -125.81 134.96 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.263 -0.898 . . . . 0.0 109.917 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -98.41 145.09 27.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.078 -1.014 . . . . 0.0 110.016 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.528 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 m-20 -122.47 131.44 53.86 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.093 -1.005 . . . . 0.0 110.466 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -78.08 168.99 22.99 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 110.048 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.97 -33.77 73.98 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.896 1.472 . . . . 0.0 109.911 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.88 -40.27 91.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.142 -0.974 . . . . 0.0 109.904 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.426 ' O ' ' CG2' ' A' ' 19' ' ' VAL . . . -54.0 -179.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 109.895 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 40.2 t -157.7 -43.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.408 ' HG3' HG12 ' A' ' 19' ' ' VAL . 98.8 mttt -134.49 116.03 14.63 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.7 t -45.73 131.64 9.03 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.93 0.872 . . . . 0.0 111.946 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.81 -46.27 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.522 -0.736 . . . . 0.0 111.373 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.03 88.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.157 -0.965 . . . . 0.0 109.345 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -153.97 84.52 1.15 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.13 0.967 . . . . 0.0 109.242 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 21' ' ' CYS . 92.0 mt-10 -33.07 88.38 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 24' ' ' CYS . 21.4 p -67.92 147.28 98.5 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.0 . . . . 0.0 109.818 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 38.2 Cg_endo -73.5 -8.35 21.57 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.862 1.454 . . . . 0.0 110.995 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER 66.25 67.15 0.71 Allowed Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.225 -0.922 . . . . 0.0 110.746 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 11.5 Cg_exo -68.17 152.35 76.25 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.859 1.452 . . . . 0.0 110.708 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.94 -176.72 50.91 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.8 m -116.2 124.16 49.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.01 -1.288 . . . . 0.0 110.971 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.31 173.71 33.06 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.3 t -121.24 134.11 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -1.227 . . . . 0.0 109.391 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -62.77 131.84 50.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 110.398 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.219 179.699 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.303 0.573 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.434 ' CG2' ' HB ' ' A' ' 4' ' ' THR . 34.0 mm -63.66 -44.63 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.505 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.95 20.36 78.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.434 ' HB ' ' CG2' ' A' ' 2' ' ' ILE . 64.4 m -114.07 133.12 55.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.232 -1.158 . . . . 0.0 110.159 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 33.3 p-90 -142.37 152.84 43.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 110.516 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 43.8 p-10 -118.13 142.79 47.05 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.466 -0.771 . . . . 0.0 110.017 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 t -88.97 113.22 24.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.17 -0.956 . . . . 0.0 109.689 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 43.3 p-10 -84.98 -8.87 58.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.943 . . . . 0.0 109.94 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -64.46 -44.37 91.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.157 -0.964 . . . . 0.0 110.123 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.404 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -126.03 28.75 6.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 111.306 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt 53.21 42.74 32.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.27 -0.894 . . . . 0.0 111.978 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 44.0 t -125.0 134.75 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.785 -1.197 . . . . 0.0 110.696 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -103.87 142.49 34.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.183 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.437 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 82.3 m-20 -130.43 134.88 47.46 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.023 -1.048 . . . . 0.0 110.302 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.19 169.62 18.42 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.438 -0.789 . . . . 0.0 110.165 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.25 -34.49 88.42 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.958 1.504 . . . . 0.0 110.623 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.82 -32.97 74.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.004 . . . . 0.0 109.766 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.437 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -51.52 179.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.496 -0.752 . . . . 0.0 109.696 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 39.2 t -156.36 -42.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.139 -0.976 . . . . 0.0 108.773 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 99.3 mttt -137.02 115.88 12.25 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.669 0.747 . . . . 0.0 109.309 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.463 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 12.8 t -46.35 132.52 10.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.79 0.805 . . . . 0.0 111.198 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.66 -45.61 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.184 -0.947 . . . . 0.0 111.195 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.94 85.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.959 -1.088 . . . . 0.0 109.757 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.446 ' O ' ' C ' ' A' ' 25' ' ' GLU . 31.8 p -148.97 78.47 1.4 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.762 0.791 . . . . 0.0 109.166 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.463 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 95.5 mt-10 -29.22 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.594 0.712 . . . . 0.0 111.867 -178.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.429 ' N ' ' O ' ' A' ' 24' ' ' CYS . 42.8 p -52.42 154.63 4.25 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.999 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.38 23.21 0.85 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.083 1.57 . . . . 0.0 110.694 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -132.24 93.79 25.1 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.95 -1.094 . . . . 0.0 110.621 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -60.82 145.14 99.44 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.914 1.481 . . . . 0.0 109.637 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.97 169.1 23.91 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.4 m -123.98 129.67 51.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.469 -1.018 . . . . 0.0 110.049 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.54 171.22 53.95 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.1 t -124.03 130.71 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -1.108 . . . . 0.0 109.901 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.89 -41.66 99.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.034 -1.041 . . . . 0.0 109.755 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.2 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.336 0.589 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.87 129.36 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.155 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.51 18.42 71.05 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.7 p -132.73 163.18 29.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -1.199 . . . . 0.0 109.992 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -140.84 156.27 46.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.058 -1.026 . . . . 0.0 110.651 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.432 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 79.9 m-20 -139.36 154.32 47.84 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 110.138 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 t -89.09 114.23 25.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 110.285 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -80.66 -18.74 47.09 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.22 -0.925 . . . . 0.0 110.494 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.1 m -61.67 -44.6 96.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.934 . . . . 0.0 110.71 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.0 p -118.89 26.3 9.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.106 -0.996 . . . . 0.0 111.033 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 37.2 tp 48.27 56.39 7.48 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.324 -0.86 . . . . 0.0 111.224 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 28.9 t -130.16 133.51 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.005 -1.06 . . . . 0.0 110.088 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . 84.4 mt-30 -101.05 133.69 45.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 110.103 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 78.6 m-20 -128.98 119.69 24.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.04 -1.038 . . . . 0.0 109.713 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.55 174.74 2.34 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 110.303 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -56.2 -30.55 80.3 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.166 1.614 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -62.38 -37.52 86.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.875 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -54.22 -174.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 110.031 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 80.7 t -155.67 -46.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 99.7 mttt -140.9 120.94 13.69 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.674 0.75 . . . . 0.0 109.047 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 25' ' ' GLU . 9.7 t -46.36 130.09 10.66 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.697 0.76 . . . . 0.0 111.017 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.49 -46.02 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.25 -0.906 . . . . 0.0 111.64 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.5 -41.47 96.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.97 -1.081 . . . . 0.0 109.75 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.43 ' O ' ' C ' ' A' ' 25' ' ' GLU . 32.1 p -153.57 80.77 1.17 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 122.068 0.937 . . . . 0.0 109.036 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 21' ' ' CYS . 96.5 mt-10 -30.3 93.3 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.544 0.688 . . . . 0.0 112.432 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.8 p -54.94 157.99 5.12 Favored Pre-proline 0 N--CA 1.49 1.543 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.492 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.58 4.73 5.74 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.909 1.478 . . . . 0.0 111.261 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -88.32 115.22 62.6 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.794 -1.192 . . . . 0.0 110.391 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.64 146.6 96.69 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.579 1.305 . . . . 0.0 110.213 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' CA ' ' HA ' ' A' ' 19' ' ' VAL . . . -65.26 160.22 43.41 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.7 p -133.83 160.11 38.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -1.103 . . . . 0.0 110.445 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.76 17.39 72.96 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.0 t -124.6 131.6 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.059 -1.259 . . . . 0.0 110.378 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -81.71 146.08 30.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 0.0 109.923 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.27 -179.898 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.235 0.54 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mm -107.97 126.78 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.964 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.61 172.46 54.98 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.6 p -81.52 162.4 23.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -1.142 . . . . 0.0 110.021 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 46.9 p-90 -146.65 155.06 42.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.95 . . . . 0.0 110.875 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -135.88 149.57 49.04 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.242 -0.911 . . . . 0.0 109.778 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' VAL . 8.2 t -87.44 120.29 28.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.979 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -95.09 -6.02 42.95 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.254 -0.904 . . . . 0.0 110.759 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.3 p -74.7 -21.29 59.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.913 -1.117 . . . . 0.0 109.941 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.418 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -141.15 20.87 2.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.693 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt 54.82 58.37 4.87 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.413 -0.804 . . . . 0.0 111.592 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.418 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 27.3 t -131.63 135.94 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.899 . . . . 0.0 110.247 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -103.14 134.05 47.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.451 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 94.9 m-20 -134.66 116.41 14.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.062 -1.024 . . . . 0.0 110.494 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.403 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -69.52 176.66 1.55 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.0 110.496 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 35.4 Cg_exo -54.23 -32.02 69.0 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.936 1.492 . . . . 0.0 110.321 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.51 -35.73 81.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 110.607 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -60.35 176.69 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.002 . . . . 0.0 110.5 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 18' ' ' ALA . 44.9 t -156.66 -43.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.325 -0.859 . . . . 0.0 109.23 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.28 106.86 9.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.487 -0.758 . . . . 0.0 109.716 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 25' ' ' GLU . 15.9 t -45.91 135.16 7.42 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.063 0.935 . . . . 0.0 111.253 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.93 -43.33 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.192 -0.942 . . . . 0.0 111.038 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.27 89.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.355 -0.841 . . . . 0.0 112.187 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 25' ' ' GLU . 23.1 p -155.83 25.25 0.38 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.939 -1.1 . . . . 0.0 111.104 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.9 mt-10 33.96 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.424 0.63 . . . . 0.0 111.952 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.449 ' CG2' ' HD2' ' A' ' 27' ' ' PRO . 86.5 m -64.49 146.01 98.26 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 110.219 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.449 ' HD2' ' CG2' ' A' ' 26' ' ' THR . 58.5 Cg_endo -80.7 44.21 1.7 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.927 1.488 . . . . 0.0 110.694 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.48 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -48.17 -58.25 8.47 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.18 -0.95 . . . . 0.0 110.466 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 28' ' ' LYS . 29.6 Cg_endo -66.51 154.73 73.25 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.585 1.308 . . . . 0.0 110.438 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.8 18.4 61.61 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 74.4 m -62.49 -44.7 95.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.066 -1.255 . . . . 0.0 110.025 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.33 -171.94 39.77 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 34' ' ' LYS . 24.3 m -63.6 -40.68 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -1.088 . . . . 0.0 110.154 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.4 ' N ' ' CG2' ' A' ' 33' ' ' VAL . 87.2 tttt -67.88 131.32 45.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.824 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.076 -1.015 . . . . 0.0 110.332 -179.616 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.53 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 35.0 p-90 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.38 0.61 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -120.07 140.68 50.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.167 -0.958 . . . . 0.0 109.816 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.669 ' SG ' HG21 ' A' ' 26' ' ' THR . 19.2 t -87.43 115.92 25.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.519 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -94.51 -5.22 46.55 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.256 -0.903 . . . . 0.0 110.929 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -68.77 -31.21 70.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.95 -1.094 . . . . 0.0 109.634 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.409 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.9 p -135.74 21.03 3.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.811 . . . . 0.0 111.234 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 9.3 mp 58.83 46.55 13.84 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.292 -0.88 . . . . 0.0 111.838 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 48.0 t -127.89 134.66 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.153 -0.967 . . . . 0.0 110.117 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -96.65 145.69 25.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.005 -1.059 . . . . 0.0 110.507 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.53 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 m-20 -125.73 142.1 51.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.202 -0.936 . . . . 0.0 109.876 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -90.95 170.69 9.39 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.766 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.38 -34.32 80.4 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.898 1.473 . . . . 0.0 110.418 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.21 -36.67 82.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.111 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.495 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -51.52 -179.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.462 -0.774 . . . . 0.0 110.667 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.768 HG12 ' HG3' ' A' ' 20' ' ' LYS . 74.2 t -155.31 -47.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.768 ' HG3' HG12 ' A' ' 19' ' ' VAL . 98.4 mttt -137.32 119.54 15.63 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.51 ' O ' ' N ' ' A' ' 25' ' ' GLU . 14.6 t -45.04 140.49 2.69 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.097 0.951 . . . . 0.0 111.595 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.09 -44.45 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.629 -1.294 . . . . 0.0 111.62 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.24 93.2 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.294 -0.879 . . . . 0.0 112.516 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.5 p -140.57 11.9 2.3 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.894 -1.129 . . . . 0.0 112.088 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.3 mt-10 40.8 78.01 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.63 -0.669 . . . . 0.0 111.247 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.669 HG21 ' SG ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.922 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 121.385 0.612 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 47.5 p-10 -132.84 148.43 52.3 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.402 -0.811 . . . . 0.0 110.117 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 t -83.0 106.13 14.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.045 -1.035 . . . . 0.0 109.911 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -71.59 -18.13 62.24 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.423 -0.798 . . . . 0.0 110.185 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.0 m -60.87 -44.35 97.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.867 . . . . 0.0 111.082 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 23' ' ' ALA . 14.0 p -128.96 33.77 4.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.04 -1.037 . . . . 0.0 110.897 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 11' ' ' LEU . 39.0 tp 42.49 65.66 0.88 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.56 -0.712 . . . . 0.0 112.409 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.546 HG11 ' SG ' ' A' ' 21' ' ' CYS . 39.4 t -133.81 135.53 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.945 -1.097 . . . . 0.0 109.906 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -100.78 141.01 34.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.245 -0.909 . . . . 0.0 110.702 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 21' ' ' CYS . 3.6 m-20 -145.91 121.12 10.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 109.557 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -70.2 178.01 1.2 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.412 -0.805 . . . . 0.0 110.298 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.11 -29.83 84.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.0 1.526 . . . . 0.0 109.764 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.64 -37.8 88.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.459 -0.776 . . . . 0.0 109.764 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.794 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -54.92 -172.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.405 -0.809 . . . . 0.0 110.426 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -168.91 -37.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.467 -0.771 . . . . 0.0 109.113 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -131.9 111.04 11.23 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.675 0.75 . . . . 0.0 109.402 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.546 ' SG ' HG11 ' A' ' 12' ' ' VAL . 8.9 t -45.99 141.27 3.26 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.902 0.858 . . . . 0.0 110.924 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.68 -43.86 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.611 -1.306 . . . . 0.0 111.639 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.607 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -63.93 -38.07 89.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.319 -0.863 . . . . 0.0 112.437 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.9 p -142.77 13.07 1.89 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.003 -1.061 . . . . 0.0 112.1 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 21' ' ' CYS . 96.7 mt-10 43.78 73.08 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.418 -0.801 . . . . 0.0 110.105 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.944 -0.472 . . . . 0.0 110.558 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.477 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 19.7 p-90 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.359 0.599 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -130.41 134.29 47.01 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.083 -1.01 . . . . 0.0 109.908 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.7 t -83.66 114.79 21.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.361 -0.837 . . . . 0.0 108.769 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -92.06 -7.3 49.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.002 -1.061 . . . . 0.0 110.631 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.4 p -68.5 -33.88 74.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 109.406 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 12' ' ' VAL . 12.6 p -128.3 20.46 6.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.363 -0.836 . . . . 0.0 111.108 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt 53.15 48.99 20.97 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.291 -0.881 . . . . 0.0 112.393 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.4 ' HB ' ' SG ' ' A' ' 10' ' ' CYS . 51.2 t -128.07 131.79 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.852 -1.155 . . . . 0.0 110.527 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -89.18 142.49 27.6 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.593 -0.692 . . . . 0.0 109.992 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 8.4 m-20 -129.92 126.21 37.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.961 -1.087 . . . . 0.0 110.114 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.502 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 15.5 mmtp -73.14 171.43 10.46 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.55 -0.719 . . . . 0.0 110.592 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 34.7 Cg_exo -55.44 -32.02 80.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.915 1.481 . . . . 0.0 110.028 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' OE1' ' HB3' ' A' ' 15' ' ' LYS . 52.5 mp0 -66.47 -31.05 71.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.401 -0.812 . . . . 0.0 109.703 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 15' ' ' LYS . . . -61.52 151.01 34.11 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.347 0.594 . . . . 0.0 110.536 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.2 t -137.5 -42.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.516 -0.74 . . . . 0.0 109.195 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 25' ' ' GLU . 99.7 mttt -130.46 107.72 9.43 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.466 -0.894 . . . . 0.0 108.701 178.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.469 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.5 t -45.54 130.25 8.75 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.471 0.653 . . . . 0.0 110.837 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.7 t -62.71 -46.73 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.206 -0.934 . . . . 0.0 112.079 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.22 -38.59 91.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.781 -1.199 . . . . 0.0 109.673 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -155.43 83.22 1.05 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.057 0.932 . . . . 0.0 109.043 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.469 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.5 mt-10 -33.68 92.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.056 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 24' ' ' CYS . 13.4 p . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.129 -0.982 . . . . 0.0 110.147 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.541 ' CZ2' ' CB ' ' A' ' 14' ' ' ASN . 29.0 p-90 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.553 0.692 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -130.91 127.64 38.9 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.438 -0.788 . . . . 0.0 109.926 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.55 ' SG ' HG21 ' A' ' 26' ' ' THR . 30.6 t -76.97 120.46 22.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.628 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -92.8 -8.58 43.22 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.465 -0.772 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 m -64.17 -44.55 91.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 110.521 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.428 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.3 p -124.14 18.81 9.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 110.915 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.3 mt 56.53 52.59 9.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.36 -0.837 . . . . 0.0 111.572 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.428 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 37.9 t -127.15 132.76 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.304 -0.873 . . . . 0.0 109.6 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -93.62 136.48 33.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 110.637 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' CZ2' ' A' ' 5' ' ' TRP . 1.6 m120 -126.18 130.38 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.111 -0.993 . . . . 0.0 109.576 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -69.15 166.89 24.4 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 0.0 109.864 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -52.71 -36.59 73.24 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 124.041 1.548 . . . . 0.0 109.754 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.34 -35.87 76.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.917 . . . . 0.0 109.849 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.615 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -60.88 146.02 48.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 110.193 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -157.38 23.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.393 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -158.0 75.27 0.75 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.486 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.6 t -45.27 129.47 8.04 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.031 0.92 . . . . 0.0 111.078 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.19 -43.73 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.106 . . . . 0.0 111.576 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.19 -40.69 96.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.368 -0.833 . . . . 0.0 112.211 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 p -149.95 24.39 0.85 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.833 -1.167 . . . . 0.0 111.344 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 21' ' ' CYS . 75.2 tt0 36.9 96.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.392 0.615 . . . . 0.0 112.447 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.55 HG21 ' SG ' ' A' ' 7' ' ' CYS . 22.3 p . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.422 -0.799 . . . . 0.0 109.831 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.492 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 26.8 p-90 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.261 0.553 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -130.69 134.58 47.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.049 -1.032 . . . . 0.0 110.456 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 t -87.59 118.27 26.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.83 . . . . 0.0 109.699 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -89.89 -11.96 40.35 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.16 -0.962 . . . . 0.0 111.09 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.2 p -66.97 -31.42 71.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.912 -1.117 . . . . 0.0 110.29 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.461 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.8 p -133.92 24.8 3.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.988 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 37.6 tp 46.83 57.33 5.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.277 -0.89 . . . . 0.0 111.531 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 10' ' ' CYS . 41.8 t -131.28 133.78 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.987 -1.071 . . . . 0.0 109.866 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -101.19 130.77 47.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.292 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.492 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 85.6 m-20 -132.17 125.73 31.91 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.056 -1.027 . . . . 0.0 109.936 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 2.6 mttt -78.34 176.53 3.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.813 . . . . 0.0 110.477 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 32.2 Cg_exo -56.36 -29.73 78.22 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.016 1.534 . . . . 0.0 110.01 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -64.89 -36.0 82.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.362 -0.836 . . . . 0.0 109.831 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.503 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -52.35 -179.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.334 -0.854 . . . . 0.0 110.095 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.77 HG12 ' HG3' ' A' ' 20' ' ' LYS . 76.6 t -154.73 -43.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.959 . . . . 0.0 109.099 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.77 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.1 mttt -135.77 110.79 8.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.567 0.698 . . . . 0.0 109.305 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.58 ' CB ' HG23 ' A' ' 26' ' ' THR . 12.2 t -46.2 132.21 9.96 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.503 0.668 . . . . 0.0 111.075 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.55 -46.72 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.524 -0.735 . . . . 0.0 111.731 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.7 96.02 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.964 -1.085 . . . . 0.0 109.694 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.439 ' O ' ' C ' ' A' ' 25' ' ' GLU . 32.1 p -153.63 81.91 1.17 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.794 0.807 . . . . 0.0 109.201 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.515 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.1 mt-10 -30.37 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.545 0.688 . . . . 0.0 112.12 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.58 HG23 ' CB ' ' A' ' 21' ' ' CYS . 78.0 p . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.482 -0.762 . . . . 0.0 110.035 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.527 ' HH2' ' HG1' ' A' ' 26' ' ' THR . 56.4 p-90 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.442 0.639 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.445 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 47.0 p-10 -134.82 151.89 51.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.31 -0.869 . . . . 0.0 110.256 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' VAL . 13.4 t -84.31 107.06 16.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.343 -0.848 . . . . 0.0 110.365 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -72.05 -18.71 61.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.27 -0.894 . . . . 0.0 110.279 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.8 m -60.97 -45.1 96.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.912 . . . . 0.0 110.661 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.485 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.9 p -121.85 29.74 6.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.126 -0.984 . . . . 0.0 110.783 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 35.1 tp 44.45 55.46 5.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.522 -0.736 . . . . 0.0 111.594 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 10' ' ' CYS . 34.7 t -129.26 133.88 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.999 -1.063 . . . . 0.0 109.808 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.445 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . 88.6 mt-30 -100.33 132.35 45.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.98 . . . . 0.0 110.606 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 4.0 m-20 -118.01 124.24 47.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.46 -0.775 . . . . 0.0 109.433 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -68.0 170.67 6.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.981 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -54.92 -32.58 78.73 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.987 1.52 . . . . 0.0 110.013 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.49 -34.34 78.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 109.818 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -51.96 -179.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.408 -0.807 . . . . 0.0 110.507 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.781 HG12 ' HG3' ' A' ' 20' ' ' LYS . 69.8 t -155.17 -45.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.781 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.6 mttt -139.62 118.76 12.68 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 25' ' ' GLU . 12.5 t -45.57 130.18 8.82 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.581 0.705 . . . . 0.0 111.384 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.77 -46.46 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.411 -0.806 . . . . 0.0 111.641 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.4 97.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.911 -1.118 . . . . 0.0 109.33 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.436 ' O ' ' C ' ' A' ' 25' ' ' GLU . 31.0 p -155.45 84.99 1.05 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.834 0.826 . . . . 0.0 109.25 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 24' ' ' CYS . 95.7 mt-10 -30.99 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.591 0.71 . . . . 0.0 112.683 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.527 ' HG1' ' HH2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.519 0 O-C-N 121.58 -0.7 . . . . 0.0 109.926 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.511 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 45.7 p-90 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.395 0.617 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 45.0 p-10 -136.82 148.79 47.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.352 -0.843 . . . . 0.0 110.124 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.6 t -83.89 135.54 34.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.867 . . . . 0.0 109.833 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -101.61 -16.9 16.58 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.097 -1.002 . . . . 0.0 110.854 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.5 p -65.29 -31.23 72.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.003 -1.06 . . . . 0.0 110.277 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.2 p -131.02 21.74 4.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 110.854 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 41.2 tp 49.4 59.59 4.37 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.217 -0.927 . . . . 0.0 111.424 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 28.0 t -132.72 135.03 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.126 -0.984 . . . . 0.0 110.262 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -99.44 137.23 38.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.164 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 61.7 m-20 -131.13 134.47 46.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.162 -0.961 . . . . 0.0 109.703 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -76.94 169.71 19.9 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 110.421 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -54.27 -33.29 75.05 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.168 1.615 . . . . 0.0 110.586 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.4 mp0 -65.64 -36.33 83.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.146 -0.971 . . . . 0.0 110.203 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -52.38 175.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.442 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.528 HG12 ' HG3' ' A' ' 20' ' ' LYS . 76.0 t -156.94 -41.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.332 -0.855 . . . . 0.0 109.167 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.528 ' HG3' HG12 ' A' ' 19' ' ' VAL . 96.9 mttt -127.33 107.41 9.96 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.141 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.504 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.4 t -46.64 132.42 10.95 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.52 0.676 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.05 -45.73 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.835 . . . . 0.0 111.659 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.26 99.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.851 -1.156 . . . . 0.0 109.556 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -155.02 83.66 1.08 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.793 0.806 . . . . 0.0 108.87 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.504 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.5 mt-10 -31.45 91.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.519 0.676 . . . . 0.0 112.333 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 24' ' ' CYS . 6.6 m . . . . . 0 N--CA 1.487 1.42 0 O-C-N 121.422 -0.799 . . . . 0.0 109.372 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.517 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 48.4 p-90 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.251 0.548 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -129.74 130.04 44.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.265 -0.897 . . . . 0.0 110.416 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.9 t -75.55 100.27 4.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.422 -0.799 . . . . 0.0 109.83 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -69.51 -16.53 63.46 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.475 -0.765 . . . . 0.0 110.563 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.1 m -60.95 -44.43 97.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.034 -1.041 . . . . 0.0 110.392 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.9 p -124.24 21.16 8.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.014 -1.053 . . . . 0.0 111.282 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.5 mt 53.84 52.31 13.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.172 -0.955 . . . . 0.0 111.959 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 48.8 t -129.0 132.14 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.089 -1.007 . . . . 0.0 109.685 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -96.45 137.02 36.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.0 110.565 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.517 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 79.6 m-20 -132.46 124.43 28.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.368 -0.832 . . . . 0.0 109.874 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 37.8 mtpt -73.39 168.39 25.72 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.929 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 52.2 Cg_exo -51.94 -33.15 50.71 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.797 1.419 . . . . 0.0 110.581 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -60.89 -35.13 75.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.925 . . . . 0.0 108.879 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.506 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -52.96 177.45 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.623 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.782 HG12 ' HG3' ' A' ' 20' ' ' LYS . 78.3 t -155.8 -43.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -0.82 . . . . 0.0 108.804 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.782 ' HG3' HG12 ' A' ' 19' ' ' VAL . 97.4 mttt -136.49 112.36 9.55 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.802 0.811 . . . . 0.0 109.228 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.459 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.1 t -45.37 131.73 8.08 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.755 0.788 . . . . 0.0 111.473 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.1 t -64.01 -46.66 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.052 -1.03 . . . . 0.0 111.106 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.84 88.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.576 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 26' ' ' THR . 32.1 p -148.48 81.12 1.46 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.823 0.821 . . . . 0.0 109.081 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.459 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 95.8 mt-10 -30.54 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.615 0.721 . . . . 0.0 112.209 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 24' ' ' CYS . 6.7 p . . . . . 0 N--CA 1.487 1.407 0 O-C-N 121.737 -0.602 . . . . 0.0 109.921 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.471 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 51.0 p-90 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.361 0.6 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -135.22 150.33 50.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.046 -1.034 . . . . 0.0 110.311 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.7 t -90.15 123.72 34.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.0 110.098 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -96.76 -4.19 41.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.169 -0.957 . . . . 0.0 111.143 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.6 p -74.19 -23.17 59.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.91 -1.119 . . . . 0.0 109.847 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.5 p -141.31 21.35 2.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.371 -0.83 . . . . 0.0 111.014 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt 54.23 48.96 19.68 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.325 -0.859 . . . . 0.0 111.686 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 41.0 t -125.35 132.21 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -0.967 . . . . 0.0 109.811 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -97.44 139.37 33.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.186 -0.946 . . . . 0.0 110.356 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 95.2 m-20 -134.65 106.02 6.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.294 -0.879 . . . . 0.0 110.014 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 3.1 mttm -56.55 172.93 0.32 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.857 . . . . 0.0 110.372 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 31.7 Cg_exo -56.89 -29.29 81.24 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.959 1.505 . . . . 0.0 110.231 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -65.14 -34.66 78.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 109.972 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -52.54 -177.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.78 . . . . 0.0 110.364 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.91 HG12 ' HG3' ' A' ' 20' ' ' LYS . 20.6 t -155.13 -44.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 108.882 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.91 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.2 mttt -142.56 115.62 8.84 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.804 0.811 . . . . 0.0 109.571 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.47 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 12.2 t -45.73 132.41 8.7 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.877 0.846 . . . . 0.0 111.793 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.92 -47.06 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.451 -0.781 . . . . 0.0 111.301 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.94 83.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.066 -1.021 . . . . 0.0 109.573 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 26' ' ' THR . 32.0 p -146.91 80.72 1.54 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.807 0.813 . . . . 0.0 109.426 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.47 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 96.6 mt-10 -29.24 89.7 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.487 0.661 . . . . 0.0 112.666 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 24' ' ' CYS . 2.1 p . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.756 -0.59 . . . . 0.0 109.912 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.478 0.656 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -125.73 142.64 51.41 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.012 -1.055 . . . . 0.0 110.291 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.2 t -87.78 117.21 26.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.945 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 42.3 p-10 -92.77 -8.21 44.35 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.055 -1.028 . . . . 0.0 110.619 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.2 m -63.16 -43.55 97.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 109.037 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.422 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -123.11 21.06 9.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.579 -0.7 . . . . 0.0 110.319 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 37.8 tp 53.08 59.36 4.5 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.482 -0.761 . . . . 0.0 111.548 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 38.6 t -131.95 134.56 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -0.91 . . . . 0.0 109.722 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.99 136.01 38.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.164 -0.96 . . . . 0.0 110.589 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.456 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 99.4 m-20 -137.09 123.79 21.12 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.84 172.77 6.38 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.988 . . . . 0.0 110.612 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -53.96 -32.96 70.45 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.16 1.61 . . . . 0.0 110.379 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.77 -32.17 73.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.014 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -50.85 178.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.405 -0.81 . . . . 0.0 110.383 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -158.6 -41.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.475 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.86 108.14 6.46 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.533 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 14.3 t -46.02 137.18 6.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.894 0.854 . . . . 0.0 110.931 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.04 -44.81 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 111.958 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.65 85.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.166 -0.959 . . . . 0.0 112.35 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 25' ' ' GLU . 26.8 p -146.75 24.6 1.2 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.844 -1.16 . . . . 0.0 111.741 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.533 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.0 mt-10 28.87 86.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.309 -0.869 . . . . 0.0 110.352 179.383 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.462 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 48.3 p-90 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.33 0.586 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -120.9 140.74 51.39 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.307 -0.871 . . . . 0.0 109.99 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.6 t -84.52 113.41 21.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.19 -0.944 . . . . 0.0 109.206 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -88.69 -10.02 49.95 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.27 -0.894 . . . . 0.0 111.059 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.1 p -66.93 -31.5 72.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.008 -1.057 . . . . 0.0 109.989 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.413 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.1 p -133.55 22.53 3.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 111.341 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.1 mt 55.58 48.68 18.15 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.237 -0.914 . . . . 0.0 111.746 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.448 HG11 ' SG ' ' A' ' 21' ' ' CYS . 40.9 t -126.53 132.07 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.195 -0.94 . . . . 0.0 109.708 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.03 134.2 42.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.085 -1.009 . . . . 0.0 110.492 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 m-20 -120.17 131.5 55.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.195 -0.941 . . . . 0.0 109.934 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 3.0 mttt -80.28 173.38 7.81 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.9 . . . . 0.0 110.03 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -54.74 -34.48 84.53 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.982 1.517 . . . . 0.0 110.249 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.74 -35.6 80.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.562 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.523 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -51.09 174.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.486 -0.759 . . . . 0.0 110.419 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.69 HG12 ' HG3' ' A' ' 20' ' ' LYS . 75.4 t -156.44 -44.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.69 ' HG3' HG12 ' A' ' 19' ' ' VAL . 98.0 mttt -133.1 112.53 11.85 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 25' ' ' GLU . 12.4 t -45.74 138.4 4.74 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.086 0.946 . . . . 0.0 111.316 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.63 -44.84 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.636 -1.29 . . . . 0.0 111.871 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.01 90.91 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.212 -0.93 . . . . 0.0 112.61 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.3 p -140.5 16.28 2.37 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.833 -1.167 . . . . 0.0 111.961 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.2 mt-10 38.43 78.36 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.692 -0.63 . . . . 0.0 111.784 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.497 ' HZ3' HG21 ' A' ' 26' ' ' THR . 33.2 p-90 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.368 0.604 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -135.06 151.07 50.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.159 -0.963 . . . . 0.0 110.091 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.8 t -90.96 111.25 22.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.163 -0.961 . . . . 0.0 110.657 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -80.56 -17.17 52.29 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.511 -0.743 . . . . 0.0 110.515 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.4 m -62.22 -44.35 96.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -0.998 . . . . 0.0 110.895 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.0 p -120.4 24.22 10.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 111.347 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt 53.81 50.9 15.92 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.289 -0.882 . . . . 0.0 111.637 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 40.2 t -130.15 133.4 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.146 -0.971 . . . . 0.0 110.506 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -96.8 137.29 36.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.055 -1.028 . . . . 0.0 110.064 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 2.4 m-20 -119.24 120.45 37.07 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.149 -0.97 . . . . 0.0 110.403 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.38 172.19 2.75 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.954 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.48 -33.6 92.81 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.996 1.524 . . . . 0.0 110.174 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.87 -36.1 79.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -0.801 . . . . 0.0 109.765 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.02 157.91 29.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 0.0 110.55 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.9 t -147.05 -41.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.418 -0.802 . . . . 0.0 108.93 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . 97.4 mttt -115.57 101.55 8.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.421 -0.8 . . . . 0.0 108.984 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.2 t -45.27 133.02 7.29 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.183 0.992 . . . . 0.0 111.256 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.72 -43.4 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 111.546 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.47 91.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.189 -0.944 . . . . 0.0 112.429 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 p -151.01 21.43 0.77 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.771 -1.205 . . . . 0.0 111.406 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 21' ' ' CYS . 86.4 tt0 41.14 91.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.731 -0.606 . . . . 0.0 111.489 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.497 HG21 ' HZ3' ' A' ' 5' ' ' TRP . 2.0 m . . . . . 0 C--N 1.301 -1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.378 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 53.7 p-90 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.487 0.661 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -131.07 146.75 52.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.389 -0.819 . . . . 0.0 109.658 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.828 ' HB3' HG22 ' A' ' 12' ' ' VAL . 6.5 t -79.19 114.59 18.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 110.273 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -71.47 -24.1 61.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.0 110.191 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.8 m -62.15 -45.61 92.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.885 . . . . 0.0 110.5 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.521 ' SG ' HG13 ' A' ' 12' ' ' VAL . 14.0 p -125.28 13.73 8.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.166 -0.959 . . . . 0.0 110.934 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 11' ' ' LEU . 42.7 tp 48.25 85.31 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.261 -0.9 . . . . 0.0 112.219 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.843 HG21 ' SG ' ' A' ' 21' ' ' CYS . 18.6 m -138.64 163.6 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 109.299 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -108.3 107.87 18.64 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.046 -1.034 . . . . 0.0 110.836 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.461 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 44.3 m-20 -125.79 125.68 43.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.183 -0.948 . . . . 0.0 109.186 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -80.35 176.38 3.85 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.895 . . . . 0.0 110.482 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.17 -32.14 78.87 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.124 1.592 . . . . 0.0 110.437 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.58 -31.89 72.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 110.162 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -49.9 176.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -0.858 . . . . 0.0 110.602 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -160.92 -38.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.402 -0.812 . . . . 0.0 109.538 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -127.73 101.95 6.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.458 -0.776 . . . . 0.0 109.603 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.843 ' SG ' HG21 ' A' ' 12' ' ' VAL . 13.9 t -47.29 131.82 13.09 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.937 0.875 . . . . 0.0 110.759 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -67.78 -43.48 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 111.419 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.472 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -63.39 -40.25 96.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.236 -0.915 . . . . 0.0 112.341 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.7 p -149.97 22.26 0.87 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.92 -1.112 . . . . 0.0 111.17 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' CYS . 82.5 tt0 35.77 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.423 0.63 . . . . 0.0 112.538 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 C--N 1.301 -1.522 0 O-C-N 121.407 -0.808 . . . . 0.0 108.966 178.417 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.53 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 24.2 p-90 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.348 0.595 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 7' ' ' CYS . 67.8 t0 -131.97 139.35 48.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.165 -0.96 . . . . 0.0 110.418 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.426 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 13.5 t -89.6 112.99 24.36 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.394 -0.816 . . . . 0.0 109.617 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -91.91 -7.22 49.81 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.163 -0.96 . . . . 0.0 110.511 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -66.99 -34.13 77.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.023 -1.048 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 12.8 p -128.27 18.95 6.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 110.432 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 75.5 mt 58.87 45.35 15.41 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.677 -0.639 . . . . 0.0 111.869 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -128.57 132.96 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.07 -1.018 . . . . 0.0 110.184 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -100.86 144.45 29.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.74 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.53 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.2 m-20 -121.03 122.54 40.32 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.028 -1.045 . . . . 0.0 109.894 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 16.8 mttm -67.84 168.87 11.06 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.25 -0.906 . . . . 0.0 109.614 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.71 -35.49 78.47 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.91 1.479 . . . . 0.0 110.601 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -66.66 -35.03 79.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.553 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.644 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -51.3 179.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.499 -0.751 . . . . 0.0 110.075 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -162.45 -39.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.007 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . 96.7 mttt -135.44 111.8 9.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.5 t -45.68 130.6 9.13 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.997 0.903 . . . . 0.0 111.344 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -68.28 -43.09 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.02 -1.05 . . . . 0.0 111.377 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.37 92.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.262 -0.899 . . . . 0.0 112.44 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.6 p -147.38 20.11 1.2 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.733 -1.23 . . . . 0.0 111.553 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 21' ' ' CYS . 80.9 tt0 42.38 90.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.661 -0.649 . . . . 0.0 111.767 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.52 ' HG1' ' HH2' ' A' ' 5' ' ' TRP . 2.1 p . . . . . 0 C--N 1.301 -1.515 0 O-C-N 121.365 -0.835 . . . . 0.0 109.237 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.44 ' HH2' ' HG1' ' A' ' 26' ' ' THR . 59.1 p-90 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.207 0.527 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -130.5 148.74 52.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.143 -0.973 . . . . 0.0 110.59 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.4 t -85.31 113.8 21.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.145 -0.972 . . . . 0.0 109.689 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -83.06 -14.05 54.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.359 -0.838 . . . . 0.0 110.503 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.6 m -61.96 -43.47 98.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 109.711 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.403 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.2 p -120.83 21.91 11.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.832 . . . . 0.0 110.925 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.7 mt 54.15 47.6 22.84 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.242 -0.911 . . . . 0.0 111.995 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 43.9 t -125.94 130.7 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.837 -1.164 . . . . 0.0 110.238 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -97.53 132.46 43.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.071 -1.018 . . . . 0.0 110.218 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.426 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 3.0 m-20 -117.02 127.27 54.01 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.138 -0.976 . . . . 0.0 109.658 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -69.82 170.91 8.34 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.985 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -54.9 -32.54 78.41 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.011 1.532 . . . . 0.0 110.512 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.49 -32.07 73.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.468 ' C ' HG22 ' A' ' 19' ' ' VAL . . . -64.39 -179.95 0.52 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.395 -0.815 . . . . 0.0 110.412 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.468 HG22 ' C ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -159.94 -42.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 62.3 pttt -128.96 114.74 16.81 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.111 0.958 . . . . 0.0 109.141 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.45 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.0 t -46.43 132.0 10.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.52 -0.737 . . . . 0.0 111.344 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -64.11 -46.25 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.508 -0.745 . . . . 0.0 111.88 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.36 -41.24 94.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.953 -1.092 . . . . 0.0 109.849 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 32.1 p -152.45 80.66 1.24 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.032 0.92 . . . . 0.0 109.146 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.45 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 95.5 mt-10 -31.35 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.374 0.607 . . . . 0.0 112.549 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.44 ' HG1' ' HH2' ' A' ' 5' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.095 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.282 0.563 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.421 ' HB3' ' HG3' ' A' ' 13' ' ' GLN . 49.3 p-10 -119.99 151.28 39.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.936 -1.102 . . . . 0.0 111.148 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.425 ' SG ' HG23 ' A' ' 26' ' ' THR . 13.7 t -94.6 121.21 35.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.093 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -96.85 -14.79 21.61 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.051 -1.031 . . . . 0.0 110.526 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -60.09 -39.02 84.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.052 -1.03 . . . . 0.0 109.892 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 13.7 p -124.83 22.24 8.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.86 . . . . 0.0 111.073 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 84.6 mt 56.09 44.9 24.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.511 -0.743 . . . . 0.0 112.007 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.405 ' HB ' ' SG ' ' A' ' 10' ' ' CYS . 47.2 t -126.48 130.16 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.069 -1.02 . . . . 0.0 109.829 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.421 ' HG3' ' HB3' ' A' ' 6' ' ' ASP . 56.7 tt0 -101.24 145.55 28.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.043 -1.036 . . . . 0.0 110.17 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -134.12 149.7 51.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.065 -1.022 . . . . 0.0 110.091 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 8.6 mttt -82.2 169.73 17.35 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 109.949 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 34.3 Cg_exo -56.51 -33.19 91.98 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.091 1.574 . . . . 0.0 110.731 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -65.41 -27.89 68.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 110.011 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.44 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -50.53 178.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.37 -0.831 . . . . 0.0 110.394 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.755 HG12 ' HG3' ' A' ' 20' ' ' LYS . 75.1 t -152.15 -46.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.755 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.7 mttt -139.99 117.86 11.74 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 109.103 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.484 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 18.1 t -45.42 140.06 3.33 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.2 1.0 . . . . 0.0 111.585 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.37 -44.49 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.847 -1.158 . . . . 0.0 111.894 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.4 -38.7 85.06 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.173 -0.954 . . . . 0.0 112.358 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 25' ' ' GLU . 20.5 p -147.0 22.36 1.22 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.81 -1.181 . . . . 0.0 111.451 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.484 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 94.6 mt-10 31.54 85.11 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.425 HG23 ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.925 . . . . 0.0 109.58 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.528 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 52.2 p-90 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.158 0.504 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.403 ' HB2' ' HG2' ' A' ' 13' ' ' GLN . 46.9 p-10 -124.62 149.01 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.956 . . . . 0.0 110.773 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.526 ' SG ' HG21 ' A' ' 26' ' ' THR . 20.6 t -92.8 120.9 33.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.36 -0.838 . . . . 0.0 110.429 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.6 p30 -96.86 -6.08 36.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.821 -1.175 . . . . 0.0 110.279 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.4 m -63.13 -42.39 99.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.167 -0.958 . . . . 0.0 109.409 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.415 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.6 p -125.04 18.14 8.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.535 -0.728 . . . . 0.0 111.35 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mp 62.95 43.45 6.72 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.217 -0.927 . . . . 0.0 111.767 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.415 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 48.8 t -125.81 134.96 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.263 -0.898 . . . . 0.0 109.917 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.403 ' HG2' ' HB2' ' A' ' 6' ' ' ASP . 79.0 mt-30 -98.41 145.09 27.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.078 -1.014 . . . . 0.0 110.016 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.528 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 m-20 -122.47 131.44 53.86 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.093 -1.005 . . . . 0.0 110.466 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -78.08 168.99 22.99 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 110.048 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.97 -33.77 73.98 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.896 1.472 . . . . 0.0 109.911 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.88 -40.27 91.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.142 -0.974 . . . . 0.0 109.904 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.58 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -54.0 -179.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 109.895 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.843 HG12 ' HG3' ' A' ' 20' ' ' LYS . 40.2 t -157.7 -43.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.843 ' HG3' HG12 ' A' ' 19' ' ' VAL . 98.8 mttt -134.49 116.03 14.63 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.7 t -45.73 131.64 9.03 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.93 0.872 . . . . 0.0 111.946 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.81 -46.27 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.522 -0.736 . . . . 0.0 111.373 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.03 88.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.157 -0.965 . . . . 0.0 109.345 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -153.97 84.52 1.15 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.13 0.967 . . . . 0.0 109.242 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 21' ' ' CYS . 92.0 mt-10 -33.07 88.38 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.526 HG21 ' SG ' ' A' ' 7' ' ' CYS . 21.4 p . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.0 . . . . 0.0 109.818 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.491 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 33.3 p-90 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.442 0.639 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.444 ' HB2' ' HG2' ' A' ' 13' ' ' GLN . 43.8 p-10 -118.13 142.79 47.05 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.466 -0.771 . . . . 0.0 110.017 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 t -88.97 113.22 24.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.17 -0.956 . . . . 0.0 109.689 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 43.3 p-10 -84.98 -8.87 58.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.943 . . . . 0.0 109.94 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -64.46 -44.37 91.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.157 -0.964 . . . . 0.0 110.123 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.404 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -126.03 28.75 6.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 111.306 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt 53.21 42.74 32.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.27 -0.894 . . . . 0.0 111.978 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 44.0 t -125.0 134.75 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.785 -1.197 . . . . 0.0 110.696 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' A' ' 6' ' ' ASP . 87.6 mt-30 -103.87 142.49 34.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.183 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 82.3 m-20 -130.43 134.88 47.46 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.023 -1.048 . . . . 0.0 110.302 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.19 169.62 18.42 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.438 -0.789 . . . . 0.0 110.165 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.25 -34.49 88.42 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.958 1.504 . . . . 0.0 110.623 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.82 -32.97 74.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.004 . . . . 0.0 109.766 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -51.52 179.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.496 -0.752 . . . . 0.0 109.696 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.888 HG12 ' HG3' ' A' ' 20' ' ' LYS . 39.2 t -156.36 -42.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.139 -0.976 . . . . 0.0 108.773 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.888 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.3 mttt -137.02 115.88 12.25 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.669 0.747 . . . . 0.0 109.309 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.652 ' HB2' HG23 ' A' ' 26' ' ' THR . 12.8 t -46.35 132.52 10.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.79 0.805 . . . . 0.0 111.198 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.66 -45.61 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.184 -0.947 . . . . 0.0 111.195 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.94 85.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.959 -1.088 . . . . 0.0 109.757 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.446 ' O ' ' C ' ' A' ' 25' ' ' GLU . 31.8 p -148.97 78.47 1.4 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.762 0.791 . . . . 0.0 109.166 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.504 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 95.5 mt-10 -29.22 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.594 0.712 . . . . 0.0 111.867 -178.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.652 HG23 ' HB2' ' A' ' 21' ' ' CYS . 42.8 p . . . . . 0 N--CA 1.49 1.542 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.999 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.465 0.65 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.423 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 79.9 m-20 -139.36 154.32 47.84 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 110.138 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 t -89.09 114.23 25.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 110.285 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -80.66 -18.74 47.09 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.22 -0.925 . . . . 0.0 110.494 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.1 m -61.67 -44.6 96.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.934 . . . . 0.0 110.71 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.0 p -118.89 26.3 9.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.106 -0.996 . . . . 0.0 111.033 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 37.2 tp 48.27 56.39 7.48 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.324 -0.86 . . . . 0.0 111.224 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 28.9 t -130.16 133.51 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.005 -1.06 . . . . 0.0 110.088 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.423 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . 84.4 mt-30 -101.05 133.69 45.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 110.103 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 78.6 m-20 -128.98 119.69 24.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.04 -1.038 . . . . 0.0 109.713 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.55 174.74 2.34 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 110.303 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -56.2 -30.55 80.3 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.166 1.614 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -62.38 -37.52 86.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.875 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.518 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -54.22 -174.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 110.031 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.763 HG12 ' HG3' ' A' ' 20' ' ' LYS . 80.7 t -155.67 -46.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.763 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.7 mttt -140.9 120.94 13.69 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.674 0.75 . . . . 0.0 109.047 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.726 ' HB2' HG23 ' A' ' 26' ' ' THR . 9.7 t -46.36 130.09 10.66 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.697 0.76 . . . . 0.0 111.017 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.49 -46.02 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.25 -0.906 . . . . 0.0 111.64 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.5 -41.47 96.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.97 -1.081 . . . . 0.0 109.75 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.43 ' O ' ' C ' ' A' ' 25' ' ' GLU . 32.1 p -153.57 80.77 1.17 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 122.068 0.937 . . . . 0.0 109.036 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.464 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 96.5 mt-10 -30.3 93.3 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.544 0.688 . . . . 0.0 112.432 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.726 HG23 ' HB2' ' A' ' 21' ' ' CYS . 51.8 p . . . . . 0 N--CA 1.49 1.543 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.492 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 46.9 p-90 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.601 0.715 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -135.88 149.57 49.04 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.242 -0.911 . . . . 0.0 109.778 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' VAL . 8.2 t -87.44 120.29 28.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.979 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -95.09 -6.02 42.95 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.254 -0.904 . . . . 0.0 110.759 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.3 p -74.7 -21.29 59.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.913 -1.117 . . . . 0.0 109.941 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.418 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -141.15 20.87 2.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.693 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt 54.82 58.37 4.87 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.413 -0.804 . . . . 0.0 111.592 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.557 HG11 ' SG ' ' A' ' 21' ' ' CYS . 27.3 t -131.63 135.94 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.899 . . . . 0.0 110.247 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -103.14 134.05 47.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.447 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 94.9 m-20 -134.66 116.41 14.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.062 -1.024 . . . . 0.0 110.494 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.52 176.66 1.55 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.0 110.496 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.23 -32.02 69.0 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.936 1.492 . . . . 0.0 110.321 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.51 -35.73 81.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 110.607 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.558 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -60.35 176.69 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.002 . . . . 0.0 110.5 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.729 HG12 ' HG3' ' A' ' 20' ' ' LYS . 44.9 t -156.66 -43.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.325 -0.859 . . . . 0.0 109.23 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.729 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.5 mttt -128.28 106.86 9.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.487 -0.758 . . . . 0.0 109.716 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.557 ' SG ' HG11 ' A' ' 12' ' ' VAL . 15.9 t -45.91 135.16 7.42 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.063 0.935 . . . . 0.0 111.253 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.93 -43.33 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.192 -0.942 . . . . 0.0 111.038 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.27 89.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.355 -0.841 . . . . 0.0 112.187 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 25' ' ' GLU . 23.1 p -155.83 25.25 0.38 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.939 -1.1 . . . . 0.0 111.104 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.9 mt-10 33.96 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.424 0.63 . . . . 0.0 111.952 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.5 m . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 110.219 179.609 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.238 0.542 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.76 -43.44 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.351 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.86 -0.15 59.12 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.645 HG22 ' HG3' ' A' ' 16' ' ' PRO . 71.1 p -128.24 150.35 50.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.988 -1.301 . . . . 0.0 109.751 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.53 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 35.0 p-90 -148.56 157.85 43.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.024 -1.048 . . . . 0.0 110.473 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -120.07 140.68 50.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.167 -0.958 . . . . 0.0 109.816 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.669 ' SG ' HG21 ' A' ' 26' ' ' THR . 19.2 t -87.43 115.92 25.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.519 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -94.51 -5.22 46.55 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.256 -0.903 . . . . 0.0 110.929 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -68.77 -31.21 70.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.95 -1.094 . . . . 0.0 109.634 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.409 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.9 p -135.74 21.03 3.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.811 . . . . 0.0 111.234 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 9.3 mp 58.83 46.55 13.84 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.292 -0.88 . . . . 0.0 111.838 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 48.0 t -127.89 134.66 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.153 -0.967 . . . . 0.0 110.117 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -96.65 145.69 25.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.005 -1.059 . . . . 0.0 110.507 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.53 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 m-20 -125.73 142.1 51.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.202 -0.936 . . . . 0.0 109.876 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -90.95 170.69 9.39 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.766 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.645 ' HG3' HG22 ' A' ' 4' ' ' THR . 39.6 Cg_exo -54.38 -34.32 80.4 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.898 1.473 . . . . 0.0 110.418 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.21 -36.67 82.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.111 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.495 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -51.52 -179.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.462 -0.774 . . . . 0.0 110.667 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.768 HG12 ' HG3' ' A' ' 20' ' ' LYS . 74.2 t -155.31 -47.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.768 ' HG3' HG12 ' A' ' 19' ' ' VAL . 98.4 mttt -137.32 119.54 15.63 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.51 ' O ' ' N ' ' A' ' 25' ' ' GLU . 14.6 t -45.04 140.49 2.69 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.097 0.951 . . . . 0.0 111.595 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.09 -44.45 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.629 -1.294 . . . . 0.0 111.62 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.24 93.2 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.294 -0.879 . . . . 0.0 112.516 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.5 p -140.57 11.9 2.3 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.894 -1.129 . . . . 0.0 112.088 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.3 mt-10 40.8 78.01 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.63 -0.669 . . . . 0.0 111.247 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.669 HG21 ' SG ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -71.2 149.59 94.35 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.922 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 38.6 Cg_exo -58.29 -23.53 63.1 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.905 1.476 . . . . 0.0 110.303 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HG3' ' CZ2' ' A' ' 5' ' ' TRP . 1.5 ttpt 63.03 65.86 1.29 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.881 . . . . 0.0 109.847 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 21.1 Cg_exo -61.22 145.21 98.86 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.921 1.485 . . . . 0.0 110.434 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.25 103.42 3.02 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.3 m -123.05 129.09 51.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -1.176 . . . . 0.0 110.167 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.99 -40.26 98.06 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.5 t -123.41 130.87 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.141 -1.211 . . . . 0.0 110.387 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.05 -42.03 97.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 110.384 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.201 179.791 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.319 0.58 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.6 mt -119.89 129.22 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.039 -1.038 . . . . 0.0 110.671 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -173.52 175.27 46.26 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.828 HG22 ' HD3' ' A' ' 16' ' ' PRO . 16.7 p -79.1 166.09 22.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -1.199 . . . . 0.0 110.045 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -141.24 153.4 45.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.25 -0.906 . . . . 0.0 110.289 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 47.5 p-10 -132.84 148.43 52.3 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.402 -0.811 . . . . 0.0 110.117 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 t -83.0 106.13 14.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.045 -1.035 . . . . 0.0 109.911 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -71.59 -18.13 62.24 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.423 -0.798 . . . . 0.0 110.185 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.0 m -60.87 -44.35 97.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.867 . . . . 0.0 111.082 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 23' ' ' ALA . 14.0 p -128.96 33.77 4.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.04 -1.037 . . . . 0.0 110.897 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 11' ' ' LEU . 39.0 tp 42.49 65.66 0.88 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.56 -0.712 . . . . 0.0 112.409 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.546 HG11 ' SG ' ' A' ' 21' ' ' CYS . 39.4 t -133.81 135.53 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.945 -1.097 . . . . 0.0 109.906 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -100.78 141.01 34.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.245 -0.909 . . . . 0.0 110.702 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 21' ' ' CYS . 3.6 m-20 -145.91 121.12 10.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 109.557 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -70.2 178.01 1.2 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.412 -0.805 . . . . 0.0 110.298 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.828 ' HD3' HG22 ' A' ' 4' ' ' THR . 31.4 Cg_exo -57.11 -29.83 84.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.0 1.526 . . . . 0.0 109.764 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.64 -37.8 88.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.459 -0.776 . . . . 0.0 109.764 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.794 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -54.92 -172.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.405 -0.809 . . . . 0.0 110.426 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -168.91 -37.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.467 -0.771 . . . . 0.0 109.113 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -131.9 111.04 11.23 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.675 0.75 . . . . 0.0 109.402 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.546 ' SG ' HG11 ' A' ' 12' ' ' VAL . 8.9 t -45.99 141.27 3.26 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.902 0.858 . . . . 0.0 110.924 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.68 -43.86 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.611 -1.306 . . . . 0.0 111.639 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.607 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -63.93 -38.07 89.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.319 -0.863 . . . . 0.0 112.437 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.9 p -142.77 13.07 1.89 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.003 -1.061 . . . . 0.0 112.1 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 21' ' ' CYS . 96.7 mt-10 43.78 73.08 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.418 -0.801 . . . . 0.0 110.105 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -44.54 157.21 0.32 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.944 -0.472 . . . . 0.0 110.558 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -66.91 -14.96 45.72 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 124.192 1.627 . . . . 0.0 109.631 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HE3' HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 57.68 75.17 0.57 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.247 -0.908 . . . . 0.0 109.97 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -60.31 145.14 99.22 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.092 1.575 . . . . 0.0 110.031 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.5 55.78 0.55 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.4 p -63.37 -33.77 76.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -1.212 . . . . 0.0 109.731 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.02 151.25 51.82 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.71 140.27 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -1.13 . . . . 0.0 110.045 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.79 -43.19 99.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.447 -0.783 . . . . 0.0 110.61 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 117.888 -1.053 . . . . 0.0 110.264 -179.819 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.385 0.612 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.03 -42.89 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.429 -0.795 . . . . 0.0 109.903 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 168.69 -168.38 41.02 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.1 m -121.07 131.14 54.09 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.078 -1.248 . . . . 0.0 109.839 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.477 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 19.7 p-90 -142.7 161.42 38.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 110.371 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -130.41 134.29 47.01 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.083 -1.01 . . . . 0.0 109.908 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.7 t -83.66 114.79 21.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.361 -0.837 . . . . 0.0 108.769 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -92.06 -7.3 49.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.002 -1.061 . . . . 0.0 110.631 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.4 p -68.5 -33.88 74.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 109.406 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 12' ' ' VAL . 12.6 p -128.3 20.46 6.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.363 -0.836 . . . . 0.0 111.108 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt 53.15 48.99 20.97 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.291 -0.881 . . . . 0.0 112.393 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.4 ' HB ' ' SG ' ' A' ' 10' ' ' CYS . 51.2 t -128.07 131.79 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.852 -1.155 . . . . 0.0 110.527 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -89.18 142.49 27.6 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.593 -0.692 . . . . 0.0 109.992 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 8.4 m-20 -129.92 126.21 37.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.961 -1.087 . . . . 0.0 110.114 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.502 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 15.5 mmtp -73.14 171.43 10.46 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.55 -0.719 . . . . 0.0 110.592 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 34.7 Cg_exo -55.44 -32.02 80.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.915 1.481 . . . . 0.0 110.028 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' OE1' ' HB3' ' A' ' 15' ' ' LYS . 52.5 mp0 -66.47 -31.05 71.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.401 -0.812 . . . . 0.0 109.703 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 15' ' ' LYS . . . -61.52 151.01 34.11 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.347 0.594 . . . . 0.0 110.536 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.495 HG12 ' HG3' ' A' ' 29' ' ' PRO . 58.2 t -137.5 -42.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.516 -0.74 . . . . 0.0 109.195 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 25' ' ' GLU . 99.7 mttt -130.46 107.72 9.43 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.466 -0.894 . . . . 0.0 108.701 178.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.469 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.5 t -45.54 130.25 8.75 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.471 0.653 . . . . 0.0 110.837 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.7 t -62.71 -46.73 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.206 -0.934 . . . . 0.0 112.079 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.22 -38.59 91.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.781 -1.199 . . . . 0.0 109.673 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -155.43 83.22 1.05 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.057 0.932 . . . . 0.0 109.043 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.469 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.5 mt-10 -33.68 92.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.056 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 24' ' ' CYS . 13.4 p -54.01 158.07 3.82 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.129 -0.982 . . . . 0.0 110.147 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -77.7 18.92 0.79 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.866 1.456 . . . . 0.0 111.996 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 5.4 mmtt -45.26 -46.62 32.83 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 120.948 -1.095 . . . . 0.0 111.728 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 28' ' ' LYS . 20.7 Cg_exo -62.7 144.9 94.77 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.302 1.159 . . . . 0.0 109.731 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.98 23.71 71.18 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 91.3 m -122.16 127.37 49.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.227 -1.161 . . . . 0.0 109.994 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.28 16.85 61.78 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.8 t -123.47 130.22 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.33 -1.1 . . . . 0.0 109.545 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.63 -39.01 89.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.318 -0.863 . . . . 0.0 110.198 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 . . . . . 0 C--N 1.299 -1.592 0 CA-C-O 118.346 -0.835 . . . . 0.0 109.987 -179.291 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.318 0.58 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.66 -43.39 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.387 -0.82 . . . . 0.0 110.197 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 94.54 10.49 57.98 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 m -73.09 134.79 44.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.962 -1.317 . . . . 0.0 109.562 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.541 ' CZ2' ' CB ' ' A' ' 14' ' ' ASN . 29.0 p-90 -140.17 155.36 46.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.904 -1.122 . . . . 0.0 110.626 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -130.91 127.64 38.9 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.438 -0.788 . . . . 0.0 109.926 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.55 ' SG ' HG21 ' A' ' 26' ' ' THR . 30.6 t -76.97 120.46 22.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.628 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -92.8 -8.58 43.22 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.465 -0.772 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 m -64.17 -44.55 91.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 110.521 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.428 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.3 p -124.14 18.81 9.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 110.915 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.3 mt 56.53 52.59 9.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.36 -0.837 . . . . 0.0 111.572 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.428 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 37.9 t -127.15 132.76 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.304 -0.873 . . . . 0.0 109.6 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -93.62 136.48 33.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 110.637 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' CZ2' ' A' ' 5' ' ' TRP . 1.6 m120 -126.18 130.38 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.111 -0.993 . . . . 0.0 109.576 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -69.15 166.89 24.4 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 0.0 109.864 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -52.71 -36.59 73.24 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 124.041 1.548 . . . . 0.0 109.754 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.34 -35.87 76.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.917 . . . . 0.0 109.849 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.615 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -60.88 146.02 48.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 110.193 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -157.38 23.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.393 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -158.0 75.27 0.75 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.486 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.6 t -45.27 129.47 8.04 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.031 0.92 . . . . 0.0 111.078 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.19 -43.73 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.106 . . . . 0.0 111.576 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.19 -40.69 96.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.368 -0.833 . . . . 0.0 112.211 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 p -149.95 24.39 0.85 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.833 -1.167 . . . . 0.0 111.344 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 21' ' ' CYS . 75.2 tt0 36.9 96.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.392 0.615 . . . . 0.0 112.447 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.55 HG21 ' SG ' ' A' ' 7' ' ' CYS . 22.3 p -87.45 152.43 52.24 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.422 -0.799 . . . . 0.0 109.831 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -84.62 40.78 0.89 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.768 1.404 . . . . 0.0 110.6 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 37.0 tttm 56.58 67.86 2.49 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.099 -1.0 . . . . 0.0 110.374 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD2' ' CE3' ' A' ' 5' ' ' TRP . 24.9 Cg_exo -60.94 144.11 99.5 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.012 1.532 . . . . 0.0 110.462 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.14 159.76 30.33 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.6 p -132.03 159.27 39.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -1.201 . . . . 0.0 110.428 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.61 165.56 54.44 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.1 p -136.6 142.11 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.205 -1.173 . . . . 0.0 109.793 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.67 -45.28 93.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.131 -0.981 . . . . 0.0 109.683 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.934 179.531 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.327 0.584 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.82 -43.21 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.825 . . . . 0.0 110.54 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.91 -42.05 96.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.564 HG22 ' HD3' ' A' ' 16' ' ' PRO . 10.6 p -83.74 166.31 18.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.003 -1.293 . . . . 0.0 110.399 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.492 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 26.8 p-90 -142.23 159.37 42.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 109.979 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -130.69 134.58 47.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.049 -1.032 . . . . 0.0 110.456 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 t -87.59 118.27 26.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.83 . . . . 0.0 109.699 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -89.89 -11.96 40.35 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.16 -0.962 . . . . 0.0 111.09 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.2 p -66.97 -31.42 71.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.912 -1.117 . . . . 0.0 110.29 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.461 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.8 p -133.92 24.8 3.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.988 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 37.6 tp 46.83 57.33 5.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.277 -0.89 . . . . 0.0 111.531 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 10' ' ' CYS . 41.8 t -131.28 133.78 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.987 -1.071 . . . . 0.0 109.866 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -101.19 130.77 47.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.292 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.492 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 85.6 m-20 -132.17 125.73 31.91 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.056 -1.027 . . . . 0.0 109.936 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 2.6 mttt -78.34 176.53 3.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.813 . . . . 0.0 110.477 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.564 ' HD3' HG22 ' A' ' 4' ' ' THR . 32.2 Cg_exo -56.36 -29.73 78.22 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.016 1.534 . . . . 0.0 110.01 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -64.89 -36.0 82.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.362 -0.836 . . . . 0.0 109.831 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.503 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -52.35 -179.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.334 -0.854 . . . . 0.0 110.095 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.77 HG12 ' HG3' ' A' ' 20' ' ' LYS . 76.6 t -154.73 -43.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.959 . . . . 0.0 109.099 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.77 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.1 mttt -135.77 110.79 8.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.567 0.698 . . . . 0.0 109.305 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.58 ' CB ' HG23 ' A' ' 26' ' ' THR . 12.2 t -46.2 132.21 9.96 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.503 0.668 . . . . 0.0 111.075 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.55 -46.72 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.524 -0.735 . . . . 0.0 111.731 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.7 96.02 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.964 -1.085 . . . . 0.0 109.694 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.439 ' O ' ' C ' ' A' ' 25' ' ' GLU . 32.1 p -153.63 81.91 1.17 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.794 0.807 . . . . 0.0 109.201 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.515 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.1 mt-10 -30.37 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.545 0.688 . . . . 0.0 112.12 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.58 HG23 ' CB ' ' A' ' 21' ' ' CYS . 78.0 p -67.6 151.9 96.75 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.482 -0.762 . . . . 0.0 110.035 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.89 41.47 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.977 1.514 . . . . 0.0 110.362 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -101.58 109.22 58.61 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.154 -0.966 . . . . 0.0 110.214 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -61.44 145.28 98.2 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.592 1.312 . . . . 0.0 110.277 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.73 -37.87 95.36 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.9 p -132.77 155.72 48.39 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.312 -1.111 . . . . 0.0 110.176 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.0 176.67 28.42 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.75 157.5 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -1.136 . . . . 0.0 110.226 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.94 -41.85 97.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 110.244 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.228 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.421 0.629 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.2 mm -62.37 -44.58 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.574 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.47 176.87 47.95 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.3 p -92.26 164.6 13.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -1.165 . . . . 0.0 110.343 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.527 ' HH2' ' HG1' ' A' ' 26' ' ' THR . 56.4 p-90 -145.43 156.1 43.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.369 -0.832 . . . . 0.0 110.673 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.445 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 47.0 p-10 -134.82 151.89 51.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.31 -0.869 . . . . 0.0 110.256 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' VAL . 13.4 t -84.31 107.06 16.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.343 -0.848 . . . . 0.0 110.365 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -72.05 -18.71 61.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.27 -0.894 . . . . 0.0 110.279 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.8 m -60.97 -45.1 96.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.912 . . . . 0.0 110.661 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.485 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.9 p -121.85 29.74 6.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.126 -0.984 . . . . 0.0 110.783 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 35.1 tp 44.45 55.46 5.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.522 -0.736 . . . . 0.0 111.594 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 10' ' ' CYS . 34.7 t -129.26 133.88 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.999 -1.063 . . . . 0.0 109.808 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.445 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . 88.6 mt-30 -100.33 132.35 45.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.98 . . . . 0.0 110.606 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 4.0 m-20 -118.01 124.24 47.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.46 -0.775 . . . . 0.0 109.433 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -68.0 170.67 6.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.981 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -54.92 -32.58 78.73 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.987 1.52 . . . . 0.0 110.013 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.49 -34.34 78.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 109.818 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -51.96 -179.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.408 -0.807 . . . . 0.0 110.507 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.781 HG12 ' HG3' ' A' ' 20' ' ' LYS . 69.8 t -155.17 -45.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.781 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.6 mttt -139.62 118.76 12.68 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 25' ' ' GLU . 12.5 t -45.57 130.18 8.82 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.581 0.705 . . . . 0.0 111.384 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.77 -46.46 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.411 -0.806 . . . . 0.0 111.641 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.4 97.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.911 -1.118 . . . . 0.0 109.33 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.436 ' O ' ' C ' ' A' ' 25' ' ' GLU . 31.0 p -155.45 84.99 1.05 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.834 0.826 . . . . 0.0 109.25 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 24' ' ' CYS . 95.7 mt-10 -30.99 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.591 0.71 . . . . 0.0 112.683 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.527 ' HG1' ' HH2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -51.28 158.36 1.36 Allowed Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.58 -0.7 . . . . 0.0 109.926 178.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -68.44 -10.74 29.91 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.984 1.518 . . . . 0.0 110.407 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER 54.53 67.38 3.38 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.092 -1.005 . . . . 0.0 110.062 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 20.4 Cg_exo -62.16 146.68 95.95 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.146 1.603 . . . . 0.0 110.364 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.26 -177.02 50.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 88.4 m -117.45 130.96 56.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.413 -1.051 . . . . 0.0 110.293 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.06 22.09 61.74 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.68 130.47 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.074 -1.251 . . . . 0.0 110.284 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -79.0 132.27 36.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.129 -0.982 . . . . 0.0 109.683 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.07 -0.966 . . . . 0.0 110.296 -179.715 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.276 0.56 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 91.0 mt -111.02 130.15 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.969 . . . . 0.0 110.204 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 16' ' ' PRO . . . -88.89 179.53 45.65 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 t -151.76 155.52 38.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -1.097 . . . . 0.0 110.132 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.511 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 45.7 p-90 -143.55 154.14 43.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.044 -1.035 . . . . 0.0 110.647 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 45.0 p-10 -136.82 148.79 47.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.352 -0.843 . . . . 0.0 110.124 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.6 t -83.89 135.54 34.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.867 . . . . 0.0 109.833 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -101.61 -16.9 16.58 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.097 -1.002 . . . . 0.0 110.854 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.5 p -65.29 -31.23 72.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.003 -1.06 . . . . 0.0 110.277 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.2 p -131.02 21.74 4.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 110.854 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 41.2 tp 49.4 59.59 4.37 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.217 -0.927 . . . . 0.0 111.424 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 28.0 t -132.72 135.03 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.126 -0.984 . . . . 0.0 110.262 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -99.44 137.23 38.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.164 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 61.7 m-20 -131.13 134.47 46.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.162 -0.961 . . . . 0.0 109.703 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -76.94 169.71 19.9 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 110.421 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 3' ' ' GLY . 46.1 Cg_exo -54.27 -33.29 75.05 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.168 1.615 . . . . 0.0 110.586 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.4 mp0 -65.64 -36.33 83.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.146 -0.971 . . . . 0.0 110.203 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -52.38 175.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.442 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.528 HG12 ' HG3' ' A' ' 20' ' ' LYS . 76.0 t -156.94 -41.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.332 -0.855 . . . . 0.0 109.167 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.528 ' HG3' HG12 ' A' ' 19' ' ' VAL . 96.9 mttt -127.33 107.41 9.96 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.141 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.504 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.4 t -46.64 132.42 10.95 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.52 0.676 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.05 -45.73 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.835 . . . . 0.0 111.659 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.26 99.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.851 -1.156 . . . . 0.0 109.556 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -155.02 83.66 1.08 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.793 0.806 . . . . 0.0 108.87 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.504 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.5 mt-10 -31.45 91.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.519 0.676 . . . . 0.0 112.333 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 24' ' ' CYS . 6.6 m -64.39 142.69 98.42 Favored Pre-proline 0 N--CA 1.487 1.42 0 O-C-N 121.422 -0.799 . . . . 0.0 109.372 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -81.46 44.67 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.607 1.32 . . . . 0.0 110.418 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -106.5 116.63 58.75 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.1 -1.0 . . . . 0.0 110.007 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.97 144.68 99.63 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.569 1.3 . . . . 0.0 110.513 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.92 -34.39 89.76 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.5 m -113.27 125.37 54.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.5 -1.0 . . . . 0.0 109.593 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.43 171.06 39.6 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.8 t -125.56 132.94 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.13 . . . . 0.0 110.426 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.75 -43.04 99.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 0.0 110.105 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.144 -179.903 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.309 0.576 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.3 pt -128.06 156.23 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 110.499 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' A' ' 16' ' ' PRO . . . -128.23 143.48 14.44 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.2 t -152.05 168.11 26.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.237 . . . . 0.0 110.136 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.517 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 48.4 p-90 -135.98 158.59 44.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.081 -1.012 . . . . 0.0 109.906 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -129.74 130.04 44.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.265 -0.897 . . . . 0.0 110.416 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.9 t -75.55 100.27 4.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.422 -0.799 . . . . 0.0 109.83 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -69.51 -16.53 63.46 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.475 -0.765 . . . . 0.0 110.563 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.1 m -60.95 -44.43 97.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.034 -1.041 . . . . 0.0 110.392 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.9 p -124.24 21.16 8.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.014 -1.053 . . . . 0.0 111.282 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.5 mt 53.84 52.31 13.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.172 -0.955 . . . . 0.0 111.959 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 48.8 t -129.0 132.14 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.089 -1.007 . . . . 0.0 109.685 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -96.45 137.02 36.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.0 110.565 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.517 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 79.6 m-20 -132.46 124.43 28.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.368 -0.832 . . . . 0.0 109.874 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 37.8 mtpt -73.39 168.39 25.72 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.929 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HG3' ' O ' ' A' ' 3' ' ' GLY . 52.2 Cg_exo -51.94 -33.15 50.71 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.797 1.419 . . . . 0.0 110.581 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -60.89 -35.13 75.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.925 . . . . 0.0 108.879 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.506 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -52.96 177.45 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.623 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.782 HG12 ' HG3' ' A' ' 20' ' ' LYS . 78.3 t -155.8 -43.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -0.82 . . . . 0.0 108.804 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.782 ' HG3' HG12 ' A' ' 19' ' ' VAL . 97.4 mttt -136.49 112.36 9.55 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.802 0.811 . . . . 0.0 109.228 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.459 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.1 t -45.37 131.73 8.08 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.755 0.788 . . . . 0.0 111.473 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.1 t -64.01 -46.66 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.052 -1.03 . . . . 0.0 111.106 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.84 88.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.576 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 26' ' ' THR . 32.1 p -148.48 81.12 1.46 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.823 0.821 . . . . 0.0 109.081 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.459 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 95.8 mt-10 -30.54 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.615 0.721 . . . . 0.0 112.209 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 24' ' ' CYS . 6.7 p -62.0 158.5 43.96 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.737 -0.602 . . . . 0.0 109.921 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.3 -8.83 23.19 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 O-C-N 123.996 1.524 . . . . 0.0 110.8 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.55 93.41 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.999 -1.063 . . . . 0.0 110.147 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.15 146.41 97.59 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.022 1.538 . . . . 0.0 110.357 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.71 8.02 59.73 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.8 p -131.56 161.37 32.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.022 -1.281 . . . . 0.0 110.272 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.85 175.99 50.8 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.5 t -63.92 -43.96 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -1.095 . . . . 0.0 110.364 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.39 -41.2 98.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.346 -0.846 . . . . 0.0 110.818 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.4 ttt-85 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.345 -179.872 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.239 0.543 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 pt -129.32 160.58 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 110.413 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.41 165.41 39.7 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.8 m -66.22 131.97 47.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -1.098 . . . . 0.0 110.295 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.491 ' CE2' ' HD2' ' A' ' 28' ' ' LYS . 51.0 p-90 -144.21 159.69 42.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.449 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -135.22 150.33 50.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.046 -1.034 . . . . 0.0 110.311 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.7 t -90.15 123.72 34.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.0 110.098 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -96.76 -4.19 41.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.169 -0.957 . . . . 0.0 111.143 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.6 p -74.19 -23.17 59.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.91 -1.119 . . . . 0.0 109.847 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.5 p -141.31 21.35 2.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.371 -0.83 . . . . 0.0 111.014 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt 54.23 48.96 19.68 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.325 -0.859 . . . . 0.0 111.686 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 41.0 t -125.35 132.21 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -0.967 . . . . 0.0 109.811 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -97.44 139.37 33.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.186 -0.946 . . . . 0.0 110.356 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 95.2 m-20 -134.65 106.02 6.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.294 -0.879 . . . . 0.0 110.014 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 3.1 mttm -56.55 172.93 0.32 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.857 . . . . 0.0 110.372 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 31.7 Cg_exo -56.89 -29.29 81.24 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.959 1.505 . . . . 0.0 110.231 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -65.14 -34.66 78.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 109.972 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -52.54 -177.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.78 . . . . 0.0 110.364 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.91 HG12 ' HG3' ' A' ' 20' ' ' LYS . 20.6 t -155.13 -44.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 108.882 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.91 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.2 mttt -142.56 115.62 8.84 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.804 0.811 . . . . 0.0 109.571 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 12.2 t -45.73 132.41 8.7 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.877 0.846 . . . . 0.0 111.793 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.92 -47.06 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.451 -0.781 . . . . 0.0 111.301 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.94 83.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.066 -1.021 . . . . 0.0 109.573 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 26' ' ' THR . 32.0 p -146.91 80.72 1.54 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.807 0.813 . . . . 0.0 109.426 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.47 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 96.6 mt-10 -29.24 89.7 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.487 0.661 . . . . 0.0 112.666 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 24' ' ' CYS . 2.1 p -48.01 158.53 0.55 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.756 -0.59 . . . . 0.0 109.912 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -65.66 -15.08 47.85 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.084 1.57 . . . . 0.0 110.803 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.491 ' HD2' ' CE2' ' A' ' 5' ' ' TRP . 12.1 tttt -48.64 106.05 0.57 Allowed Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.184 -0.948 . . . . 0.0 110.383 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -54.83 -38.35 92.23 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.75 1.395 . . . . 0.0 110.47 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.62 174.54 15.16 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.6 p -65.05 -32.33 73.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -1.18 . . . . 0.0 110.114 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.92 -166.25 53.93 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.4 t -121.19 131.21 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -1.166 . . . . 0.0 109.972 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -118.1 146.58 44.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 110.279 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.336 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.147 0.498 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 3' ' ' GLY . 46.7 pt -73.13 -27.65 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.131 -0.981 . . . . 0.0 110.233 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.425 ' N ' HG13 ' A' ' 2' ' ' ILE . . . 66.42 -174.81 22.08 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 p -84.76 167.56 15.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -1.079 . . . . 0.0 110.127 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -143.58 152.49 41.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 110.244 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -125.73 142.64 51.41 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.012 -1.055 . . . . 0.0 110.291 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.2 t -87.78 117.21 26.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.945 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 42.3 p-10 -92.77 -8.21 44.35 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.055 -1.028 . . . . 0.0 110.619 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.2 m -63.16 -43.55 97.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 109.037 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.422 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -123.11 21.06 9.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.579 -0.7 . . . . 0.0 110.319 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 37.8 tp 53.08 59.36 4.5 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.482 -0.761 . . . . 0.0 111.548 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 38.6 t -131.95 134.56 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -0.91 . . . . 0.0 109.722 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.99 136.01 38.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.164 -0.96 . . . . 0.0 110.589 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.456 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 99.4 m-20 -137.09 123.79 21.12 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.84 172.77 6.38 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.988 . . . . 0.0 110.612 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -53.96 -32.96 70.45 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.16 1.61 . . . . 0.0 110.379 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.77 -32.17 73.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.014 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -50.85 178.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.405 -0.81 . . . . 0.0 110.383 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -158.6 -41.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.475 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.86 108.14 6.46 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.533 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 14.3 t -46.02 137.18 6.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.894 0.854 . . . . 0.0 110.931 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.04 -44.81 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 111.958 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.65 85.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.166 -0.959 . . . . 0.0 112.35 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 25' ' ' GLU . 26.8 p -146.75 24.6 1.2 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.844 -1.16 . . . . 0.0 111.741 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.533 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.0 mt-10 28.87 86.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 p -59.68 156.6 32.63 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.309 -0.869 . . . . 0.0 110.352 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -85.45 31.03 0.49 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.041 1.548 . . . . 0.0 111.047 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -48.47 -49.54 63.2 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 120.928 -1.107 . . . . 0.0 110.52 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 28' ' ' LYS . 24.7 Cg_exo -59.82 142.48 98.7 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.436 1.23 . . . . 0.0 110.043 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.77 -10.26 70.79 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.8 p -132.25 154.97 49.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.003 -1.292 . . . . 0.0 110.074 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -172.91 176.62 45.69 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.706 HG12 ' HG3' ' A' ' 35' ' ' ARG . 57.4 t -121.09 130.55 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -1.159 . . . . 0.0 110.11 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.77 -41.49 99.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.296 -0.878 . . . . 0.0 109.812 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.706 ' HG3' HG12 ' A' ' 33' ' ' VAL . 96.2 mtt-85 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.052 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.25 0.547 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.6 pt -68.47 -24.87 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 110.089 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.8 -37.59 94.9 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.4 m -118.96 129.69 55.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.385 -1.068 . . . . 0.0 110.096 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.462 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 48.3 p-90 -141.7 154.62 45.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 0.0 110.316 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -120.9 140.74 51.39 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.307 -0.871 . . . . 0.0 109.99 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.6 t -84.52 113.41 21.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.19 -0.944 . . . . 0.0 109.206 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -88.69 -10.02 49.95 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.27 -0.894 . . . . 0.0 111.059 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.1 p -66.93 -31.5 72.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.008 -1.057 . . . . 0.0 109.989 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.413 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.1 p -133.55 22.53 3.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 111.341 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.1 mt 55.58 48.68 18.15 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.237 -0.914 . . . . 0.0 111.746 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.448 HG11 ' SG ' ' A' ' 21' ' ' CYS . 40.9 t -126.53 132.07 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.195 -0.94 . . . . 0.0 109.708 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.03 134.2 42.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.085 -1.009 . . . . 0.0 110.492 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 m-20 -120.17 131.5 55.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.195 -0.941 . . . . 0.0 109.934 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 3.0 mttt -80.28 173.38 7.81 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.9 . . . . 0.0 110.03 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -54.74 -34.48 84.53 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.982 1.517 . . . . 0.0 110.249 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.74 -35.6 80.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.562 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.523 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -51.09 174.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.486 -0.759 . . . . 0.0 110.419 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.69 HG12 ' HG3' ' A' ' 20' ' ' LYS . 75.4 t -156.44 -44.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.69 ' HG3' HG12 ' A' ' 19' ' ' VAL . 98.0 mttt -133.1 112.53 11.85 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 25' ' ' GLU . 12.4 t -45.74 138.4 4.74 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.086 0.946 . . . . 0.0 111.316 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.63 -44.84 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.636 -1.29 . . . . 0.0 111.871 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.01 90.91 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.212 -0.93 . . . . 0.0 112.61 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.3 p -140.5 16.28 2.37 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.833 -1.167 . . . . 0.0 111.961 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.2 mt-10 38.43 78.36 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.692 -0.63 . . . . 0.0 111.784 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -50.76 157.09 1.41 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.15 -16.15 48.15 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 123.942 1.496 . . . . 0.0 110.864 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' CD ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER 52.07 81.27 0.26 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 0.0 110.138 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.424 ' O ' ' CE ' ' A' ' 28' ' ' LYS . 22.5 Cg_exo -61.15 147.08 96.65 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.011 1.532 . . . . 0.0 110.284 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.72 -6.57 58.9 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.424 ' OG1' ' CD ' ' A' ' 28' ' ' LYS . 63.6 m -120.68 129.38 53.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.008 -1.289 . . . . 0.0 109.872 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -120.81 130.48 8.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 34' ' ' LYS . 14.9 p -64.47 -34.3 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -1.079 . . . . 0.0 110.111 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.439 ' N ' HG13 ' A' ' 33' ' ' VAL . 99.4 mttt -74.59 143.23 44.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.233 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.242 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.518 0.675 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.17 -43.21 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.453 -0.779 . . . . 0.0 110.218 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.44 -37.05 94.2 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.3 p -80.71 164.28 22.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.021 -1.282 . . . . 0.0 110.879 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.497 ' HZ3' HG21 ' A' ' 26' ' ' THR . 33.2 p-90 -143.76 152.41 41.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.558 -0.714 . . . . 0.0 109.777 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -135.06 151.07 50.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.159 -0.963 . . . . 0.0 110.091 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.8 t -90.96 111.25 22.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.163 -0.961 . . . . 0.0 110.657 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -80.56 -17.17 52.29 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.511 -0.743 . . . . 0.0 110.515 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.4 m -62.22 -44.35 96.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -0.998 . . . . 0.0 110.895 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.0 p -120.4 24.22 10.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 111.347 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt 53.81 50.9 15.92 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.289 -0.882 . . . . 0.0 111.637 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 40.2 t -130.15 133.4 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.146 -0.971 . . . . 0.0 110.506 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -96.8 137.29 36.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.055 -1.028 . . . . 0.0 110.064 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 2.4 m-20 -119.24 120.45 37.07 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.149 -0.97 . . . . 0.0 110.403 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.38 172.19 2.75 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.954 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.48 -33.6 92.81 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.996 1.524 . . . . 0.0 110.174 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.87 -36.1 79.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -0.801 . . . . 0.0 109.765 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.02 157.91 29.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 0.0 110.55 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.446 HG13 ' HA ' ' A' ' 29' ' ' PRO . 71.9 t -147.05 -41.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.418 -0.802 . . . . 0.0 108.93 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . 97.4 mttt -115.57 101.55 8.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.421 -0.8 . . . . 0.0 108.984 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.2 t -45.27 133.02 7.29 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.183 0.992 . . . . 0.0 111.256 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.72 -43.4 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 111.546 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.47 91.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.189 -0.944 . . . . 0.0 112.429 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 p -151.01 21.43 0.77 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.771 -1.205 . . . . 0.0 111.406 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 21' ' ' CYS . 86.4 tt0 41.14 91.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.731 -0.606 . . . . 0.0 111.489 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.497 HG21 ' HZ3' ' A' ' 5' ' ' TRP . 2.0 m -73.22 131.91 82.72 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.378 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.91 45.94 1.93 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.526 1.277 . . . . 0.0 110.811 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.63 93.07 29.34 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.089 -1.007 . . . . 0.0 109.836 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.446 ' HA ' HG13 ' A' ' 19' ' ' VAL . 17.1 Cg_exo -64.5 145.07 86.96 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.751 1.395 . . . . 0.0 109.719 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.71 165.98 50.2 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.1 p -134.3 163.24 30.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -1.113 . . . . 0.0 109.607 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.28 164.89 54.9 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.19 -46.06 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.136 -1.214 . . . . 0.0 109.663 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -75.03 134.41 41.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.507 -0.746 . . . . 0.0 110.561 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.458 179.811 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.263 0.554 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.7 pt -69.81 -21.29 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 110.251 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.01 -39.33 97.44 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.5 t -144.86 156.53 44.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -1.21 . . . . 0.0 110.094 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 53.7 p-90 -142.01 153.85 44.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 110.343 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -131.07 146.75 52.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.389 -0.819 . . . . 0.0 109.658 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.828 ' HB3' HG22 ' A' ' 12' ' ' VAL . 6.5 t -79.19 114.59 18.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 110.273 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -71.47 -24.1 61.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.0 110.191 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.8 m -62.15 -45.61 92.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.885 . . . . 0.0 110.5 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.521 ' SG ' HG13 ' A' ' 12' ' ' VAL . 14.0 p -125.28 13.73 8.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.166 -0.959 . . . . 0.0 110.934 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 11' ' ' LEU . 42.7 tp 48.25 85.31 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.261 -0.9 . . . . 0.0 112.219 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.843 HG21 ' SG ' ' A' ' 21' ' ' CYS . 18.6 m -138.64 163.6 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 109.299 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -108.3 107.87 18.64 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.046 -1.034 . . . . 0.0 110.836 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.461 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 44.3 m-20 -125.79 125.68 43.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.183 -0.948 . . . . 0.0 109.186 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -80.35 176.38 3.85 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.895 . . . . 0.0 110.482 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.17 -32.14 78.87 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.124 1.592 . . . . 0.0 110.437 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.58 -31.89 72.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 110.162 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -49.9 176.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -0.858 . . . . 0.0 110.602 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -160.92 -38.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.402 -0.812 . . . . 0.0 109.538 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -127.73 101.95 6.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.458 -0.776 . . . . 0.0 109.603 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.843 ' SG ' HG21 ' A' ' 12' ' ' VAL . 13.9 t -47.29 131.82 13.09 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.937 0.875 . . . . 0.0 110.759 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -67.78 -43.48 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 111.419 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.472 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -63.39 -40.25 96.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.236 -0.915 . . . . 0.0 112.341 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.7 p -149.97 22.26 0.87 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.92 -1.112 . . . . 0.0 111.17 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' CYS . 82.5 tt0 35.77 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.423 0.63 . . . . 0.0 112.538 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.502 HG23 ' HD2' ' A' ' 27' ' ' PRO . 98.6 m -88.24 145.64 36.38 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.407 -0.808 . . . . 0.0 108.966 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HD2' HG23 ' A' ' 26' ' ' THR . 50.5 Cg_endo -77.48 47.34 2.25 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.607 1.32 . . . . 0.0 110.58 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -122.92 80.82 50.17 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 110.429 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.43 ' HA ' HG12 ' A' ' 19' ' ' VAL . 38.7 Cg_exo -53.92 -38.85 86.33 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.825 1.434 . . . . 0.0 110.079 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.55 167.15 38.92 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.5 p -66.5 -33.16 75.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -1.212 . . . . 0.0 110.128 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.77 7.07 86.37 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.45 -45.36 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.899 -1.353 . . . . 0.0 109.865 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.85 -41.16 97.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.826 . . . . 0.0 110.245 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.254 -179.88 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.204 0.526 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 93.7 mt -63.47 -43.47 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.285 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.26 150.15 51.54 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.918 HG22 ' HG3' ' A' ' 16' ' ' PRO . 69.6 p -83.24 163.47 20.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.131 -1.217 . . . . 0.0 110.138 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.53 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 24.2 p-90 -144.96 158.64 43.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.948 . . . . 0.0 110.174 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 7' ' ' CYS . 67.8 t0 -131.97 139.35 48.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.165 -0.96 . . . . 0.0 110.418 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 13.5 t -89.6 112.99 24.36 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.394 -0.816 . . . . 0.0 109.617 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -91.91 -7.22 49.81 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.163 -0.96 . . . . 0.0 110.511 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -66.99 -34.13 77.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.023 -1.048 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 12.8 p -128.27 18.95 6.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 110.432 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 75.5 mt 58.87 45.35 15.41 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.677 -0.639 . . . . 0.0 111.869 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -128.57 132.96 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.07 -1.018 . . . . 0.0 110.184 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -100.86 144.45 29.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.74 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.53 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.2 m-20 -121.03 122.54 40.32 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.028 -1.045 . . . . 0.0 109.894 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 16.8 mttm -67.84 168.87 11.06 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.25 -0.906 . . . . 0.0 109.614 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.918 ' HG3' HG22 ' A' ' 4' ' ' THR . 47.2 Cg_exo -53.71 -35.49 78.47 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.91 1.479 . . . . 0.0 110.601 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -66.66 -35.03 79.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.553 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.644 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -51.3 179.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.499 -0.751 . . . . 0.0 110.075 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -162.45 -39.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.007 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . 96.7 mttt -135.44 111.8 9.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.5 t -45.68 130.6 9.13 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.997 0.903 . . . . 0.0 111.344 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -68.28 -43.09 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.02 -1.05 . . . . 0.0 111.377 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.37 92.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.262 -0.899 . . . . 0.0 112.44 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.6 p -147.38 20.11 1.2 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.733 -1.23 . . . . 0.0 111.553 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 21' ' ' CYS . 80.9 tt0 42.38 90.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.661 -0.649 . . . . 0.0 111.767 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.52 ' HG1' ' HH2' ' A' ' 5' ' ' TRP . 2.1 p -69.54 157.6 89.09 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.365 -0.835 . . . . 0.0 109.237 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.71 -6.58 19.44 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 123.88 1.463 . . . . 0.0 110.752 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 62.8 66.7 1.22 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.012 -1.055 . . . . 0.0 109.627 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -53.86 -37.95 85.47 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.087 1.572 . . . . 0.0 110.54 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.49 -128.4 9.33 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.4 p -132.77 156.8 46.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.275 -1.132 . . . . 0.0 110.119 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.58 -165.05 36.87 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -131.88 160.77 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -1.112 . . . . 0.0 109.862 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.31 138.82 43.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.32 -0.862 . . . . 0.0 110.08 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.273 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.346 0.593 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.3 pt -127.5 152.06 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.379 -0.826 . . . . 0.0 109.957 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.44 177.13 45.21 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 62.8 m -117.9 131.81 56.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -1.107 . . . . 0.0 110.262 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.44 ' HH2' ' HG1' ' A' ' 26' ' ' THR . 59.1 p-90 -143.36 158.84 43.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.453 -0.779 . . . . 0.0 110.246 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -130.5 148.74 52.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.143 -0.973 . . . . 0.0 110.59 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.4 t -85.31 113.8 21.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.145 -0.972 . . . . 0.0 109.689 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -83.06 -14.05 54.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.359 -0.838 . . . . 0.0 110.503 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.6 m -61.96 -43.47 98.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 109.711 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.403 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.2 p -120.83 21.91 11.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.832 . . . . 0.0 110.925 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.7 mt 54.15 47.6 22.84 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.242 -0.911 . . . . 0.0 111.995 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 43.9 t -125.94 130.7 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.837 -1.164 . . . . 0.0 110.238 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -97.53 132.46 43.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.071 -1.018 . . . . 0.0 110.218 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.426 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 3.0 m-20 -117.02 127.27 54.01 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.138 -0.976 . . . . 0.0 109.658 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -69.82 170.91 8.34 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.985 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -54.9 -32.54 78.41 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.011 1.532 . . . . 0.0 110.512 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.49 -32.07 73.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.468 ' C ' HG22 ' A' ' 19' ' ' VAL . . . -64.39 -179.95 0.52 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.395 -0.815 . . . . 0.0 110.412 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.468 HG22 ' C ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -159.94 -42.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 62.3 pttt -128.96 114.74 16.81 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.111 0.958 . . . . 0.0 109.141 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.45 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.0 t -46.43 132.0 10.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.52 -0.737 . . . . 0.0 111.344 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -64.11 -46.25 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.508 -0.745 . . . . 0.0 111.88 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.36 -41.24 94.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.953 -1.092 . . . . 0.0 109.849 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 32.1 p -152.45 80.66 1.24 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.032 0.92 . . . . 0.0 109.146 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.45 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 95.5 mt-10 -31.35 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.374 0.607 . . . . 0.0 112.549 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.44 ' HG1' ' HH2' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -63.97 154.85 80.42 Favored Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.095 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -66.32 -16.47 51.64 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 123.963 1.507 . . . . 0.0 111.228 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 12.8 tttp 50.87 64.31 8.42 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.072 -1.017 . . . . 0.0 109.37 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 19.3 Cg_exo -61.83 145.1 97.33 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.887 1.467 . . . . 0.0 110.546 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.15 162.56 35.35 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.2 m -63.53 -45.78 89.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.192 -1.181 . . . . 0.0 110.773 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.64 171.94 42.48 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.06 132.84 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.348 -1.089 . . . . 0.0 110.352 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -117.11 140.81 49.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.229 -0.919 . . . . 0.0 110.464 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.208 -179.997 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.352 0.596 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 4' ' ' THR . 48.0 pt -125.11 160.94 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.754 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.8 -37.96 95.46 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.453 ' N ' ' HG3' ' A' ' 16' ' ' PRO . 31.2 m -72.28 136.34 46.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -1.087 . . . . 0.0 110.984 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -143.54 153.51 42.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -0.971 . . . . 0.0 109.683 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.421 ' HB3' ' HG3' ' A' ' 13' ' ' GLN . 49.3 p-10 -119.99 151.28 39.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.936 -1.102 . . . . 0.0 111.148 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.425 ' SG ' HG23 ' A' ' 26' ' ' THR . 13.7 t -94.6 121.21 35.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.093 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -96.85 -14.79 21.61 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.051 -1.031 . . . . 0.0 110.526 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -60.09 -39.02 84.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.052 -1.03 . . . . 0.0 109.892 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 13.7 p -124.83 22.24 8.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.86 . . . . 0.0 111.073 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 84.6 mt 56.09 44.9 24.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.511 -0.743 . . . . 0.0 112.007 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.405 ' HB ' ' SG ' ' A' ' 10' ' ' CYS . 47.2 t -126.48 130.16 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.069 -1.02 . . . . 0.0 109.829 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.421 ' HG3' ' HB3' ' A' ' 6' ' ' ASP . 56.7 tt0 -101.24 145.55 28.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.043 -1.036 . . . . 0.0 110.17 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -134.12 149.7 51.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.065 -1.022 . . . . 0.0 110.091 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 8.6 mttt -82.2 169.73 17.35 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 109.949 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HG3' ' N ' ' A' ' 4' ' ' THR . 34.3 Cg_exo -56.51 -33.19 91.98 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.091 1.574 . . . . 0.0 110.731 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -65.41 -27.89 68.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 110.011 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.44 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -50.53 178.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.37 -0.831 . . . . 0.0 110.394 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.755 HG12 ' HG3' ' A' ' 20' ' ' LYS . 75.1 t -152.15 -46.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.755 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.7 mttt -139.99 117.86 11.74 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 109.103 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.484 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 18.1 t -45.42 140.06 3.33 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.2 1.0 . . . . 0.0 111.585 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.37 -44.49 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.847 -1.158 . . . . 0.0 111.894 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.4 -38.7 85.06 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.173 -0.954 . . . . 0.0 112.358 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 25' ' ' GLU . 20.5 p -147.0 22.36 1.22 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.81 -1.181 . . . . 0.0 111.451 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.484 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 94.6 mt-10 31.54 85.11 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.425 HG23 ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -57.0 156.99 11.9 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.925 . . . . 0.0 109.58 178.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.89 -12.17 34.45 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.885 1.466 . . . . 0.0 111.103 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER 61.23 73.51 0.59 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.09 -1.006 . . . . 0.0 109.765 -179.021 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.12 -40.46 85.69 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.97 1.51 . . . . 0.0 110.207 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.12 -175.88 54.92 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 83.7 m -112.71 121.22 44.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -1.158 . . . . 0.0 109.809 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.18 -15.23 57.98 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.0 t -119.73 132.59 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.052 -1.264 . . . . 0.0 110.303 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -111.78 144.93 40.26 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.216 -0.928 . . . . 0.0 110.429 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.483 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.497 0.665 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.554 HD13 ' O ' ' A' ' 16' ' ' PRO . 18.0 tt -67.55 -36.83 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.823 . . . . 0.0 110.236 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 2' ' ' ILE . . . 70.27 -156.49 53.37 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.3 m -121.52 131.2 54.0 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.035 -1.274 . . . . 0.0 110.631 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.528 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 52.2 p-90 -135.9 156.48 48.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.082 -1.011 . . . . 0.0 109.829 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.403 ' HB2' ' HG2' ' A' ' 13' ' ' GLN . 46.9 p-10 -124.62 149.01 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.956 . . . . 0.0 110.773 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.526 ' SG ' HG21 ' A' ' 26' ' ' THR . 20.6 t -92.8 120.9 33.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.36 -0.838 . . . . 0.0 110.429 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.6 p30 -96.86 -6.08 36.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.821 -1.175 . . . . 0.0 110.279 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.4 m -63.13 -42.39 99.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.167 -0.958 . . . . 0.0 109.409 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.415 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.6 p -125.04 18.14 8.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.535 -0.728 . . . . 0.0 111.35 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mp 62.95 43.45 6.72 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.217 -0.927 . . . . 0.0 111.767 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.415 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 48.8 t -125.81 134.96 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.263 -0.898 . . . . 0.0 109.917 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.403 ' HG2' ' HB2' ' A' ' 6' ' ' ASP . 79.0 mt-30 -98.41 145.09 27.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.078 -1.014 . . . . 0.0 110.016 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.528 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 m-20 -122.47 131.44 53.86 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.093 -1.005 . . . . 0.0 110.466 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -78.08 168.99 22.99 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 110.048 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.554 ' O ' HD13 ' A' ' 2' ' ' ILE . 50.8 Cg_exo -53.97 -33.77 73.98 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.896 1.472 . . . . 0.0 109.911 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.88 -40.27 91.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.142 -0.974 . . . . 0.0 109.904 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.58 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -54.0 -179.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 109.895 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.843 HG12 ' HG3' ' A' ' 20' ' ' LYS . 40.2 t -157.7 -43.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.843 ' HG3' HG12 ' A' ' 19' ' ' VAL . 98.8 mttt -134.49 116.03 14.63 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.7 t -45.73 131.64 9.03 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.93 0.872 . . . . 0.0 111.946 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.81 -46.27 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.522 -0.736 . . . . 0.0 111.373 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.03 88.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.157 -0.965 . . . . 0.0 109.345 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -153.97 84.52 1.15 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.13 0.967 . . . . 0.0 109.242 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 21' ' ' CYS . 92.0 mt-10 -33.07 88.38 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.526 HG21 ' SG ' ' A' ' 7' ' ' CYS . 21.4 p -67.92 147.28 98.5 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.0 . . . . 0.0 109.818 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 38.2 Cg_endo -73.5 -8.35 21.57 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.862 1.454 . . . . 0.0 110.995 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER 66.25 67.15 0.71 Allowed Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.225 -0.922 . . . . 0.0 110.746 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 11.5 Cg_exo -68.17 152.35 76.25 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.859 1.452 . . . . 0.0 110.708 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.94 -176.72 50.91 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.8 m -116.2 124.16 49.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.01 -1.288 . . . . 0.0 110.971 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.31 173.71 33.06 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.3 t -121.24 134.11 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -1.227 . . . . 0.0 109.391 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -62.77 131.84 50.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 110.398 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.219 179.699 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.303 0.573 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 4' ' ' THR . 34.0 mm -63.66 -44.63 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.505 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.95 20.36 78.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.489 ' HB ' HG22 ' A' ' 2' ' ' ILE . 64.4 m -114.07 133.12 55.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.232 -1.158 . . . . 0.0 110.159 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.491 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 33.3 p-90 -142.37 152.84 43.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 110.516 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.444 ' HB2' ' HG2' ' A' ' 13' ' ' GLN . 43.8 p-10 -118.13 142.79 47.05 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.466 -0.771 . . . . 0.0 110.017 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 t -88.97 113.22 24.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.17 -0.956 . . . . 0.0 109.689 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 43.3 p-10 -84.98 -8.87 58.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.943 . . . . 0.0 109.94 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -64.46 -44.37 91.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.157 -0.964 . . . . 0.0 110.123 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.404 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -126.03 28.75 6.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 111.306 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt 53.21 42.74 32.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.27 -0.894 . . . . 0.0 111.978 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 44.0 t -125.0 134.75 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.785 -1.197 . . . . 0.0 110.696 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' A' ' 6' ' ' ASP . 87.6 mt-30 -103.87 142.49 34.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.183 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 82.3 m-20 -130.43 134.88 47.46 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.023 -1.048 . . . . 0.0 110.302 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.19 169.62 18.42 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.438 -0.789 . . . . 0.0 110.165 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.25 -34.49 88.42 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.958 1.504 . . . . 0.0 110.623 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.82 -32.97 74.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.004 . . . . 0.0 109.766 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -51.52 179.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.496 -0.752 . . . . 0.0 109.696 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.888 HG12 ' HG3' ' A' ' 20' ' ' LYS . 39.2 t -156.36 -42.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.139 -0.976 . . . . 0.0 108.773 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.888 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.3 mttt -137.02 115.88 12.25 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.669 0.747 . . . . 0.0 109.309 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.652 ' HB2' HG23 ' A' ' 26' ' ' THR . 12.8 t -46.35 132.52 10.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.79 0.805 . . . . 0.0 111.198 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.66 -45.61 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.184 -0.947 . . . . 0.0 111.195 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.94 85.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.959 -1.088 . . . . 0.0 109.757 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.446 ' O ' ' C ' ' A' ' 25' ' ' GLU . 31.8 p -148.97 78.47 1.4 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.762 0.791 . . . . 0.0 109.166 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.504 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 95.5 mt-10 -29.22 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.594 0.712 . . . . 0.0 111.867 -178.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.652 HG23 ' HB2' ' A' ' 21' ' ' CYS . 42.8 p -52.42 154.63 4.25 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.999 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.38 23.21 0.85 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.083 1.57 . . . . 0.0 110.694 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -132.24 93.79 25.1 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.95 -1.094 . . . . 0.0 110.621 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -60.82 145.14 99.44 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.914 1.481 . . . . 0.0 109.637 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.97 169.1 23.91 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.4 m -123.98 129.67 51.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.469 -1.018 . . . . 0.0 110.049 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.54 171.22 53.95 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.1 t -124.03 130.71 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -1.108 . . . . 0.0 109.901 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.89 -41.66 99.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.034 -1.041 . . . . 0.0 109.755 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.2 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.336 0.589 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.87 129.36 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.155 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.51 18.42 71.05 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.7 p -132.73 163.18 29.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -1.199 . . . . 0.0 109.992 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -140.84 156.27 46.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.058 -1.026 . . . . 0.0 110.651 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.423 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 79.9 m-20 -139.36 154.32 47.84 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 110.138 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 t -89.09 114.23 25.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 110.285 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -80.66 -18.74 47.09 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.22 -0.925 . . . . 0.0 110.494 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.1 m -61.67 -44.6 96.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.934 . . . . 0.0 110.71 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.0 p -118.89 26.3 9.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.106 -0.996 . . . . 0.0 111.033 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.417 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 37.2 tp 48.27 56.39 7.48 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.324 -0.86 . . . . 0.0 111.224 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 28.9 t -130.16 133.51 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.005 -1.06 . . . . 0.0 110.088 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.423 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . 84.4 mt-30 -101.05 133.69 45.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 110.103 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 78.6 m-20 -128.98 119.69 24.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.04 -1.038 . . . . 0.0 109.713 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.55 174.74 2.34 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 110.303 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -56.2 -30.55 80.3 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.166 1.614 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -62.38 -37.52 86.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.875 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.518 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -54.22 -174.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 110.031 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.763 HG12 ' HG3' ' A' ' 20' ' ' LYS . 80.7 t -155.67 -46.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.763 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.7 mttt -140.9 120.94 13.69 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.674 0.75 . . . . 0.0 109.047 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.726 ' HB2' HG23 ' A' ' 26' ' ' THR . 9.7 t -46.36 130.09 10.66 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.697 0.76 . . . . 0.0 111.017 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.49 -46.02 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.25 -0.906 . . . . 0.0 111.64 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.5 -41.47 96.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.97 -1.081 . . . . 0.0 109.75 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.43 ' O ' ' C ' ' A' ' 25' ' ' GLU . 32.1 p -153.57 80.77 1.17 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 122.068 0.937 . . . . 0.0 109.036 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.464 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 96.5 mt-10 -30.3 93.3 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.544 0.688 . . . . 0.0 112.432 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.726 HG23 ' HB2' ' A' ' 21' ' ' CYS . 51.8 p -54.94 157.99 5.12 Favored Pre-proline 0 N--CA 1.49 1.543 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.492 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.58 4.73 5.74 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.909 1.478 . . . . 0.0 111.261 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -88.32 115.22 62.6 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.794 -1.192 . . . . 0.0 110.391 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.64 146.6 96.69 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.579 1.305 . . . . 0.0 110.213 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 19' ' ' VAL . . . -65.26 160.22 43.41 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.7 p -133.83 160.11 38.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -1.103 . . . . 0.0 110.445 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.76 17.39 72.96 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.0 t -124.6 131.6 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.059 -1.259 . . . . 0.0 110.378 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -81.71 146.08 30.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 0.0 109.923 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.27 -179.898 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.235 0.54 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mm -107.97 126.78 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.964 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.61 172.46 54.98 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.529 HG22 ' HD3' ' A' ' 16' ' ' PRO . 82.6 p -81.52 162.4 23.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -1.142 . . . . 0.0 110.021 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 46.9 p-90 -146.65 155.06 42.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.95 . . . . 0.0 110.875 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -135.88 149.57 49.04 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.242 -0.911 . . . . 0.0 109.778 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' VAL . 8.2 t -87.44 120.29 28.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.979 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -95.09 -6.02 42.95 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.254 -0.904 . . . . 0.0 110.759 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.3 p -74.7 -21.29 59.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.913 -1.117 . . . . 0.0 109.941 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.418 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -141.15 20.87 2.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.693 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt 54.82 58.37 4.87 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.413 -0.804 . . . . 0.0 111.592 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.557 HG11 ' SG ' ' A' ' 21' ' ' CYS . 27.3 t -131.63 135.94 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.899 . . . . 0.0 110.247 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -103.14 134.05 47.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.447 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 94.9 m-20 -134.66 116.41 14.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.062 -1.024 . . . . 0.0 110.494 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.52 176.66 1.55 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.0 110.496 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.529 ' HD3' HG22 ' A' ' 4' ' ' THR . 35.4 Cg_exo -54.23 -32.02 69.0 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.936 1.492 . . . . 0.0 110.321 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.51 -35.73 81.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 110.607 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.558 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -60.35 176.69 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.002 . . . . 0.0 110.5 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.729 HG12 ' HG3' ' A' ' 20' ' ' LYS . 44.9 t -156.66 -43.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.325 -0.859 . . . . 0.0 109.23 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.729 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.5 mttt -128.28 106.86 9.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.487 -0.758 . . . . 0.0 109.716 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.557 ' SG ' HG11 ' A' ' 12' ' ' VAL . 15.9 t -45.91 135.16 7.42 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.063 0.935 . . . . 0.0 111.253 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.93 -43.33 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.192 -0.942 . . . . 0.0 111.038 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.27 89.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.355 -0.841 . . . . 0.0 112.187 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 25' ' ' GLU . 23.1 p -155.83 25.25 0.38 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.939 -1.1 . . . . 0.0 111.104 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.9 mt-10 33.96 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.424 0.63 . . . . 0.0 111.952 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.484 HG23 ' HD2' ' A' ' 27' ' ' PRO . 86.5 m -64.49 146.01 98.26 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 110.219 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.484 ' HD2' HG23 ' A' ' 26' ' ' THR . 58.5 Cg_endo -80.7 44.21 1.7 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.927 1.488 . . . . 0.0 110.694 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -48.17 -58.25 8.47 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.18 -0.95 . . . . 0.0 110.466 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 28' ' ' LYS . 29.6 Cg_endo -66.51 154.73 73.25 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.585 1.308 . . . . 0.0 110.438 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.8 18.4 61.61 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 74.4 m -62.49 -44.7 95.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.066 -1.255 . . . . 0.0 110.025 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.33 -171.94 39.77 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 34' ' ' LYS . 24.3 m -63.6 -40.68 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -1.088 . . . . 0.0 110.154 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.53 ' N ' HG23 ' A' ' 33' ' ' VAL . 87.2 tttt -67.88 131.32 45.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.824 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.076 -1.015 . . . . 0.0 110.332 -179.616 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.53 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 35.0 p-90 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.38 0.61 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -120.07 140.68 50.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.167 -0.958 . . . . 0.0 109.816 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.669 ' SG ' HG21 ' A' ' 26' ' ' THR . 19.2 t -87.43 115.92 25.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.519 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -94.51 -5.22 46.55 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.256 -0.903 . . . . 0.0 110.929 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -68.77 -31.21 70.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.95 -1.094 . . . . 0.0 109.634 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.409 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.9 p -135.74 21.03 3.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.811 . . . . 0.0 111.234 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 9.3 mp 58.83 46.55 13.84 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.292 -0.88 . . . . 0.0 111.838 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 48.0 t -127.89 134.66 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.153 -0.967 . . . . 0.0 110.117 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -96.65 145.69 25.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.005 -1.059 . . . . 0.0 110.507 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.53 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 m-20 -125.73 142.1 51.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.202 -0.936 . . . . 0.0 109.876 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -90.95 170.69 9.39 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.766 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -54.38 -34.32 80.4 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.898 1.473 . . . . 0.0 110.418 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.21 -36.67 82.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.111 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.495 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -51.52 -179.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.462 -0.774 . . . . 0.0 110.667 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.768 HG12 ' HG3' ' A' ' 20' ' ' LYS . 74.2 t -155.31 -47.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.768 ' HG3' HG12 ' A' ' 19' ' ' VAL . 98.4 mttt -137.32 119.54 15.63 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.51 ' O ' ' N ' ' A' ' 25' ' ' GLU . 14.6 t -45.04 140.49 2.69 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.097 0.951 . . . . 0.0 111.595 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.09 -44.45 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.629 -1.294 . . . . 0.0 111.62 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.24 93.2 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.294 -0.879 . . . . 0.0 112.516 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.5 p -140.57 11.9 2.3 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.894 -1.129 . . . . 0.0 112.088 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.3 mt-10 40.8 78.01 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.63 -0.669 . . . . 0.0 111.247 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.669 HG21 ' SG ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.922 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 121.385 0.612 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 47.5 p-10 -132.84 148.43 52.3 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.402 -0.811 . . . . 0.0 110.117 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 t -83.0 106.13 14.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.045 -1.035 . . . . 0.0 109.911 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -71.59 -18.13 62.24 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.423 -0.798 . . . . 0.0 110.185 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.0 m -60.87 -44.35 97.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.867 . . . . 0.0 111.082 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 23' ' ' ALA . 14.0 p -128.96 33.77 4.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.04 -1.037 . . . . 0.0 110.897 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 11' ' ' LEU . 39.0 tp 42.49 65.66 0.88 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.56 -0.712 . . . . 0.0 112.409 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.546 HG11 ' SG ' ' A' ' 21' ' ' CYS . 39.4 t -133.81 135.53 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.945 -1.097 . . . . 0.0 109.906 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -100.78 141.01 34.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.245 -0.909 . . . . 0.0 110.702 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 21' ' ' CYS . 3.6 m-20 -145.91 121.12 10.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 109.557 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -70.2 178.01 1.2 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.412 -0.805 . . . . 0.0 110.298 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.11 -29.83 84.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.0 1.526 . . . . 0.0 109.764 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.64 -37.8 88.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.459 -0.776 . . . . 0.0 109.764 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.794 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -54.92 -172.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.405 -0.809 . . . . 0.0 110.426 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -168.91 -37.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.467 -0.771 . . . . 0.0 109.113 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -131.9 111.04 11.23 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.675 0.75 . . . . 0.0 109.402 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.546 ' SG ' HG11 ' A' ' 12' ' ' VAL . 8.9 t -45.99 141.27 3.26 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.902 0.858 . . . . 0.0 110.924 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.68 -43.86 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.611 -1.306 . . . . 0.0 111.639 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.607 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -63.93 -38.07 89.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.319 -0.863 . . . . 0.0 112.437 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.9 p -142.77 13.07 1.89 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.003 -1.061 . . . . 0.0 112.1 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 21' ' ' CYS . 96.7 mt-10 43.78 73.08 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.418 -0.801 . . . . 0.0 110.105 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.944 -0.472 . . . . 0.0 110.558 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.477 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 19.7 p-90 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.359 0.599 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -130.41 134.29 47.01 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.083 -1.01 . . . . 0.0 109.908 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.7 t -83.66 114.79 21.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.361 -0.837 . . . . 0.0 108.769 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -92.06 -7.3 49.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.002 -1.061 . . . . 0.0 110.631 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.4 p -68.5 -33.88 74.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 109.406 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 12' ' ' VAL . 12.6 p -128.3 20.46 6.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.363 -0.836 . . . . 0.0 111.108 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt 53.15 48.99 20.97 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.291 -0.881 . . . . 0.0 112.393 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.4 ' HB ' ' SG ' ' A' ' 10' ' ' CYS . 51.2 t -128.07 131.79 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.852 -1.155 . . . . 0.0 110.527 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -89.18 142.49 27.6 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.593 -0.692 . . . . 0.0 109.992 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 8.4 m-20 -129.92 126.21 37.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.961 -1.087 . . . . 0.0 110.114 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.502 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 15.5 mmtp -73.14 171.43 10.46 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.55 -0.719 . . . . 0.0 110.592 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 34.7 Cg_exo -55.44 -32.02 80.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.915 1.481 . . . . 0.0 110.028 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' OE1' ' HB3' ' A' ' 15' ' ' LYS . 52.5 mp0 -66.47 -31.05 71.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.401 -0.812 . . . . 0.0 109.703 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 15' ' ' LYS . . . -61.52 151.01 34.11 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.347 0.594 . . . . 0.0 110.536 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.2 t -137.5 -42.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.516 -0.74 . . . . 0.0 109.195 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 25' ' ' GLU . 99.7 mttt -130.46 107.72 9.43 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.466 -0.894 . . . . 0.0 108.701 178.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.469 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.5 t -45.54 130.25 8.75 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.471 0.653 . . . . 0.0 110.837 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.7 t -62.71 -46.73 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.206 -0.934 . . . . 0.0 112.079 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.22 -38.59 91.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.781 -1.199 . . . . 0.0 109.673 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -155.43 83.22 1.05 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.057 0.932 . . . . 0.0 109.043 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.469 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.5 mt-10 -33.68 92.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.056 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 24' ' ' CYS . 13.4 p . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.129 -0.982 . . . . 0.0 110.147 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.541 ' CZ2' ' CB ' ' A' ' 14' ' ' ASN . 29.0 p-90 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.553 0.692 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -130.91 127.64 38.9 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.438 -0.788 . . . . 0.0 109.926 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.55 ' SG ' HG21 ' A' ' 26' ' ' THR . 30.6 t -76.97 120.46 22.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.628 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -92.8 -8.58 43.22 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.465 -0.772 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 m -64.17 -44.55 91.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 110.521 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.428 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.3 p -124.14 18.81 9.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 110.915 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.3 mt 56.53 52.59 9.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.36 -0.837 . . . . 0.0 111.572 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.428 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 37.9 t -127.15 132.76 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.304 -0.873 . . . . 0.0 109.6 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -93.62 136.48 33.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 110.637 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' CZ2' ' A' ' 5' ' ' TRP . 1.6 m120 -126.18 130.38 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.111 -0.993 . . . . 0.0 109.576 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -69.15 166.89 24.4 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 0.0 109.864 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -52.71 -36.59 73.24 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 124.041 1.548 . . . . 0.0 109.754 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.34 -35.87 76.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.917 . . . . 0.0 109.849 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.615 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -60.88 146.02 48.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 110.193 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -157.38 23.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.393 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -158.0 75.27 0.75 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.486 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.6 t -45.27 129.47 8.04 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.031 0.92 . . . . 0.0 111.078 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.19 -43.73 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.106 . . . . 0.0 111.576 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.19 -40.69 96.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.368 -0.833 . . . . 0.0 112.211 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 p -149.95 24.39 0.85 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.833 -1.167 . . . . 0.0 111.344 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 21' ' ' CYS . 75.2 tt0 36.9 96.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.392 0.615 . . . . 0.0 112.447 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.55 HG21 ' SG ' ' A' ' 7' ' ' CYS . 22.3 p . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.422 -0.799 . . . . 0.0 109.831 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 26.8 p-90 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.261 0.553 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -130.69 134.58 47.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.049 -1.032 . . . . 0.0 110.456 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 t -87.59 118.27 26.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.83 . . . . 0.0 109.699 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -89.89 -11.96 40.35 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.16 -0.962 . . . . 0.0 111.09 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.2 p -66.97 -31.42 71.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.912 -1.117 . . . . 0.0 110.29 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.461 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.8 p -133.92 24.8 3.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.988 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 37.6 tp 46.83 57.33 5.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.277 -0.89 . . . . 0.0 111.531 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 10' ' ' CYS . 41.8 t -131.28 133.78 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.987 -1.071 . . . . 0.0 109.866 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -101.19 130.77 47.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.292 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.492 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 85.6 m-20 -132.17 125.73 31.91 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.056 -1.027 . . . . 0.0 109.936 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 2.6 mttt -78.34 176.53 3.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.813 . . . . 0.0 110.477 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 32.2 Cg_exo -56.36 -29.73 78.22 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.016 1.534 . . . . 0.0 110.01 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -64.89 -36.0 82.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.362 -0.836 . . . . 0.0 109.831 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.503 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -52.35 -179.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.334 -0.854 . . . . 0.0 110.095 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.77 HG12 ' HG3' ' A' ' 20' ' ' LYS . 76.6 t -154.73 -43.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.959 . . . . 0.0 109.099 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.77 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.1 mttt -135.77 110.79 8.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.567 0.698 . . . . 0.0 109.305 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.58 ' CB ' HG23 ' A' ' 26' ' ' THR . 12.2 t -46.2 132.21 9.96 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.503 0.668 . . . . 0.0 111.075 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.55 -46.72 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.524 -0.735 . . . . 0.0 111.731 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.7 96.02 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.964 -1.085 . . . . 0.0 109.694 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.439 ' O ' ' C ' ' A' ' 25' ' ' GLU . 32.1 p -153.63 81.91 1.17 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.794 0.807 . . . . 0.0 109.201 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.515 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.1 mt-10 -30.37 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.545 0.688 . . . . 0.0 112.12 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.58 HG23 ' CB ' ' A' ' 21' ' ' CYS . 78.0 p . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.482 -0.762 . . . . 0.0 110.035 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.527 ' HH2' ' HG1' ' A' ' 26' ' ' THR . 56.4 p-90 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.442 0.639 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.445 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 47.0 p-10 -134.82 151.89 51.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.31 -0.869 . . . . 0.0 110.256 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' VAL . 13.4 t -84.31 107.06 16.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.343 -0.848 . . . . 0.0 110.365 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -72.05 -18.71 61.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.27 -0.894 . . . . 0.0 110.279 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.8 m -60.97 -45.1 96.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.912 . . . . 0.0 110.661 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.485 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.9 p -121.85 29.74 6.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.126 -0.984 . . . . 0.0 110.783 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 35.1 tp 44.45 55.46 5.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.522 -0.736 . . . . 0.0 111.594 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 10' ' ' CYS . 34.7 t -129.26 133.88 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.999 -1.063 . . . . 0.0 109.808 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.445 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . 88.6 mt-30 -100.33 132.35 45.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.98 . . . . 0.0 110.606 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 4.0 m-20 -118.01 124.24 47.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.46 -0.775 . . . . 0.0 109.433 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -68.0 170.67 6.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.981 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -54.92 -32.58 78.73 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.987 1.52 . . . . 0.0 110.013 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.49 -34.34 78.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 109.818 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -51.96 -179.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.408 -0.807 . . . . 0.0 110.507 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.781 HG12 ' HG3' ' A' ' 20' ' ' LYS . 69.8 t -155.17 -45.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.781 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.6 mttt -139.62 118.76 12.68 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 25' ' ' GLU . 12.5 t -45.57 130.18 8.82 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.581 0.705 . . . . 0.0 111.384 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.77 -46.46 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.411 -0.806 . . . . 0.0 111.641 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.4 97.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.911 -1.118 . . . . 0.0 109.33 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.436 ' O ' ' C ' ' A' ' 25' ' ' GLU . 31.0 p -155.45 84.99 1.05 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.834 0.826 . . . . 0.0 109.25 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 24' ' ' CYS . 95.7 mt-10 -30.99 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.591 0.71 . . . . 0.0 112.683 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.527 ' HG1' ' HH2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.519 0 O-C-N 121.58 -0.7 . . . . 0.0 109.926 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.511 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 45.7 p-90 . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.395 0.617 . . . . 0.0 110.647 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 45.0 p-10 -136.82 148.79 47.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.352 -0.843 . . . . 0.0 110.124 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.6 t -83.89 135.54 34.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.867 . . . . 0.0 109.833 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -101.61 -16.9 16.58 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.097 -1.002 . . . . 0.0 110.854 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.5 p -65.29 -31.23 72.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.003 -1.06 . . . . 0.0 110.277 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.2 p -131.02 21.74 4.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 110.854 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 41.2 tp 49.4 59.59 4.37 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.217 -0.927 . . . . 0.0 111.424 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 28.0 t -132.72 135.03 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.126 -0.984 . . . . 0.0 110.262 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -99.44 137.23 38.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.164 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 61.7 m-20 -131.13 134.47 46.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.162 -0.961 . . . . 0.0 109.703 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -76.94 169.71 19.9 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 110.421 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -54.27 -33.29 75.05 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.168 1.615 . . . . 0.0 110.586 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.4 mp0 -65.64 -36.33 83.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.146 -0.971 . . . . 0.0 110.203 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -52.38 175.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.442 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.528 HG12 ' HG3' ' A' ' 20' ' ' LYS . 76.0 t -156.94 -41.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.332 -0.855 . . . . 0.0 109.167 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.528 ' HG3' HG12 ' A' ' 19' ' ' VAL . 96.9 mttt -127.33 107.41 9.96 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.141 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.504 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.4 t -46.64 132.42 10.95 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.52 0.676 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.05 -45.73 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.835 . . . . 0.0 111.659 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.26 99.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.851 -1.156 . . . . 0.0 109.556 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -155.02 83.66 1.08 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.793 0.806 . . . . 0.0 108.87 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.504 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.5 mt-10 -31.45 91.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.519 0.676 . . . . 0.0 112.333 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 24' ' ' CYS . 6.6 m . . . . . 0 N--CA 1.487 1.42 0 O-C-N 121.422 -0.799 . . . . 0.0 109.372 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.517 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 48.4 p-90 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.251 0.548 . . . . 0.0 109.906 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -129.74 130.04 44.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.265 -0.897 . . . . 0.0 110.416 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.9 t -75.55 100.27 4.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.422 -0.799 . . . . 0.0 109.83 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -69.51 -16.53 63.46 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.475 -0.765 . . . . 0.0 110.563 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.1 m -60.95 -44.43 97.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.034 -1.041 . . . . 0.0 110.392 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.9 p -124.24 21.16 8.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.014 -1.053 . . . . 0.0 111.282 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.5 mt 53.84 52.31 13.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.172 -0.955 . . . . 0.0 111.959 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 48.8 t -129.0 132.14 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.089 -1.007 . . . . 0.0 109.685 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -96.45 137.02 36.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.0 110.565 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.517 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 79.6 m-20 -132.46 124.43 28.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.368 -0.832 . . . . 0.0 109.874 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 37.8 mtpt -73.39 168.39 25.72 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.929 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 52.2 Cg_exo -51.94 -33.15 50.71 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.797 1.419 . . . . 0.0 110.581 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -60.89 -35.13 75.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.925 . . . . 0.0 108.879 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.506 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -52.96 177.45 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.623 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.782 HG12 ' HG3' ' A' ' 20' ' ' LYS . 78.3 t -155.8 -43.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -0.82 . . . . 0.0 108.804 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.782 ' HG3' HG12 ' A' ' 19' ' ' VAL . 97.4 mttt -136.49 112.36 9.55 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.802 0.811 . . . . 0.0 109.228 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.459 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.1 t -45.37 131.73 8.08 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.755 0.788 . . . . 0.0 111.473 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.1 t -64.01 -46.66 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.052 -1.03 . . . . 0.0 111.106 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.84 88.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.576 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 26' ' ' THR . 32.1 p -148.48 81.12 1.46 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.823 0.821 . . . . 0.0 109.081 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.459 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 95.8 mt-10 -30.54 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.615 0.721 . . . . 0.0 112.209 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 24' ' ' CYS . 6.7 p . . . . . 0 N--CA 1.487 1.407 0 O-C-N 121.737 -0.602 . . . . 0.0 109.921 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.471 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 51.0 p-90 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.361 0.6 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -135.22 150.33 50.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.046 -1.034 . . . . 0.0 110.311 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.7 t -90.15 123.72 34.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.0 110.098 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -96.76 -4.19 41.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.169 -0.957 . . . . 0.0 111.143 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.6 p -74.19 -23.17 59.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.91 -1.119 . . . . 0.0 109.847 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.5 p -141.31 21.35 2.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.371 -0.83 . . . . 0.0 111.014 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt 54.23 48.96 19.68 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.325 -0.859 . . . . 0.0 111.686 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 41.0 t -125.35 132.21 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -0.967 . . . . 0.0 109.811 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -97.44 139.37 33.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.186 -0.946 . . . . 0.0 110.356 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 95.2 m-20 -134.65 106.02 6.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.294 -0.879 . . . . 0.0 110.014 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 3.1 mttm -56.55 172.93 0.32 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.857 . . . . 0.0 110.372 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 31.7 Cg_exo -56.89 -29.29 81.24 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.959 1.505 . . . . 0.0 110.231 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -65.14 -34.66 78.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 109.972 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -52.54 -177.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.78 . . . . 0.0 110.364 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.91 HG12 ' HG3' ' A' ' 20' ' ' LYS . 20.6 t -155.13 -44.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 108.882 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.91 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.2 mttt -142.56 115.62 8.84 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.804 0.811 . . . . 0.0 109.571 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.47 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 12.2 t -45.73 132.41 8.7 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.877 0.846 . . . . 0.0 111.793 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.92 -47.06 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.451 -0.781 . . . . 0.0 111.301 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.94 83.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.066 -1.021 . . . . 0.0 109.573 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 26' ' ' THR . 32.0 p -146.91 80.72 1.54 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.807 0.813 . . . . 0.0 109.426 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.47 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 96.6 mt-10 -29.24 89.7 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.487 0.661 . . . . 0.0 112.666 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 24' ' ' CYS . 2.1 p . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.756 -0.59 . . . . 0.0 109.912 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.478 0.656 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -125.73 142.64 51.41 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.012 -1.055 . . . . 0.0 110.291 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.2 t -87.78 117.21 26.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.945 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 42.3 p-10 -92.77 -8.21 44.35 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.055 -1.028 . . . . 0.0 110.619 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.2 m -63.16 -43.55 97.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 109.037 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.422 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -123.11 21.06 9.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.579 -0.7 . . . . 0.0 110.319 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 37.8 tp 53.08 59.36 4.5 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.482 -0.761 . . . . 0.0 111.548 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 38.6 t -131.95 134.56 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -0.91 . . . . 0.0 109.722 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.99 136.01 38.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.164 -0.96 . . . . 0.0 110.589 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.456 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 99.4 m-20 -137.09 123.79 21.12 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.84 172.77 6.38 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.988 . . . . 0.0 110.612 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -53.96 -32.96 70.45 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.16 1.61 . . . . 0.0 110.379 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.77 -32.17 73.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.014 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -50.85 178.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.405 -0.81 . . . . 0.0 110.383 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -158.6 -41.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.475 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.86 108.14 6.46 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.533 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 14.3 t -46.02 137.18 6.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.894 0.854 . . . . 0.0 110.931 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.04 -44.81 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 111.958 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.65 85.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.166 -0.959 . . . . 0.0 112.35 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 25' ' ' GLU . 26.8 p -146.75 24.6 1.2 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.844 -1.16 . . . . 0.0 111.741 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.533 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.0 mt-10 28.87 86.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.309 -0.869 . . . . 0.0 110.352 179.383 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.462 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 48.3 p-90 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.33 0.586 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -120.9 140.74 51.39 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.307 -0.871 . . . . 0.0 109.99 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.6 t -84.52 113.41 21.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.19 -0.944 . . . . 0.0 109.206 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -88.69 -10.02 49.95 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.27 -0.894 . . . . 0.0 111.059 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.1 p -66.93 -31.5 72.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.008 -1.057 . . . . 0.0 109.989 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.413 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.1 p -133.55 22.53 3.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 111.341 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.1 mt 55.58 48.68 18.15 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.237 -0.914 . . . . 0.0 111.746 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.448 HG11 ' SG ' ' A' ' 21' ' ' CYS . 40.9 t -126.53 132.07 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.195 -0.94 . . . . 0.0 109.708 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.03 134.2 42.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.085 -1.009 . . . . 0.0 110.492 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 m-20 -120.17 131.5 55.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.195 -0.941 . . . . 0.0 109.934 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 3.0 mttt -80.28 173.38 7.81 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.9 . . . . 0.0 110.03 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -54.74 -34.48 84.53 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.982 1.517 . . . . 0.0 110.249 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.74 -35.6 80.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.562 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.523 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -51.09 174.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.486 -0.759 . . . . 0.0 110.419 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.69 HG12 ' HG3' ' A' ' 20' ' ' LYS . 75.4 t -156.44 -44.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.69 ' HG3' HG12 ' A' ' 19' ' ' VAL . 98.0 mttt -133.1 112.53 11.85 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 25' ' ' GLU . 12.4 t -45.74 138.4 4.74 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.086 0.946 . . . . 0.0 111.316 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.63 -44.84 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.636 -1.29 . . . . 0.0 111.871 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.01 90.91 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.212 -0.93 . . . . 0.0 112.61 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.3 p -140.5 16.28 2.37 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.833 -1.167 . . . . 0.0 111.961 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.2 mt-10 38.43 78.36 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.692 -0.63 . . . . 0.0 111.784 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.497 ' HZ3' HG21 ' A' ' 26' ' ' THR . 33.2 p-90 . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.368 0.604 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -135.06 151.07 50.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.159 -0.963 . . . . 0.0 110.091 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.8 t -90.96 111.25 22.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.163 -0.961 . . . . 0.0 110.657 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -80.56 -17.17 52.29 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.511 -0.743 . . . . 0.0 110.515 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.4 m -62.22 -44.35 96.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -0.998 . . . . 0.0 110.895 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.0 p -120.4 24.22 10.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 111.347 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt 53.81 50.9 15.92 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.289 -0.882 . . . . 0.0 111.637 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 40.2 t -130.15 133.4 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.146 -0.971 . . . . 0.0 110.506 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -96.8 137.29 36.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.055 -1.028 . . . . 0.0 110.064 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 2.4 m-20 -119.24 120.45 37.07 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.149 -0.97 . . . . 0.0 110.403 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.38 172.19 2.75 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.954 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.48 -33.6 92.81 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.996 1.524 . . . . 0.0 110.174 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.87 -36.1 79.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -0.801 . . . . 0.0 109.765 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.02 157.91 29.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 0.0 110.55 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.9 t -147.05 -41.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.418 -0.802 . . . . 0.0 108.93 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . 97.4 mttt -115.57 101.55 8.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.421 -0.8 . . . . 0.0 108.984 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.2 t -45.27 133.02 7.29 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.183 0.992 . . . . 0.0 111.256 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.72 -43.4 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 111.546 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.47 91.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.189 -0.944 . . . . 0.0 112.429 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 p -151.01 21.43 0.77 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.771 -1.205 . . . . 0.0 111.406 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 21' ' ' CYS . 86.4 tt0 41.14 91.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.731 -0.606 . . . . 0.0 111.489 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.497 HG21 ' HZ3' ' A' ' 5' ' ' TRP . 2.0 m . . . . . 0 C--N 1.301 -1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.378 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 53.7 p-90 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.487 0.661 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -131.07 146.75 52.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.389 -0.819 . . . . 0.0 109.658 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.828 ' HB3' HG22 ' A' ' 12' ' ' VAL . 6.5 t -79.19 114.59 18.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 110.273 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -71.47 -24.1 61.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.0 110.191 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.8 m -62.15 -45.61 92.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.885 . . . . 0.0 110.5 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.521 ' SG ' HG13 ' A' ' 12' ' ' VAL . 14.0 p -125.28 13.73 8.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.166 -0.959 . . . . 0.0 110.934 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 11' ' ' LEU . 42.7 tp 48.25 85.31 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.261 -0.9 . . . . 0.0 112.219 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.843 HG21 ' SG ' ' A' ' 21' ' ' CYS . 18.6 m -138.64 163.6 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 109.299 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -108.3 107.87 18.64 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.046 -1.034 . . . . 0.0 110.836 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.461 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 44.3 m-20 -125.79 125.68 43.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.183 -0.948 . . . . 0.0 109.186 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -80.35 176.38 3.85 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.895 . . . . 0.0 110.482 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.17 -32.14 78.87 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.124 1.592 . . . . 0.0 110.437 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.58 -31.89 72.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 110.162 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -49.9 176.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -0.858 . . . . 0.0 110.602 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -160.92 -38.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.402 -0.812 . . . . 0.0 109.538 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -127.73 101.95 6.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.458 -0.776 . . . . 0.0 109.603 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.843 ' SG ' HG21 ' A' ' 12' ' ' VAL . 13.9 t -47.29 131.82 13.09 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.937 0.875 . . . . 0.0 110.759 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -67.78 -43.48 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 111.419 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.472 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -63.39 -40.25 96.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.236 -0.915 . . . . 0.0 112.341 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.7 p -149.97 22.26 0.87 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.92 -1.112 . . . . 0.0 111.17 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' CYS . 82.5 tt0 35.77 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.423 0.63 . . . . 0.0 112.538 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 C--N 1.301 -1.522 0 O-C-N 121.407 -0.808 . . . . 0.0 108.966 178.417 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.53 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 24.2 p-90 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.348 0.595 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 7' ' ' CYS . 67.8 t0 -131.97 139.35 48.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.165 -0.96 . . . . 0.0 110.418 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.426 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 13.5 t -89.6 112.99 24.36 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.394 -0.816 . . . . 0.0 109.617 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -91.91 -7.22 49.81 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.163 -0.96 . . . . 0.0 110.511 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -66.99 -34.13 77.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.023 -1.048 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 12.8 p -128.27 18.95 6.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 110.432 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 75.5 mt 58.87 45.35 15.41 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.677 -0.639 . . . . 0.0 111.869 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -128.57 132.96 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.07 -1.018 . . . . 0.0 110.184 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -100.86 144.45 29.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.74 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.53 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.2 m-20 -121.03 122.54 40.32 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.028 -1.045 . . . . 0.0 109.894 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 16.8 mttm -67.84 168.87 11.06 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.25 -0.906 . . . . 0.0 109.614 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -53.71 -35.49 78.47 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.91 1.479 . . . . 0.0 110.601 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -66.66 -35.03 79.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.553 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.644 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -51.3 179.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.499 -0.751 . . . . 0.0 110.075 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -162.45 -39.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.007 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . 96.7 mttt -135.44 111.8 9.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.5 t -45.68 130.6 9.13 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.997 0.903 . . . . 0.0 111.344 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -68.28 -43.09 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.02 -1.05 . . . . 0.0 111.377 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.37 92.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.262 -0.899 . . . . 0.0 112.44 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.6 p -147.38 20.11 1.2 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.733 -1.23 . . . . 0.0 111.553 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 21' ' ' CYS . 80.9 tt0 42.38 90.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.661 -0.649 . . . . 0.0 111.767 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.52 ' HG1' ' HH2' ' A' ' 5' ' ' TRP . 2.1 p . . . . . 0 C--N 1.301 -1.515 0 O-C-N 121.365 -0.835 . . . . 0.0 109.237 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.44 ' HH2' ' HG1' ' A' ' 26' ' ' THR . 59.1 p-90 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.207 0.527 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -130.5 148.74 52.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.143 -0.973 . . . . 0.0 110.59 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.4 t -85.31 113.8 21.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.145 -0.972 . . . . 0.0 109.689 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -83.06 -14.05 54.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.359 -0.838 . . . . 0.0 110.503 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.6 m -61.96 -43.47 98.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 109.711 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.403 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.2 p -120.83 21.91 11.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.832 . . . . 0.0 110.925 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.7 mt 54.15 47.6 22.84 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.242 -0.911 . . . . 0.0 111.995 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 43.9 t -125.94 130.7 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.837 -1.164 . . . . 0.0 110.238 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -97.53 132.46 43.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.071 -1.018 . . . . 0.0 110.218 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.426 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 3.0 m-20 -117.02 127.27 54.01 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.138 -0.976 . . . . 0.0 109.658 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -69.82 170.91 8.34 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.985 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -54.9 -32.54 78.41 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.011 1.532 . . . . 0.0 110.512 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.49 -32.07 73.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.468 ' C ' HG22 ' A' ' 19' ' ' VAL . . . -64.39 -179.95 0.52 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.395 -0.815 . . . . 0.0 110.412 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.468 HG22 ' C ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -159.94 -42.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 62.3 pttt -128.96 114.74 16.81 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.111 0.958 . . . . 0.0 109.141 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.45 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.0 t -46.43 132.0 10.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.52 -0.737 . . . . 0.0 111.344 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -64.11 -46.25 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.508 -0.745 . . . . 0.0 111.88 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.36 -41.24 94.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.953 -1.092 . . . . 0.0 109.849 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 32.1 p -152.45 80.66 1.24 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.032 0.92 . . . . 0.0 109.146 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.45 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 95.5 mt-10 -31.35 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.374 0.607 . . . . 0.0 112.549 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.44 ' HG1' ' HH2' ' A' ' 5' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.095 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.282 0.563 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.421 ' HB3' ' HG3' ' A' ' 13' ' ' GLN . 49.3 p-10 -119.99 151.28 39.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.936 -1.102 . . . . 0.0 111.148 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.425 ' SG ' HG23 ' A' ' 26' ' ' THR . 13.7 t -94.6 121.21 35.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.093 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -96.85 -14.79 21.61 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.051 -1.031 . . . . 0.0 110.526 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -60.09 -39.02 84.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.052 -1.03 . . . . 0.0 109.892 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 13.7 p -124.83 22.24 8.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.86 . . . . 0.0 111.073 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 84.6 mt 56.09 44.9 24.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.511 -0.743 . . . . 0.0 112.007 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.405 ' HB ' ' SG ' ' A' ' 10' ' ' CYS . 47.2 t -126.48 130.16 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.069 -1.02 . . . . 0.0 109.829 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.421 ' HG3' ' HB3' ' A' ' 6' ' ' ASP . 56.7 tt0 -101.24 145.55 28.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.043 -1.036 . . . . 0.0 110.17 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -134.12 149.7 51.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.065 -1.022 . . . . 0.0 110.091 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 8.6 mttt -82.2 169.73 17.35 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 109.949 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 34.3 Cg_exo -56.51 -33.19 91.98 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.091 1.574 . . . . 0.0 110.731 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -65.41 -27.89 68.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 110.011 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.44 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -50.53 178.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.37 -0.831 . . . . 0.0 110.394 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.755 HG12 ' HG3' ' A' ' 20' ' ' LYS . 75.1 t -152.15 -46.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.755 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.7 mttt -139.99 117.86 11.74 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 109.103 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.484 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 18.1 t -45.42 140.06 3.33 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.2 1.0 . . . . 0.0 111.585 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.37 -44.49 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.847 -1.158 . . . . 0.0 111.894 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.4 -38.7 85.06 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.173 -0.954 . . . . 0.0 112.358 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 25' ' ' GLU . 20.5 p -147.0 22.36 1.22 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.81 -1.181 . . . . 0.0 111.451 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.484 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 94.6 mt-10 31.54 85.11 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.425 HG23 ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.925 . . . . 0.0 109.58 178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.528 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 52.2 p-90 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.158 0.504 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.403 ' HB2' ' HG2' ' A' ' 13' ' ' GLN . 46.9 p-10 -124.62 149.01 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.956 . . . . 0.0 110.773 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.526 ' SG ' HG21 ' A' ' 26' ' ' THR . 20.6 t -92.8 120.9 33.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.36 -0.838 . . . . 0.0 110.429 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.6 p30 -96.86 -6.08 36.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.821 -1.175 . . . . 0.0 110.279 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.4 m -63.13 -42.39 99.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.167 -0.958 . . . . 0.0 109.409 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.415 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.6 p -125.04 18.14 8.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.535 -0.728 . . . . 0.0 111.35 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mp 62.95 43.45 6.72 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.217 -0.927 . . . . 0.0 111.767 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.415 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 48.8 t -125.81 134.96 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.263 -0.898 . . . . 0.0 109.917 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.403 ' HG2' ' HB2' ' A' ' 6' ' ' ASP . 79.0 mt-30 -98.41 145.09 27.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.078 -1.014 . . . . 0.0 110.016 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.528 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 m-20 -122.47 131.44 53.86 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.093 -1.005 . . . . 0.0 110.466 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -78.08 168.99 22.99 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 110.048 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.97 -33.77 73.98 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.896 1.472 . . . . 0.0 109.911 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.88 -40.27 91.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.142 -0.974 . . . . 0.0 109.904 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.58 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -54.0 -179.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 109.895 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.843 HG12 ' HG3' ' A' ' 20' ' ' LYS . 40.2 t -157.7 -43.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.843 ' HG3' HG12 ' A' ' 19' ' ' VAL . 98.8 mttt -134.49 116.03 14.63 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.7 t -45.73 131.64 9.03 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.93 0.872 . . . . 0.0 111.946 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.81 -46.27 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.522 -0.736 . . . . 0.0 111.373 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.03 88.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.157 -0.965 . . . . 0.0 109.345 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -153.97 84.52 1.15 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.13 0.967 . . . . 0.0 109.242 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 21' ' ' CYS . 92.0 mt-10 -33.07 88.38 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.526 HG21 ' SG ' ' A' ' 7' ' ' CYS . 21.4 p . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.0 . . . . 0.0 109.818 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 33.3 p-90 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.442 0.639 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.444 ' HB2' ' HG2' ' A' ' 13' ' ' GLN . 43.8 p-10 -118.13 142.79 47.05 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.466 -0.771 . . . . 0.0 110.017 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 t -88.97 113.22 24.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.17 -0.956 . . . . 0.0 109.689 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 8' ' ' ASP . 43.3 p-10 -84.98 -8.87 58.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.943 . . . . 0.0 109.94 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -64.46 -44.37 91.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.157 -0.964 . . . . 0.0 110.123 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.404 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -126.03 28.75 6.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 111.306 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt 53.21 42.74 32.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.27 -0.894 . . . . 0.0 111.978 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 44.0 t -125.0 134.75 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.785 -1.197 . . . . 0.0 110.696 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' A' ' 6' ' ' ASP . 87.6 mt-30 -103.87 142.49 34.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.183 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 82.3 m-20 -130.43 134.88 47.46 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.023 -1.048 . . . . 0.0 110.302 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.19 169.62 18.42 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.438 -0.789 . . . . 0.0 110.165 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.25 -34.49 88.42 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.958 1.504 . . . . 0.0 110.623 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.82 -32.97 74.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.004 . . . . 0.0 109.766 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -51.52 179.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.496 -0.752 . . . . 0.0 109.696 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.888 HG12 ' HG3' ' A' ' 20' ' ' LYS . 39.2 t -156.36 -42.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.139 -0.976 . . . . 0.0 108.773 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.888 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.3 mttt -137.02 115.88 12.25 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.669 0.747 . . . . 0.0 109.309 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.652 ' HB2' HG23 ' A' ' 26' ' ' THR . 12.8 t -46.35 132.52 10.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.79 0.805 . . . . 0.0 111.198 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.66 -45.61 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.184 -0.947 . . . . 0.0 111.195 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.94 85.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.959 -1.088 . . . . 0.0 109.757 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.446 ' O ' ' C ' ' A' ' 25' ' ' GLU . 31.8 p -148.97 78.47 1.4 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.762 0.791 . . . . 0.0 109.166 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.504 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 95.5 mt-10 -29.22 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.594 0.712 . . . . 0.0 111.867 -178.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.652 HG23 ' HB2' ' A' ' 21' ' ' CYS . 42.8 p . . . . . 0 N--CA 1.49 1.542 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.999 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.465 0.65 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.423 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 79.9 m-20 -139.36 154.32 47.84 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 110.138 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 t -89.09 114.23 25.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 110.285 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -80.66 -18.74 47.09 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.22 -0.925 . . . . 0.0 110.494 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.1 m -61.67 -44.6 96.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.934 . . . . 0.0 110.71 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.0 p -118.89 26.3 9.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.106 -0.996 . . . . 0.0 111.033 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 37.2 tp 48.27 56.39 7.48 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.324 -0.86 . . . . 0.0 111.224 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 28.9 t -130.16 133.51 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.005 -1.06 . . . . 0.0 110.088 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.423 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . 84.4 mt-30 -101.05 133.69 45.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 110.103 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 78.6 m-20 -128.98 119.69 24.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.04 -1.038 . . . . 0.0 109.713 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.55 174.74 2.34 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 110.303 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -56.2 -30.55 80.3 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.166 1.614 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -62.38 -37.52 86.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.875 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.518 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -54.22 -174.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 110.031 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.763 HG12 ' HG3' ' A' ' 20' ' ' LYS . 80.7 t -155.67 -46.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.763 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.7 mttt -140.9 120.94 13.69 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.674 0.75 . . . . 0.0 109.047 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.726 ' HB2' HG23 ' A' ' 26' ' ' THR . 9.7 t -46.36 130.09 10.66 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.697 0.76 . . . . 0.0 111.017 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.49 -46.02 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.25 -0.906 . . . . 0.0 111.64 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.5 -41.47 96.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.97 -1.081 . . . . 0.0 109.75 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.43 ' O ' ' C ' ' A' ' 25' ' ' GLU . 32.1 p -153.57 80.77 1.17 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 122.068 0.937 . . . . 0.0 109.036 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.464 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 96.5 mt-10 -30.3 93.3 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.544 0.688 . . . . 0.0 112.432 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.726 HG23 ' HB2' ' A' ' 21' ' ' CYS . 51.8 p . . . . . 0 N--CA 1.49 1.543 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.492 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 46.9 p-90 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.601 0.715 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -135.88 149.57 49.04 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.242 -0.911 . . . . 0.0 109.778 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' VAL . 8.2 t -87.44 120.29 28.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.979 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -95.09 -6.02 42.95 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.254 -0.904 . . . . 0.0 110.759 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.3 p -74.7 -21.29 59.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.913 -1.117 . . . . 0.0 109.941 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.418 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -141.15 20.87 2.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.693 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt 54.82 58.37 4.87 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.413 -0.804 . . . . 0.0 111.592 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.557 HG11 ' SG ' ' A' ' 21' ' ' CYS . 27.3 t -131.63 135.94 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.899 . . . . 0.0 110.247 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -103.14 134.05 47.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.447 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 94.9 m-20 -134.66 116.41 14.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.062 -1.024 . . . . 0.0 110.494 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.52 176.66 1.55 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.0 110.496 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.23 -32.02 69.0 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.936 1.492 . . . . 0.0 110.321 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.51 -35.73 81.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 110.607 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.558 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -60.35 176.69 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.002 . . . . 0.0 110.5 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.729 HG12 ' HG3' ' A' ' 20' ' ' LYS . 44.9 t -156.66 -43.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.325 -0.859 . . . . 0.0 109.23 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.729 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.5 mttt -128.28 106.86 9.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.487 -0.758 . . . . 0.0 109.716 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.557 ' SG ' HG11 ' A' ' 12' ' ' VAL . 15.9 t -45.91 135.16 7.42 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.063 0.935 . . . . 0.0 111.253 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.93 -43.33 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.192 -0.942 . . . . 0.0 111.038 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.27 89.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.355 -0.841 . . . . 0.0 112.187 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 25' ' ' GLU . 23.1 p -155.83 25.25 0.38 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.939 -1.1 . . . . 0.0 111.104 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.9 mt-10 33.96 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.424 0.63 . . . . 0.0 111.952 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.5 m . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 110.219 179.609 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.238 0.542 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.76 -43.44 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.237 -0.914 . . . . 0.0 110.351 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 97.86 -0.15 59.12 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.645 HG22 ' HG3' ' A' ' 16' ' ' PRO . 71.1 p -128.24 150.35 50.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.988 -1.301 . . . . 0.0 109.751 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.53 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 35.0 p-90 -148.56 157.85 43.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.024 -1.048 . . . . 0.0 110.473 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -120.07 140.68 50.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.167 -0.958 . . . . 0.0 109.816 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.669 ' SG ' HG21 ' A' ' 26' ' ' THR . 19.2 t -87.43 115.92 25.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.519 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -94.51 -5.22 46.55 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.256 -0.903 . . . . 0.0 110.929 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -68.77 -31.21 70.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.95 -1.094 . . . . 0.0 109.634 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.409 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.9 p -135.74 21.03 3.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.811 . . . . 0.0 111.234 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 9.3 mp 58.83 46.55 13.84 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.292 -0.88 . . . . 0.0 111.838 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 48.0 t -127.89 134.66 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.153 -0.967 . . . . 0.0 110.117 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -96.65 145.69 25.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.005 -1.059 . . . . 0.0 110.507 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.53 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 m-20 -125.73 142.1 51.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.202 -0.936 . . . . 0.0 109.876 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -90.95 170.69 9.39 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.766 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.645 ' HG3' HG22 ' A' ' 4' ' ' THR . 39.6 Cg_exo -54.38 -34.32 80.4 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 O-C-N 123.898 1.473 . . . . 0.0 110.418 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.21 -36.67 82.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.111 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.495 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -51.52 -179.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.462 -0.774 . . . . 0.0 110.667 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.768 HG12 ' HG3' ' A' ' 20' ' ' LYS . 74.2 t -155.31 -47.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.768 ' HG3' HG12 ' A' ' 19' ' ' VAL . 98.4 mttt -137.32 119.54 15.63 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.51 ' O ' ' N ' ' A' ' 25' ' ' GLU . 14.6 t -45.04 140.49 2.69 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.097 0.951 . . . . 0.0 111.595 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.09 -44.45 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.629 -1.294 . . . . 0.0 111.62 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.24 93.2 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.294 -0.879 . . . . 0.0 112.516 -178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 27.5 p -140.57 11.9 2.3 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.894 -1.129 . . . . 0.0 112.088 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.3 mt-10 40.8 78.01 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.63 -0.669 . . . . 0.0 111.247 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.669 HG21 ' SG ' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -71.2 149.59 94.35 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.922 179.658 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 38.6 Cg_exo -58.29 -23.53 63.1 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.905 1.476 . . . . 0.0 110.303 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.473 ' HG3' ' CZ2' ' A' ' 5' ' ' TRP . 1.5 ttpt 63.03 65.86 1.29 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.29 -0.881 . . . . 0.0 109.847 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 21.1 Cg_exo -61.22 145.21 98.86 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.921 1.485 . . . . 0.0 110.434 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.25 103.42 3.02 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 78.3 m -123.05 129.09 51.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -1.176 . . . . 0.0 110.167 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.99 -40.26 98.06 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.5 t -123.41 130.87 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.141 -1.211 . . . . 0.0 110.387 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.05 -42.03 97.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 110.384 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.7 mtp85 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.201 179.791 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.319 0.58 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.6 mt -119.89 129.22 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.039 -1.038 . . . . 0.0 110.671 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -173.52 175.27 46.26 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.828 HG22 ' HD3' ' A' ' 16' ' ' PRO . 16.7 p -79.1 166.09 22.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.162 -1.199 . . . . 0.0 110.045 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -141.24 153.4 45.23 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.25 -0.906 . . . . 0.0 110.289 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 47.5 p-10 -132.84 148.43 52.3 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.402 -0.811 . . . . 0.0 110.117 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 t -83.0 106.13 14.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.045 -1.035 . . . . 0.0 109.911 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -71.59 -18.13 62.24 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.423 -0.798 . . . . 0.0 110.185 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.0 m -60.87 -44.35 97.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.867 . . . . 0.0 111.082 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 23' ' ' ALA . 14.0 p -128.96 33.77 4.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.04 -1.037 . . . . 0.0 110.897 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 11' ' ' LEU . 39.0 tp 42.49 65.66 0.88 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.56 -0.712 . . . . 0.0 112.409 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.546 HG11 ' SG ' ' A' ' 21' ' ' CYS . 39.4 t -133.81 135.53 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.945 -1.097 . . . . 0.0 109.906 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -100.78 141.01 34.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.245 -0.909 . . . . 0.0 110.702 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 21' ' ' CYS . 3.6 m-20 -145.91 121.12 10.17 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.254 -0.904 . . . . 0.0 109.557 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -70.2 178.01 1.2 Allowed Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.412 -0.805 . . . . 0.0 110.298 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.828 ' HD3' HG22 ' A' ' 4' ' ' THR . 31.4 Cg_exo -57.11 -29.83 84.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.0 1.526 . . . . 0.0 109.764 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.64 -37.8 88.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.459 -0.776 . . . . 0.0 109.764 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.794 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -54.92 -172.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.405 -0.809 . . . . 0.0 110.426 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -168.91 -37.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.467 -0.771 . . . . 0.0 109.113 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -131.9 111.04 11.23 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.675 0.75 . . . . 0.0 109.402 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.546 ' SG ' HG11 ' A' ' 12' ' ' VAL . 8.9 t -45.99 141.27 3.26 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.902 0.858 . . . . 0.0 110.924 -178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.0 t -68.68 -43.86 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.611 -1.306 . . . . 0.0 111.639 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.607 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -63.93 -38.07 89.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.319 -0.863 . . . . 0.0 112.437 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.9 p -142.77 13.07 1.89 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.003 -1.061 . . . . 0.0 112.1 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 21' ' ' CYS . 96.7 mt-10 43.78 73.08 0.16 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.418 -0.801 . . . . 0.0 110.105 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -44.54 157.21 0.32 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.944 -0.472 . . . . 0.0 110.558 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -66.91 -14.96 45.72 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 124.192 1.627 . . . . 0.0 109.631 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HE3' HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER 57.68 75.17 0.57 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.247 -0.908 . . . . 0.0 109.97 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -60.31 145.14 99.22 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.092 1.575 . . . . 0.0 110.031 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.5 55.78 0.55 Allowed Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.4 p -63.37 -33.77 76.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -1.212 . . . . 0.0 109.731 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.02 151.25 51.82 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.71 140.27 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -1.13 . . . . 0.0 110.045 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.79 -43.19 99.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.447 -0.783 . . . . 0.0 110.61 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 117.888 -1.053 . . . . 0.0 110.264 -179.819 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.385 0.612 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.03 -42.89 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.429 -0.795 . . . . 0.0 109.903 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 168.69 -168.38 41.02 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.1 m -121.07 131.14 54.09 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.078 -1.248 . . . . 0.0 109.839 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.477 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 19.7 p-90 -142.7 161.42 38.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.377 -0.827 . . . . 0.0 110.371 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -130.41 134.29 47.01 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.083 -1.01 . . . . 0.0 109.908 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.7 t -83.66 114.79 21.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.361 -0.837 . . . . 0.0 108.769 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.5 p30 -92.06 -7.3 49.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.002 -1.061 . . . . 0.0 110.631 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.4 p -68.5 -33.88 74.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.115 -0.99 . . . . 0.0 109.406 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 12' ' ' VAL . 12.6 p -128.3 20.46 6.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.363 -0.836 . . . . 0.0 111.108 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt 53.15 48.99 20.97 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.291 -0.881 . . . . 0.0 112.393 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.4 ' HB ' ' SG ' ' A' ' 10' ' ' CYS . 51.2 t -128.07 131.79 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.852 -1.155 . . . . 0.0 110.527 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -89.18 142.49 27.6 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.593 -0.692 . . . . 0.0 109.992 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 8.4 m-20 -129.92 126.21 37.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.961 -1.087 . . . . 0.0 110.114 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.502 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 15.5 mmtp -73.14 171.43 10.46 Favored Pre-proline 0 C--N 1.299 -1.617 0 O-C-N 121.55 -0.719 . . . . 0.0 110.592 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 34.7 Cg_exo -55.44 -32.02 80.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.915 1.481 . . . . 0.0 110.028 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' OE1' ' HB3' ' A' ' 15' ' ' LYS . 52.5 mp0 -66.47 -31.05 71.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.401 -0.812 . . . . 0.0 109.703 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 15' ' ' LYS . . . -61.52 151.01 34.11 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.347 0.594 . . . . 0.0 110.536 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.495 HG12 ' HG3' ' A' ' 29' ' ' PRO . 58.2 t -137.5 -42.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.516 -0.74 . . . . 0.0 109.195 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 25' ' ' GLU . 99.7 mttt -130.46 107.72 9.43 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.466 -0.894 . . . . 0.0 108.701 178.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.469 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.5 t -45.54 130.25 8.75 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.471 0.653 . . . . 0.0 110.837 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.7 t -62.71 -46.73 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.206 -0.934 . . . . 0.0 112.079 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.22 -38.59 91.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.781 -1.199 . . . . 0.0 109.673 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -155.43 83.22 1.05 Allowed 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.057 0.932 . . . . 0.0 109.043 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.469 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.5 mt-10 -33.68 92.09 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.056 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 24' ' ' CYS . 13.4 p -54.01 158.07 3.82 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.129 -0.982 . . . . 0.0 110.147 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -77.7 18.92 0.79 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.866 1.456 . . . . 0.0 111.996 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 5.4 mmtt -45.26 -46.62 32.83 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 120.948 -1.095 . . . . 0.0 111.728 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 28' ' ' LYS . 20.7 Cg_exo -62.7 144.9 94.77 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.302 1.159 . . . . 0.0 109.731 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.98 23.71 71.18 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 91.3 m -122.16 127.37 49.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.227 -1.161 . . . . 0.0 109.994 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.28 16.85 61.78 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.8 t -123.47 130.22 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.33 -1.1 . . . . 0.0 109.545 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.63 -39.01 89.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.318 -0.863 . . . . 0.0 110.198 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 . . . . . 0 C--N 1.299 -1.592 0 CA-C-O 118.346 -0.835 . . . . 0.0 109.987 -179.291 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 121.318 0.58 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.66 -43.39 98.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.387 -0.82 . . . . 0.0 110.197 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 94.54 10.49 57.98 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 m -73.09 134.79 44.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.962 -1.317 . . . . 0.0 109.562 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.541 ' CZ2' ' CB ' ' A' ' 14' ' ' ASN . 29.0 p-90 -140.17 155.36 46.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.904 -1.122 . . . . 0.0 110.626 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -130.91 127.64 38.9 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.438 -0.788 . . . . 0.0 109.926 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.55 ' SG ' HG21 ' A' ' 26' ' ' THR . 30.6 t -76.97 120.46 22.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 110.628 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -92.8 -8.58 43.22 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.465 -0.772 . . . . 0.0 110.128 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 m -64.17 -44.55 91.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.007 . . . . 0.0 110.521 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.428 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.3 p -124.14 18.81 9.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 110.915 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 97.3 mt 56.53 52.59 9.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.36 -0.837 . . . . 0.0 111.572 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.428 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 37.9 t -127.15 132.76 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.304 -0.873 . . . . 0.0 109.6 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -93.62 136.48 33.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 110.637 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.541 ' CB ' ' CZ2' ' A' ' 5' ' ' TRP . 1.6 m120 -126.18 130.38 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.111 -0.993 . . . . 0.0 109.576 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -69.15 166.89 24.4 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.216 -0.927 . . . . 0.0 109.864 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -52.71 -36.59 73.24 Favored 'Trans proline' 0 C--N 1.302 -1.917 0 O-C-N 124.041 1.548 . . . . 0.0 109.754 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -69.34 -35.87 76.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -0.917 . . . . 0.0 109.849 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.615 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -60.88 146.02 48.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 110.193 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -157.38 23.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.393 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -158.0 75.27 0.75 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.486 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.6 t -45.27 129.47 8.04 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.031 0.92 . . . . 0.0 111.078 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.19 -43.73 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.931 -1.106 . . . . 0.0 111.576 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.19 -40.69 96.88 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.368 -0.833 . . . . 0.0 112.211 -177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.0 p -149.95 24.39 0.85 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.833 -1.167 . . . . 0.0 111.344 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 21' ' ' CYS . 75.2 tt0 36.9 96.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.392 0.615 . . . . 0.0 112.447 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.55 HG21 ' SG ' ' A' ' 7' ' ' CYS . 22.3 p -87.45 152.43 52.24 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.422 -0.799 . . . . 0.0 109.831 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -84.62 40.78 0.89 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.768 1.404 . . . . 0.0 110.6 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 37.0 tttm 56.58 67.86 2.49 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.099 -1.0 . . . . 0.0 110.374 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD2' ' CE3' ' A' ' 5' ' ' TRP . 24.9 Cg_exo -60.94 144.11 99.5 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.012 1.532 . . . . 0.0 110.462 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.14 159.76 30.33 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.6 p -132.03 159.27 39.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -1.201 . . . . 0.0 110.428 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.61 165.56 54.44 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.1 p -136.6 142.11 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.205 -1.173 . . . . 0.0 109.793 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.67 -45.28 93.54 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.131 -0.981 . . . . 0.0 109.683 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.934 179.531 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.327 0.584 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.82 -43.21 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.825 . . . . 0.0 110.54 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.91 -42.05 96.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.564 HG22 ' HD3' ' A' ' 16' ' ' PRO . 10.6 p -83.74 166.31 18.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.003 -1.293 . . . . 0.0 110.399 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 26.8 p-90 -142.23 159.37 42.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.321 -0.862 . . . . 0.0 109.979 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -130.69 134.58 47.05 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.049 -1.032 . . . . 0.0 110.456 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 t -87.59 118.27 26.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.83 . . . . 0.0 109.699 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -89.89 -11.96 40.35 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.16 -0.962 . . . . 0.0 111.09 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.2 p -66.97 -31.42 71.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.912 -1.117 . . . . 0.0 110.29 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.461 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.8 p -133.92 24.8 3.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.988 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 37.6 tp 46.83 57.33 5.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.277 -0.89 . . . . 0.0 111.531 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 10' ' ' CYS . 41.8 t -131.28 133.78 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.987 -1.071 . . . . 0.0 109.866 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -101.19 130.77 47.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.153 -0.967 . . . . 0.0 110.292 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.492 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 85.6 m-20 -132.17 125.73 31.91 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.056 -1.027 . . . . 0.0 109.936 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 2.6 mttt -78.34 176.53 3.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.813 . . . . 0.0 110.477 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.564 ' HD3' HG22 ' A' ' 4' ' ' THR . 32.2 Cg_exo -56.36 -29.73 78.22 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.016 1.534 . . . . 0.0 110.01 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -64.89 -36.0 82.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.362 -0.836 . . . . 0.0 109.831 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.503 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -52.35 -179.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.334 -0.854 . . . . 0.0 110.095 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.77 HG12 ' HG3' ' A' ' 20' ' ' LYS . 76.6 t -154.73 -43.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.959 . . . . 0.0 109.099 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.77 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.1 mttt -135.77 110.79 8.86 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.567 0.698 . . . . 0.0 109.305 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.58 ' CB ' HG23 ' A' ' 26' ' ' THR . 12.2 t -46.2 132.21 9.96 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.503 0.668 . . . . 0.0 111.075 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.55 -46.72 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.524 -0.735 . . . . 0.0 111.731 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -41.7 96.02 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.964 -1.085 . . . . 0.0 109.694 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.439 ' O ' ' C ' ' A' ' 25' ' ' GLU . 32.1 p -153.63 81.91 1.17 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.794 0.807 . . . . 0.0 109.201 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.515 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.1 mt-10 -30.37 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.545 0.688 . . . . 0.0 112.12 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.58 HG23 ' CB ' ' A' ' 21' ' ' CYS . 78.0 p -67.6 151.9 96.75 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.482 -0.762 . . . . 0.0 110.035 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -82.89 41.47 1.11 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.977 1.514 . . . . 0.0 110.362 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -101.58 109.22 58.61 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.154 -0.966 . . . . 0.0 110.214 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -61.44 145.28 98.2 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.592 1.312 . . . . 0.0 110.277 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.73 -37.87 95.36 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.9 p -132.77 155.72 48.39 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.312 -1.111 . . . . 0.0 110.176 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.0 176.67 28.42 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.75 157.5 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -1.136 . . . . 0.0 110.226 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.94 -41.85 97.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 110.244 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 96.4 mtm-85 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.228 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.421 0.629 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 33.2 mm -62.37 -44.58 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.574 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.47 176.87 47.95 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.3 p -92.26 164.6 13.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -1.165 . . . . 0.0 110.343 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.527 ' HH2' ' HG1' ' A' ' 26' ' ' THR . 56.4 p-90 -145.43 156.1 43.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.369 -0.832 . . . . 0.0 110.673 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.445 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 47.0 p-10 -134.82 151.89 51.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.31 -0.869 . . . . 0.0 110.256 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' VAL . 13.4 t -84.31 107.06 16.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.343 -0.848 . . . . 0.0 110.365 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -72.05 -18.71 61.92 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.27 -0.894 . . . . 0.0 110.279 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.8 m -60.97 -45.1 96.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.912 . . . . 0.0 110.661 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.485 ' O ' HG23 ' A' ' 12' ' ' VAL . 13.9 p -121.85 29.74 6.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.126 -0.984 . . . . 0.0 110.783 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 35.1 tp 44.45 55.46 5.68 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.522 -0.736 . . . . 0.0 111.594 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 10' ' ' CYS . 34.7 t -129.26 133.88 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.999 -1.063 . . . . 0.0 109.808 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.445 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . 88.6 mt-30 -100.33 132.35 45.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.98 . . . . 0.0 110.606 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 4.0 m-20 -118.01 124.24 47.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.46 -0.775 . . . . 0.0 109.433 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -68.0 170.67 6.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.981 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -54.92 -32.58 78.73 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.987 1.52 . . . . 0.0 110.013 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.49 -34.34 78.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 109.818 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.473 ' CB ' ' HB3' ' A' ' 14' ' ' ASN . . . -51.96 -179.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.408 -0.807 . . . . 0.0 110.507 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.781 HG12 ' HG3' ' A' ' 20' ' ' LYS . 69.8 t -155.17 -45.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.781 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.6 mttt -139.62 118.76 12.68 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 25' ' ' GLU . 12.5 t -45.57 130.18 8.82 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.581 0.705 . . . . 0.0 111.384 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -63.77 -46.46 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.411 -0.806 . . . . 0.0 111.641 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.4 97.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.911 -1.118 . . . . 0.0 109.33 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.436 ' O ' ' C ' ' A' ' 25' ' ' GLU . 31.0 p -155.45 84.99 1.05 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.834 0.826 . . . . 0.0 109.25 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 24' ' ' CYS . 95.7 mt-10 -30.99 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.591 0.71 . . . . 0.0 112.683 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.527 ' HG1' ' HH2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -51.28 158.36 1.36 Allowed Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.58 -0.7 . . . . 0.0 109.926 178.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -68.44 -10.74 29.91 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.984 1.518 . . . . 0.0 110.407 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER 54.53 67.38 3.38 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.092 -1.005 . . . . 0.0 110.062 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 20.4 Cg_exo -62.16 146.68 95.95 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.146 1.603 . . . . 0.0 110.364 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.26 -177.02 50.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 88.4 m -117.45 130.96 56.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.413 -1.051 . . . . 0.0 110.293 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.06 22.09 61.74 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.4 t -122.68 130.47 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.074 -1.251 . . . . 0.0 110.284 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -79.0 132.27 36.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.129 -0.982 . . . . 0.0 109.683 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.07 -0.966 . . . . 0.0 110.296 -179.715 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.276 0.56 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 91.0 mt -111.02 130.15 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.969 . . . . 0.0 110.204 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 16' ' ' PRO . . . -88.89 179.53 45.65 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 t -151.76 155.52 38.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.335 -1.097 . . . . 0.0 110.132 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.511 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 45.7 p-90 -143.55 154.14 43.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.044 -1.035 . . . . 0.0 110.647 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 6' ' ' ASP . 45.0 p-10 -136.82 148.79 47.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.352 -0.843 . . . . 0.0 110.124 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.6 t -83.89 135.54 34.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.867 . . . . 0.0 109.833 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -101.61 -16.9 16.58 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.097 -1.002 . . . . 0.0 110.854 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.5 p -65.29 -31.23 72.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.003 -1.06 . . . . 0.0 110.277 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.2 p -131.02 21.74 4.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 110.854 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 41.2 tp 49.4 59.59 4.37 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.217 -0.927 . . . . 0.0 111.424 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 28.0 t -132.72 135.03 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.126 -0.984 . . . . 0.0 110.262 178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -99.44 137.23 38.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.164 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 61.7 m-20 -131.13 134.47 46.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.162 -0.961 . . . . 0.0 109.703 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -76.94 169.71 19.9 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 110.421 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 3' ' ' GLY . 46.1 Cg_exo -54.27 -33.29 75.05 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.168 1.615 . . . . 0.0 110.586 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.4 mp0 -65.64 -36.33 83.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.146 -0.971 . . . . 0.0 110.203 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -52.38 175.85 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.312 -0.867 . . . . 0.0 110.442 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.528 HG12 ' HG3' ' A' ' 20' ' ' LYS . 76.0 t -156.94 -41.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.332 -0.855 . . . . 0.0 109.167 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.528 ' HG3' HG12 ' A' ' 19' ' ' VAL . 96.9 mttt -127.33 107.41 9.96 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.141 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.504 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.4 t -46.64 132.42 10.95 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.52 0.676 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.05 -45.73 93.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.365 -0.835 . . . . 0.0 111.659 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.69 -42.26 99.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.851 -1.156 . . . . 0.0 109.556 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -155.02 83.66 1.08 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.793 0.806 . . . . 0.0 108.87 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.504 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.5 mt-10 -31.45 91.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.519 0.676 . . . . 0.0 112.333 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 24' ' ' CYS . 6.6 m -64.39 142.69 98.42 Favored Pre-proline 0 N--CA 1.487 1.42 0 O-C-N 121.422 -0.799 . . . . 0.0 109.372 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -81.46 44.67 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.607 1.32 . . . . 0.0 110.418 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -106.5 116.63 58.75 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.1 -1.0 . . . . 0.0 110.007 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.97 144.68 99.63 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.569 1.3 . . . . 0.0 110.513 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.92 -34.39 89.76 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.5 m -113.27 125.37 54.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.5 -1.0 . . . . 0.0 109.593 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.43 171.06 39.6 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 50.8 t -125.56 132.94 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.13 . . . . 0.0 110.426 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.75 -43.04 99.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.375 -0.828 . . . . 0.0 110.105 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.144 -179.903 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.309 0.576 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.3 pt -128.06 156.23 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 110.499 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' A' ' 16' ' ' PRO . . . -128.23 143.48 14.44 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.2 t -152.05 168.11 26.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.237 . . . . 0.0 110.136 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.517 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 48.4 p-90 -135.98 158.59 44.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.081 -1.012 . . . . 0.0 109.906 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -129.74 130.04 44.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.265 -0.897 . . . . 0.0 110.416 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.9 t -75.55 100.27 4.51 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.422 -0.799 . . . . 0.0 109.83 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -69.51 -16.53 63.46 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.475 -0.765 . . . . 0.0 110.563 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.1 m -60.95 -44.43 97.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.034 -1.041 . . . . 0.0 110.392 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.9 p -124.24 21.16 8.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.014 -1.053 . . . . 0.0 111.282 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.5 mt 53.84 52.31 13.25 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.172 -0.955 . . . . 0.0 111.959 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 48.8 t -129.0 132.14 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.089 -1.007 . . . . 0.0 109.685 178.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -96.45 137.02 36.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.0 110.565 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.517 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 79.6 m-20 -132.46 124.43 28.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.368 -0.832 . . . . 0.0 109.874 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 37.8 mtpt -73.39 168.39 25.72 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 109.929 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HG3' ' O ' ' A' ' 3' ' ' GLY . 52.2 Cg_exo -51.94 -33.15 50.71 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.797 1.419 . . . . 0.0 110.581 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -60.89 -35.13 75.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.925 . . . . 0.0 108.879 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.506 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -52.96 177.45 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.623 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.782 HG12 ' HG3' ' A' ' 20' ' ' LYS . 78.3 t -155.8 -43.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -0.82 . . . . 0.0 108.804 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.782 ' HG3' HG12 ' A' ' 19' ' ' VAL . 97.4 mttt -136.49 112.36 9.55 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.802 0.811 . . . . 0.0 109.228 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.459 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.1 t -45.37 131.73 8.08 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.755 0.788 . . . . 0.0 111.473 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.1 t -64.01 -46.66 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.052 -1.03 . . . . 0.0 111.106 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.54 -46.84 88.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.014 -1.054 . . . . 0.0 109.576 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 26' ' ' THR . 32.1 p -148.48 81.12 1.46 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.823 0.821 . . . . 0.0 109.081 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.459 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 95.8 mt-10 -30.54 90.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.615 0.721 . . . . 0.0 112.209 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 24' ' ' CYS . 6.7 p -62.0 158.5 43.96 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.737 -0.602 . . . . 0.0 109.921 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.3 -8.83 23.19 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 O-C-N 123.996 1.524 . . . . 0.0 110.8 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.55 93.41 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.999 -1.063 . . . . 0.0 110.147 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -61.15 146.41 97.59 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.022 1.538 . . . . 0.0 110.357 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.71 8.02 59.73 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.8 p -131.56 161.37 32.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.022 -1.281 . . . . 0.0 110.272 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.85 175.99 50.8 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.5 t -63.92 -43.96 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.338 -1.095 . . . . 0.0 110.364 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.39 -41.2 98.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.346 -0.846 . . . . 0.0 110.818 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.4 ttt-85 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.345 -179.872 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.239 0.543 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 pt -129.32 160.58 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 110.413 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.41 165.41 39.7 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.8 m -66.22 131.97 47.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.334 -1.098 . . . . 0.0 110.295 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.491 ' CE2' ' HD2' ' A' ' 28' ' ' LYS . 51.0 p-90 -144.21 159.69 42.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 110.449 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -135.22 150.33 50.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.046 -1.034 . . . . 0.0 110.311 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.7 t -90.15 123.72 34.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.0 110.098 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 39.8 p30 -96.76 -4.19 41.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.169 -0.957 . . . . 0.0 111.143 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.6 p -74.19 -23.17 59.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.91 -1.119 . . . . 0.0 109.847 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.5 p -141.31 21.35 2.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.371 -0.83 . . . . 0.0 111.014 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt 54.23 48.96 19.68 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.325 -0.859 . . . . 0.0 111.686 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 41.0 t -125.35 132.21 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -0.967 . . . . 0.0 109.811 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -97.44 139.37 33.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.186 -0.946 . . . . 0.0 110.356 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.471 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 95.2 m-20 -134.65 106.02 6.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.294 -0.879 . . . . 0.0 110.014 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 3.1 mttm -56.55 172.93 0.32 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.857 . . . . 0.0 110.372 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 15' ' ' LYS . 31.7 Cg_exo -56.89 -29.29 81.24 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.959 1.505 . . . . 0.0 110.231 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -65.14 -34.66 78.93 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.245 -0.909 . . . . 0.0 109.972 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -52.54 -177.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.451 -0.78 . . . . 0.0 110.364 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.91 HG12 ' HG3' ' A' ' 20' ' ' LYS . 20.6 t -155.13 -44.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 108.882 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.91 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.2 mttt -142.56 115.62 8.84 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.804 0.811 . . . . 0.0 109.571 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 12.2 t -45.73 132.41 8.7 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.877 0.846 . . . . 0.0 111.793 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.92 -47.06 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.451 -0.781 . . . . 0.0 111.301 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.46 -46.94 83.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.066 -1.021 . . . . 0.0 109.573 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 26' ' ' THR . 32.0 p -146.91 80.72 1.54 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.807 0.813 . . . . 0.0 109.426 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.47 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 96.6 mt-10 -29.24 89.7 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.487 0.661 . . . . 0.0 112.666 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 24' ' ' CYS . 2.1 p -48.01 158.53 0.55 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.756 -0.59 . . . . 0.0 109.912 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -65.66 -15.08 47.85 Favored 'Trans proline' 0 C--N 1.302 -1.881 0 O-C-N 124.084 1.57 . . . . 0.0 110.803 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.491 ' HD2' ' CE2' ' A' ' 5' ' ' TRP . 12.1 tttt -48.64 106.05 0.57 Allowed Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.184 -0.948 . . . . 0.0 110.383 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -54.83 -38.35 92.23 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.75 1.395 . . . . 0.0 110.47 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.62 174.54 15.16 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.6 p -65.05 -32.33 73.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -1.18 . . . . 0.0 110.114 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.92 -166.25 53.93 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.4 t -121.19 131.21 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -1.166 . . . . 0.0 109.972 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -118.1 146.58 44.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.164 -0.96 . . . . 0.0 110.279 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.336 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.147 0.498 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 3' ' ' GLY . 46.7 pt -73.13 -27.65 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.131 -0.981 . . . . 0.0 110.233 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.425 ' N ' HG13 ' A' ' 2' ' ' ILE . . . 66.42 -174.81 22.08 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 p -84.76 167.56 15.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -1.079 . . . . 0.0 110.127 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -143.58 152.49 41.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 110.244 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -125.73 142.64 51.41 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.012 -1.055 . . . . 0.0 110.291 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.2 t -87.78 117.21 26.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.298 -0.876 . . . . 0.0 109.945 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 42.3 p-10 -92.77 -8.21 44.35 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.055 -1.028 . . . . 0.0 110.619 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.2 m -63.16 -43.55 97.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 109.037 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.422 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -123.11 21.06 9.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.579 -0.7 . . . . 0.0 110.319 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 37.8 tp 53.08 59.36 4.5 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.482 -0.761 . . . . 0.0 111.548 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 38.6 t -131.95 134.56 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -0.91 . . . . 0.0 109.722 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.99 136.01 38.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.164 -0.96 . . . . 0.0 110.589 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.456 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 99.4 m-20 -137.09 123.79 21.12 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.252 -0.905 . . . . 0.0 110.198 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.84 172.77 6.38 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.988 . . . . 0.0 110.612 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -53.96 -32.96 70.45 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.16 1.61 . . . . 0.0 110.379 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.77 -32.17 73.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.111 -0.993 . . . . 0.0 110.014 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -50.85 178.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.405 -0.81 . . . . 0.0 110.383 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -158.6 -41.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.475 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.86 108.14 6.46 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.533 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 14.3 t -46.02 137.18 6.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.894 0.854 . . . . 0.0 110.931 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.04 -44.81 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.029 -1.044 . . . . 0.0 111.958 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.65 85.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.166 -0.959 . . . . 0.0 112.35 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' A' ' 25' ' ' GLU . 26.8 p -146.75 24.6 1.2 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.844 -1.16 . . . . 0.0 111.741 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.533 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 97.0 mt-10 28.87 86.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.2 p -59.68 156.6 32.63 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.309 -0.869 . . . . 0.0 110.352 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -85.45 31.03 0.49 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.041 1.548 . . . . 0.0 111.047 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -48.47 -49.54 63.2 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 120.928 -1.107 . . . . 0.0 110.52 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 28' ' ' LYS . 24.7 Cg_exo -59.82 142.48 98.7 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.436 1.23 . . . . 0.0 110.043 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.77 -10.26 70.79 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.8 p -132.25 154.97 49.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.003 -1.292 . . . . 0.0 110.074 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -172.91 176.62 45.69 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.706 HG12 ' HG3' ' A' ' 35' ' ' ARG . 57.4 t -121.09 130.55 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -1.159 . . . . 0.0 110.11 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -62.77 -41.49 99.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.296 -0.878 . . . . 0.0 109.812 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.706 ' HG3' HG12 ' A' ' 33' ' ' VAL . 96.2 mtt-85 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.052 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.25 0.547 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.6 pt -68.47 -24.87 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 110.089 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.8 -37.59 94.9 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.4 m -118.96 129.69 55.3 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.385 -1.068 . . . . 0.0 110.096 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.462 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 48.3 p-90 -141.7 154.62 45.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 0.0 110.316 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -120.9 140.74 51.39 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.307 -0.871 . . . . 0.0 109.99 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.6 t -84.52 113.41 21.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.19 -0.944 . . . . 0.0 109.206 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -88.69 -10.02 49.95 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.27 -0.894 . . . . 0.0 111.059 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.1 p -66.93 -31.5 72.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.008 -1.057 . . . . 0.0 109.989 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.413 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.1 p -133.55 22.53 3.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 111.341 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.1 mt 55.58 48.68 18.15 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.237 -0.914 . . . . 0.0 111.746 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.448 HG11 ' SG ' ' A' ' 21' ' ' CYS . 40.9 t -126.53 132.07 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.195 -0.94 . . . . 0.0 109.708 178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -99.03 134.2 42.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.085 -1.009 . . . . 0.0 110.492 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.5 m-20 -120.17 131.5 55.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.195 -0.941 . . . . 0.0 109.934 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 3.0 mttt -80.28 173.38 7.81 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.9 . . . . 0.0 110.03 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -54.74 -34.48 84.53 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.982 1.517 . . . . 0.0 110.249 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.74 -35.6 80.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.857 . . . . 0.0 109.562 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.523 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -51.09 174.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.486 -0.759 . . . . 0.0 110.419 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.69 HG12 ' HG3' ' A' ' 20' ' ' LYS . 75.4 t -156.44 -44.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.69 ' HG3' HG12 ' A' ' 19' ' ' VAL . 98.0 mttt -133.1 112.53 11.85 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 25' ' ' GLU . 12.4 t -45.74 138.4 4.74 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.086 0.946 . . . . 0.0 111.316 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -66.63 -44.84 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.636 -1.29 . . . . 0.0 111.871 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.01 90.91 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.212 -0.93 . . . . 0.0 112.61 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 28.3 p -140.5 16.28 2.37 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.833 -1.167 . . . . 0.0 111.961 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.2 mt-10 38.43 78.36 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.692 -0.63 . . . . 0.0 111.784 179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -50.76 157.09 1.41 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.518 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.15 -16.15 48.15 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 123.942 1.496 . . . . 0.0 110.864 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' CD ' ' OG1' ' A' ' 31' ' ' THR . 0.0 OUTLIER 52.07 81.27 0.26 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.079 -1.013 . . . . 0.0 110.138 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.424 ' O ' ' CE ' ' A' ' 28' ' ' LYS . 22.5 Cg_exo -61.15 147.08 96.65 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.011 1.532 . . . . 0.0 110.284 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.72 -6.57 58.9 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.424 ' OG1' ' CD ' ' A' ' 28' ' ' LYS . 63.6 m -120.68 129.38 53.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.008 -1.289 . . . . 0.0 109.872 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -120.81 130.48 8.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 34' ' ' LYS . 14.9 p -64.47 -34.3 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -1.079 . . . . 0.0 110.111 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.439 ' N ' HG13 ' A' ' 33' ' ' VAL . 99.4 mttt -74.59 143.23 44.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.233 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 89.1 mtm-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.242 179.976 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.518 0.675 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.17 -43.21 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.453 -0.779 . . . . 0.0 110.218 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.44 -37.05 94.2 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.3 p -80.71 164.28 22.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.021 -1.282 . . . . 0.0 110.879 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.497 ' HZ3' HG21 ' A' ' 26' ' ' THR . 33.2 p-90 -143.76 152.41 41.21 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.558 -0.714 . . . . 0.0 109.777 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -135.06 151.07 50.43 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.159 -0.963 . . . . 0.0 110.091 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.8 t -90.96 111.25 22.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.163 -0.961 . . . . 0.0 110.657 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -80.56 -17.17 52.29 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.511 -0.743 . . . . 0.0 110.515 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.4 m -62.22 -44.35 96.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -0.998 . . . . 0.0 110.895 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.0 p -120.4 24.22 10.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 111.347 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt 53.81 50.9 15.92 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.289 -0.882 . . . . 0.0 111.637 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 40.2 t -130.15 133.4 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.146 -0.971 . . . . 0.0 110.506 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -96.8 137.29 36.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.055 -1.028 . . . . 0.0 110.064 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 5' ' ' TRP . 2.4 m-20 -119.24 120.45 37.07 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.149 -0.97 . . . . 0.0 110.403 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.38 172.19 2.75 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.423 -0.798 . . . . 0.0 109.954 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.48 -33.6 92.81 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.996 1.524 . . . . 0.0 110.174 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.87 -36.1 79.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -0.801 . . . . 0.0 109.765 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.02 157.91 29.69 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 0.0 110.55 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.446 HG13 ' HA ' ' A' ' 29' ' ' PRO . 71.9 t -147.05 -41.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.418 -0.802 . . . . 0.0 108.93 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . 97.4 mttt -115.57 101.55 8.97 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.421 -0.8 . . . . 0.0 108.984 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.2 t -45.27 133.02 7.29 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.183 0.992 . . . . 0.0 111.256 -178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.4 t -67.72 -43.4 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.303 -0.873 . . . . 0.0 111.546 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.15 -38.47 91.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.189 -0.944 . . . . 0.0 112.429 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 p -151.01 21.43 0.77 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.771 -1.205 . . . . 0.0 111.406 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 21' ' ' CYS . 86.4 tt0 41.14 91.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.731 -0.606 . . . . 0.0 111.489 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.497 HG21 ' HZ3' ' A' ' 5' ' ' TRP . 2.0 m -73.22 131.91 82.72 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.378 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.91 45.94 1.93 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.526 1.277 . . . . 0.0 110.811 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.63 93.07 29.34 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.089 -1.007 . . . . 0.0 109.836 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.446 ' HA ' HG13 ' A' ' 19' ' ' VAL . 17.1 Cg_exo -64.5 145.07 86.96 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.751 1.395 . . . . 0.0 109.719 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.71 165.98 50.2 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.1 p -134.3 163.24 30.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -1.113 . . . . 0.0 109.607 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.28 164.89 54.9 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.19 -46.06 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.136 -1.214 . . . . 0.0 109.663 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -75.03 134.41 41.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.507 -0.746 . . . . 0.0 110.561 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.458 179.811 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.263 0.554 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.7 pt -69.81 -21.29 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 110.251 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.01 -39.33 97.44 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.5 t -144.86 156.53 44.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -1.21 . . . . 0.0 110.094 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.461 ' CZ2' ' HB2' ' A' ' 14' ' ' ASN . 53.7 p-90 -142.01 153.85 44.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 110.343 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -131.07 146.75 52.48 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.389 -0.819 . . . . 0.0 109.658 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.828 ' HB3' HG22 ' A' ' 12' ' ' VAL . 6.5 t -79.19 114.59 18.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.197 -0.94 . . . . 0.0 110.273 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -71.47 -24.1 61.94 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.444 -0.785 . . . . 0.0 110.191 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.8 m -62.15 -45.61 92.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.885 . . . . 0.0 110.5 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.521 ' SG ' HG13 ' A' ' 12' ' ' VAL . 14.0 p -125.28 13.73 8.29 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.166 -0.959 . . . . 0.0 110.934 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 11' ' ' LEU . 42.7 tp 48.25 85.31 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.261 -0.9 . . . . 0.0 112.219 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.843 HG21 ' SG ' ' A' ' 21' ' ' CYS . 18.6 m -138.64 163.6 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 109.299 178.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -108.3 107.87 18.64 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.046 -1.034 . . . . 0.0 110.836 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.461 ' HB2' ' CZ2' ' A' ' 5' ' ' TRP . 44.3 m-20 -125.79 125.68 43.32 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.183 -0.948 . . . . 0.0 109.186 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -80.35 176.38 3.85 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.895 . . . . 0.0 110.482 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.17 -32.14 78.87 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.124 1.592 . . . . 0.0 110.437 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.58 -31.89 72.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 110.162 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -49.9 176.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.327 -0.858 . . . . 0.0 110.602 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -160.92 -38.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.402 -0.812 . . . . 0.0 109.538 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -127.73 101.95 6.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.458 -0.776 . . . . 0.0 109.603 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.843 ' SG ' HG21 ' A' ' 12' ' ' VAL . 13.9 t -47.29 131.82 13.09 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.937 0.875 . . . . 0.0 110.759 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.8 t -67.78 -43.48 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.81 -1.181 . . . . 0.0 111.419 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.472 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -63.39 -40.25 96.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.236 -0.915 . . . . 0.0 112.341 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.7 p -149.97 22.26 0.87 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.92 -1.112 . . . . 0.0 111.17 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' CYS . 82.5 tt0 35.77 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.423 0.63 . . . . 0.0 112.538 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.502 HG23 ' HD2' ' A' ' 27' ' ' PRO . 98.6 m -88.24 145.64 36.38 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.407 -0.808 . . . . 0.0 108.966 178.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HD2' HG23 ' A' ' 26' ' ' THR . 50.5 Cg_endo -77.48 47.34 2.25 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.607 1.32 . . . . 0.0 110.58 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -122.92 80.82 50.17 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.123 -0.986 . . . . 0.0 110.429 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.43 ' HA ' HG12 ' A' ' 19' ' ' VAL . 38.7 Cg_exo -53.92 -38.85 86.33 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.825 1.434 . . . . 0.0 110.079 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.55 167.15 38.92 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.5 p -66.5 -33.16 75.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.139 -1.212 . . . . 0.0 110.128 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.77 7.07 86.37 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.45 -45.36 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.899 -1.353 . . . . 0.0 109.865 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.85 -41.16 97.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.826 . . . . 0.0 110.245 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.254 -179.88 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.204 0.526 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 93.7 mt -63.47 -43.47 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 110.285 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.26 150.15 51.54 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.918 HG22 ' HG3' ' A' ' 16' ' ' PRO . 69.6 p -83.24 163.47 20.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.131 -1.217 . . . . 0.0 110.138 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.53 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 24.2 p-90 -144.96 158.64 43.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.948 . . . . 0.0 110.174 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 7' ' ' CYS . 67.8 t0 -131.97 139.35 48.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.165 -0.96 . . . . 0.0 110.418 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 13.5 t -89.6 112.99 24.36 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.394 -0.816 . . . . 0.0 109.617 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -91.91 -7.22 49.81 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.163 -0.96 . . . . 0.0 110.511 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -66.99 -34.13 77.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.023 -1.048 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 12.8 p -128.27 18.95 6.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 110.432 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 75.5 mt 58.87 45.35 15.41 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.677 -0.639 . . . . 0.0 111.869 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.8 t -128.57 132.96 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.07 -1.018 . . . . 0.0 110.184 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -100.86 144.45 29.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.74 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.53 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.2 m-20 -121.03 122.54 40.32 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.028 -1.045 . . . . 0.0 109.894 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 16.8 mttm -67.84 168.87 11.06 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.25 -0.906 . . . . 0.0 109.614 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.918 ' HG3' HG22 ' A' ' 4' ' ' THR . 47.2 Cg_exo -53.71 -35.49 78.47 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.91 1.479 . . . . 0.0 110.601 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -66.66 -35.03 79.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.553 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.644 ' O ' HG13 ' A' ' 19' ' ' VAL . . . -51.3 179.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.499 -0.751 . . . . 0.0 110.075 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -162.45 -39.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.007 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HB3' ' HG3' ' A' ' 25' ' ' GLU . 96.7 mttt -135.44 111.8 9.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 25' ' ' GLU . 11.5 t -45.68 130.6 9.13 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.997 0.903 . . . . 0.0 111.344 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -68.28 -43.09 84.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.02 -1.05 . . . . 0.0 111.377 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.37 92.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.262 -0.899 . . . . 0.0 112.44 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.6 p -147.38 20.11 1.2 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.733 -1.23 . . . . 0.0 111.553 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 21' ' ' CYS . 80.9 tt0 42.38 90.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.661 -0.649 . . . . 0.0 111.767 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.52 ' HG1' ' HH2' ' A' ' 5' ' ' TRP . 2.1 p -69.54 157.6 89.09 Favored Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.365 -0.835 . . . . 0.0 109.237 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.71 -6.58 19.44 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 123.88 1.463 . . . . 0.0 110.752 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' O ' ' HD2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 62.8 66.7 1.22 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.012 -1.055 . . . . 0.0 109.627 -179.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -53.86 -37.95 85.47 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.087 1.572 . . . . 0.0 110.54 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.49 -128.4 9.33 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.4 p -132.77 156.8 46.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.275 -1.132 . . . . 0.0 110.119 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.58 -165.05 36.87 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -131.88 160.77 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -1.112 . . . . 0.0 109.862 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.31 138.82 43.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.32 -0.862 . . . . 0.0 110.08 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.273 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.346 0.593 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.3 pt -127.5 152.06 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.379 -0.826 . . . . 0.0 109.957 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.44 177.13 45.21 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 62.8 m -117.9 131.81 56.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -1.107 . . . . 0.0 110.262 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.44 ' HH2' ' HG1' ' A' ' 26' ' ' THR . 59.1 p-90 -143.36 158.84 43.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.453 -0.779 . . . . 0.0 110.246 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -130.5 148.74 52.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.143 -0.973 . . . . 0.0 110.59 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.4 t -85.31 113.8 21.91 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.145 -0.972 . . . . 0.0 109.689 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -83.06 -14.05 54.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.359 -0.838 . . . . 0.0 110.503 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 78.6 m -61.96 -43.47 98.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.22 -0.925 . . . . 0.0 109.711 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.403 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.2 p -120.83 21.91 11.28 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.368 -0.832 . . . . 0.0 110.925 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.7 mt 54.15 47.6 22.84 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.242 -0.911 . . . . 0.0 111.995 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.403 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 43.9 t -125.94 130.7 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.837 -1.164 . . . . 0.0 110.238 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -97.53 132.46 43.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.071 -1.018 . . . . 0.0 110.218 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.426 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 3.0 m-20 -117.02 127.27 54.01 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.138 -0.976 . . . . 0.0 109.658 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -69.82 170.91 8.34 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.985 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -54.9 -32.54 78.41 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.011 1.532 . . . . 0.0 110.512 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.49 -32.07 73.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.744 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.468 ' C ' HG22 ' A' ' 19' ' ' VAL . . . -64.39 -179.95 0.52 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.395 -0.815 . . . . 0.0 110.412 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.468 HG22 ' C ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -159.94 -42.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 20' ' ' LYS . 62.3 pttt -128.96 114.74 16.81 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.111 0.958 . . . . 0.0 109.141 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.45 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 13.0 t -46.43 132.0 10.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.52 -0.737 . . . . 0.0 111.344 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -64.11 -46.25 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.508 -0.745 . . . . 0.0 111.88 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.36 -41.24 94.03 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.953 -1.092 . . . . 0.0 109.849 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 32.1 p -152.45 80.66 1.24 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 122.032 0.92 . . . . 0.0 109.146 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.45 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 95.5 mt-10 -31.35 94.47 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.374 0.607 . . . . 0.0 112.549 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.44 ' HG1' ' HH2' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -63.97 154.85 80.42 Favored Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.095 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -66.32 -16.47 51.64 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 O-C-N 123.963 1.507 . . . . 0.0 111.228 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 12.8 tttp 50.87 64.31 8.42 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.072 -1.017 . . . . 0.0 109.37 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 19.3 Cg_exo -61.83 145.1 97.33 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.887 1.467 . . . . 0.0 110.546 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.15 162.56 35.35 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.2 m -63.53 -45.78 89.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.192 -1.181 . . . . 0.0 110.773 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.64 171.94 42.48 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.06 132.84 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.348 -1.089 . . . . 0.0 110.352 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -117.11 140.81 49.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.229 -0.919 . . . . 0.0 110.464 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.208 -179.997 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.352 0.596 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 4' ' ' THR . 48.0 pt -125.11 160.94 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.754 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.8 -37.96 95.46 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.453 ' N ' ' HG3' ' A' ' 16' ' ' PRO . 31.2 m -72.28 136.34 46.25 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -1.087 . . . . 0.0 110.984 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 69.2 p-90 -143.54 153.51 42.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -0.971 . . . . 0.0 109.683 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.421 ' HB3' ' HG3' ' A' ' 13' ' ' GLN . 49.3 p-10 -119.99 151.28 39.21 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.936 -1.102 . . . . 0.0 111.148 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.425 ' SG ' HG23 ' A' ' 26' ' ' THR . 13.7 t -94.6 121.21 35.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.093 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -96.85 -14.79 21.61 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.051 -1.031 . . . . 0.0 110.526 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -60.09 -39.02 84.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.052 -1.03 . . . . 0.0 109.892 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 13.7 p -124.83 22.24 8.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.86 . . . . 0.0 111.073 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 10' ' ' CYS . 84.6 mt 56.09 44.9 24.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.511 -0.743 . . . . 0.0 112.007 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.405 ' HB ' ' SG ' ' A' ' 10' ' ' CYS . 47.2 t -126.48 130.16 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.069 -1.02 . . . . 0.0 109.829 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.421 ' HG3' ' HB3' ' A' ' 6' ' ' ASP . 56.7 tt0 -101.24 145.55 28.69 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.043 -1.036 . . . . 0.0 110.17 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -134.12 149.7 51.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.065 -1.022 . . . . 0.0 110.091 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 16' ' ' PRO . 8.6 mttt -82.2 169.73 17.35 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.304 -0.873 . . . . 0.0 109.949 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HG3' ' N ' ' A' ' 4' ' ' THR . 34.3 Cg_exo -56.51 -33.19 91.98 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.091 1.574 . . . . 0.0 110.731 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -65.41 -27.89 68.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 110.011 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.44 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -50.53 178.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.37 -0.831 . . . . 0.0 110.394 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.755 HG12 ' HG3' ' A' ' 20' ' ' LYS . 75.1 t -152.15 -46.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.755 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.7 mttt -139.99 117.86 11.74 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.432 -0.793 . . . . 0.0 109.103 178.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.484 ' N ' ' HA ' ' A' ' 25' ' ' GLU . 18.1 t -45.42 140.06 3.33 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.2 1.0 . . . . 0.0 111.585 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -68.37 -44.49 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.847 -1.158 . . . . 0.0 111.894 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.4 -38.7 85.06 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.173 -0.954 . . . . 0.0 112.358 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 25' ' ' GLU . 20.5 p -147.0 22.36 1.22 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.81 -1.181 . . . . 0.0 111.451 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.484 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 94.6 mt-10 31.54 85.11 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.425 HG23 ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -57.0 156.99 11.9 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.925 . . . . 0.0 109.58 178.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.89 -12.17 34.45 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.885 1.466 . . . . 0.0 111.103 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER 61.23 73.51 0.59 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.09 -1.006 . . . . 0.0 109.765 -179.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.12 -40.46 85.69 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.97 1.51 . . . . 0.0 110.207 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.12 -175.88 54.92 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 83.7 m -112.71 121.22 44.11 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -1.158 . . . . 0.0 109.809 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.18 -15.23 57.98 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.0 t -119.73 132.59 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.052 -1.264 . . . . 0.0 110.303 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -111.78 144.93 40.26 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.216 -0.928 . . . . 0.0 110.429 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.483 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.497 0.665 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.554 HD13 ' O ' ' A' ' 16' ' ' PRO . 18.0 tt -67.55 -36.83 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.823 . . . . 0.0 110.236 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 2' ' ' ILE . . . 70.27 -156.49 53.37 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.3 m -121.52 131.2 54.0 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.035 -1.274 . . . . 0.0 110.631 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.528 ' CH2' ' ND2' ' A' ' 14' ' ' ASN . 52.2 p-90 -135.9 156.48 48.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.082 -1.011 . . . . 0.0 109.829 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.403 ' HB2' ' HG2' ' A' ' 13' ' ' GLN . 46.9 p-10 -124.62 149.01 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.956 . . . . 0.0 110.773 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.526 ' SG ' HG21 ' A' ' 26' ' ' THR . 20.6 t -92.8 120.9 33.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.36 -0.838 . . . . 0.0 110.429 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 44.6 p30 -96.86 -6.08 36.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.821 -1.175 . . . . 0.0 110.279 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.4 m -63.13 -42.39 99.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.167 -0.958 . . . . 0.0 109.409 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.415 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.6 p -125.04 18.14 8.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.535 -0.728 . . . . 0.0 111.35 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 mp 62.95 43.45 6.72 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.217 -0.927 . . . . 0.0 111.767 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.415 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 48.8 t -125.81 134.96 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.263 -0.898 . . . . 0.0 109.917 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.403 ' HG2' ' HB2' ' A' ' 6' ' ' ASP . 79.0 mt-30 -98.41 145.09 27.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.078 -1.014 . . . . 0.0 110.016 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.528 ' ND2' ' CH2' ' A' ' 5' ' ' TRP . 1.7 m-20 -122.47 131.44 53.86 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.093 -1.005 . . . . 0.0 110.466 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -78.08 168.99 22.99 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 110.048 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.554 ' O ' HD13 ' A' ' 2' ' ' ILE . 50.8 Cg_exo -53.97 -33.77 73.98 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.896 1.472 . . . . 0.0 109.911 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.88 -40.27 91.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.142 -0.974 . . . . 0.0 109.904 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.58 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -54.0 -179.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 109.895 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.843 HG12 ' HG3' ' A' ' 20' ' ' LYS . 40.2 t -157.7 -43.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.843 ' HG3' HG12 ' A' ' 19' ' ' VAL . 98.8 mttt -134.49 116.03 14.63 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 25' ' ' GLU . 13.7 t -45.73 131.64 9.03 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.93 0.872 . . . . 0.0 111.946 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.81 -46.27 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.522 -0.736 . . . . 0.0 111.373 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.59 -38.03 88.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.157 -0.965 . . . . 0.0 109.345 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 26' ' ' THR . 30.9 p -153.97 84.52 1.15 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 122.13 0.967 . . . . 0.0 109.242 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 21' ' ' CYS . 92.0 mt-10 -33.07 88.38 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.526 HG21 ' SG ' ' A' ' 7' ' ' CYS . 21.4 p -67.92 147.28 98.5 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.0 . . . . 0.0 109.818 178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 38.2 Cg_endo -73.5 -8.35 21.57 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.862 1.454 . . . . 0.0 110.995 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.44 ' CB ' ' O ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER 66.25 67.15 0.71 Allowed Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.225 -0.922 . . . . 0.0 110.746 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 28' ' ' LYS . 11.5 Cg_exo -68.17 152.35 76.25 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.859 1.452 . . . . 0.0 110.708 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.94 -176.72 50.91 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 92.8 m -116.2 124.16 49.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.01 -1.288 . . . . 0.0 110.971 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.31 173.71 33.06 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 52.3 t -121.24 134.11 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.114 -1.227 . . . . 0.0 109.391 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -62.77 131.84 50.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 110.398 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.852 -1.071 . . . . 0.0 110.219 179.699 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.303 0.573 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.489 HG22 ' HB ' ' A' ' 4' ' ' THR . 34.0 mm -63.66 -44.63 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.505 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.95 20.36 78.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.489 ' HB ' HG22 ' A' ' 2' ' ' ILE . 64.4 m -114.07 133.12 55.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.232 -1.158 . . . . 0.0 110.159 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.491 ' CD1' ' N ' ' A' ' 5' ' ' TRP . 33.3 p-90 -142.37 152.84 43.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 110.516 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.444 ' HB2' ' HG2' ' A' ' 13' ' ' GLN . 43.8 p-10 -118.13 142.79 47.05 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.466 -0.771 . . . . 0.0 110.017 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.4 t -88.97 113.22 24.26 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.17 -0.956 . . . . 0.0 109.689 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 43.3 p-10 -84.98 -8.87 58.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.943 . . . . 0.0 109.94 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -64.46 -44.37 91.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.157 -0.964 . . . . 0.0 110.123 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.404 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -126.03 28.75 6.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 111.306 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt 53.21 42.74 32.12 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.27 -0.894 . . . . 0.0 111.978 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 44.0 t -125.0 134.75 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.785 -1.197 . . . . 0.0 110.696 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' A' ' 6' ' ' ASP . 87.6 mt-30 -103.87 142.49 34.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 0.0 110.183 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 82.3 m-20 -130.43 134.88 47.46 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.023 -1.048 . . . . 0.0 110.302 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.19 169.62 18.42 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.438 -0.789 . . . . 0.0 110.165 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.25 -34.49 88.42 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.958 1.504 . . . . 0.0 110.623 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.82 -32.97 74.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.004 . . . . 0.0 109.766 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -51.52 179.05 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.496 -0.752 . . . . 0.0 109.696 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.888 HG12 ' HG3' ' A' ' 20' ' ' LYS . 39.2 t -156.36 -42.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.139 -0.976 . . . . 0.0 108.773 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.888 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.3 mttt -137.02 115.88 12.25 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.669 0.747 . . . . 0.0 109.309 178.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.652 ' HB2' HG23 ' A' ' 26' ' ' THR . 12.8 t -46.35 132.52 10.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.79 0.805 . . . . 0.0 111.198 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.7 t -65.66 -45.61 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.184 -0.947 . . . . 0.0 111.195 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.94 85.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.959 -1.088 . . . . 0.0 109.757 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.446 ' O ' ' C ' ' A' ' 25' ' ' GLU . 31.8 p -148.97 78.47 1.4 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.762 0.791 . . . . 0.0 109.166 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.504 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 95.5 mt-10 -29.22 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.594 0.712 . . . . 0.0 111.867 -178.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.652 HG23 ' HB2' ' A' ' 21' ' ' CYS . 42.8 p -52.42 154.63 4.25 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.999 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.38 23.21 0.85 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.083 1.57 . . . . 0.0 110.694 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -132.24 93.79 25.1 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.95 -1.094 . . . . 0.0 110.621 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -60.82 145.14 99.44 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.914 1.481 . . . . 0.0 109.637 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.97 169.1 23.91 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.4 m -123.98 129.67 51.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.469 -1.018 . . . . 0.0 110.049 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.54 171.22 53.95 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.1 t -124.03 130.71 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -1.108 . . . . 0.0 109.901 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.89 -41.66 99.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.034 -1.041 . . . . 0.0 109.755 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.2 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.336 0.589 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.87 129.36 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.155 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.51 18.42 71.05 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.7 p -132.73 163.18 29.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -1.199 . . . . 0.0 109.992 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -140.84 156.27 46.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.058 -1.026 . . . . 0.0 110.651 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.423 ' CB ' ' HA ' ' A' ' 13' ' ' GLN . 79.9 m-20 -139.36 154.32 47.84 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.407 -0.808 . . . . 0.0 110.138 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.2 t -89.09 114.23 25.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.158 -0.964 . . . . 0.0 110.285 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -80.66 -18.74 47.09 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.22 -0.925 . . . . 0.0 110.494 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.1 m -61.67 -44.6 96.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.206 -0.934 . . . . 0.0 110.71 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 14.0 p -118.89 26.3 9.62 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.106 -0.996 . . . . 0.0 111.033 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 37.2 tp 48.27 56.39 7.48 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.324 -0.86 . . . . 0.0 111.224 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.419 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 28.9 t -130.16 133.51 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.005 -1.06 . . . . 0.0 110.088 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.423 ' HA ' ' CB ' ' A' ' 6' ' ' ASP . 84.4 mt-30 -101.05 133.69 45.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 110.103 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 78.6 m-20 -128.98 119.69 24.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.04 -1.038 . . . . 0.0 109.713 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.55 174.74 2.34 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 110.303 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -56.2 -30.55 80.3 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.166 1.614 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -62.38 -37.52 86.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.875 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.518 ' C ' HG23 ' A' ' 19' ' ' VAL . . . -54.22 -174.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 110.031 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.763 HG12 ' HG3' ' A' ' 20' ' ' LYS . 80.7 t -155.67 -46.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.763 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.7 mttt -140.9 120.94 13.69 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.674 0.75 . . . . 0.0 109.047 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.726 ' HB2' HG23 ' A' ' 26' ' ' THR . 9.7 t -46.36 130.09 10.66 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.697 0.76 . . . . 0.0 111.017 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.49 -46.02 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.25 -0.906 . . . . 0.0 111.64 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.5 -41.47 96.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.97 -1.081 . . . . 0.0 109.75 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.43 ' O ' ' C ' ' A' ' 25' ' ' GLU . 32.1 p -153.57 80.77 1.17 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 122.068 0.937 . . . . 0.0 109.036 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.464 ' HA ' ' N ' ' A' ' 21' ' ' CYS . 96.5 mt-10 -30.3 93.3 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.544 0.688 . . . . 0.0 112.432 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.726 HG23 ' HB2' ' A' ' 21' ' ' CYS . 51.8 p -54.94 157.99 5.12 Favored Pre-proline 0 N--CA 1.49 1.543 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.492 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -77.58 4.73 5.74 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.909 1.478 . . . . 0.0 111.261 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -88.32 115.22 62.6 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.794 -1.192 . . . . 0.0 110.391 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -61.64 146.6 96.69 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.579 1.305 . . . . 0.0 110.213 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' CA ' ' HA ' ' A' ' 19' ' ' VAL . . . -65.26 160.22 43.41 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.7 p -133.83 160.11 38.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -1.103 . . . . 0.0 110.445 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.76 17.39 72.96 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.0 t -124.6 131.6 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.059 -1.259 . . . . 0.0 110.378 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -81.71 146.08 30.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.236 -0.915 . . . . 0.0 109.923 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.27 -179.898 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.235 0.54 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.0 mm -107.97 126.78 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.964 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.61 172.46 54.98 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.529 HG22 ' HD3' ' A' ' 16' ' ' PRO . 82.6 p -81.52 162.4 23.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -1.142 . . . . 0.0 110.021 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 46.9 p-90 -146.65 155.06 42.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.95 . . . . 0.0 110.875 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -135.88 149.57 49.04 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.242 -0.911 . . . . 0.0 109.778 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.408 ' N ' ' O ' ' A' ' 12' ' ' VAL . 8.2 t -87.44 120.29 28.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.979 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -95.09 -6.02 42.95 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.254 -0.904 . . . . 0.0 110.759 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.3 p -74.7 -21.29 59.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.913 -1.117 . . . . 0.0 109.941 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.418 ' SG ' ' CG2' ' A' ' 12' ' ' VAL . 13.7 p -141.15 20.87 2.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.693 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt 54.82 58.37 4.87 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.413 -0.804 . . . . 0.0 111.592 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.557 HG11 ' SG ' ' A' ' 21' ' ' CYS . 27.3 t -131.63 135.94 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.899 . . . . 0.0 110.247 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -103.14 134.05 47.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.447 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 94.9 m-20 -134.66 116.41 14.92 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.062 -1.024 . . . . 0.0 110.494 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.52 176.66 1.55 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.0 110.496 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.529 ' HD3' HG22 ' A' ' 4' ' ' THR . 35.4 Cg_exo -54.23 -32.02 69.0 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.936 1.492 . . . . 0.0 110.321 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.51 -35.73 81.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 110.607 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.558 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -60.35 176.69 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.096 -1.002 . . . . 0.0 110.5 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.729 HG12 ' HG3' ' A' ' 20' ' ' LYS . 44.9 t -156.66 -43.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.325 -0.859 . . . . 0.0 109.23 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.729 ' HG3' HG12 ' A' ' 19' ' ' VAL . 99.5 mttt -128.28 106.86 9.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.487 -0.758 . . . . 0.0 109.716 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.557 ' SG ' HG11 ' A' ' 12' ' ' VAL . 15.9 t -45.91 135.16 7.42 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.063 0.935 . . . . 0.0 111.253 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.93 -43.33 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.192 -0.942 . . . . 0.0 111.038 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.27 89.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.355 -0.841 . . . . 0.0 112.187 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 25' ' ' GLU . 23.1 p -155.83 25.25 0.38 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.939 -1.1 . . . . 0.0 111.104 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 21' ' ' CYS . 97.9 mt-10 33.96 93.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.424 0.63 . . . . 0.0 111.952 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.484 HG23 ' HD2' ' A' ' 27' ' ' PRO . 86.5 m -64.49 146.01 98.26 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 110.219 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.484 ' HD2' HG23 ' A' ' 26' ' ' THR . 58.5 Cg_endo -80.7 44.21 1.7 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.927 1.488 . . . . 0.0 110.694 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -48.17 -58.25 8.47 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.18 -0.95 . . . . 0.0 110.466 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 28' ' ' LYS . 29.6 Cg_endo -66.51 154.73 73.25 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.585 1.308 . . . . 0.0 110.438 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.8 18.4 61.61 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 74.4 m -62.49 -44.7 95.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.066 -1.255 . . . . 0.0 110.025 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -175.33 -171.94 39.77 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 34' ' ' LYS . 24.3 m -63.6 -40.68 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -1.088 . . . . 0.0 110.154 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.53 ' N ' HG23 ' A' ' 33' ' ' VAL . 87.2 tttt -67.88 131.32 45.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 0.0 109.824 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.076 -1.015 . . . . 0.0 110.332 -179.616 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_